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ABSTRACT
This study describes the previous and current prevalence of medical diseases affecting 
geriatric cats in a referral population. Abnormalities of circulating thyroxine (T4) 
concentrations are described in sick cats and a simplified approach to treatment of 
hyperthyroidism with radioactive iodine (13 *1) evaluated.
There was an increase in the number of cats presented at Glasgow University 
Veterinary School from, 417 between 1970 and 1972, to 835 between 1990 and 1992. 
Of these, 57 (13.7 %) cats of five years of age or over were referred as medical cases in 
the former time period, whereas 162 (19.4 %) were referred in the latter period. The 
most common disorders recognised between 1970 and 1972 were systemic neoplasia 
(21.1 %), gastrointestinal disease (19.3 %) and renal disease (8.8 %). The most common 
disorders diagnosed between 1990 and 1992 were hyperthyroidism (51.2 %), systemic 
neoplasia (10.5 %), viral infections (8.0 %) and renal disease (3.7 %). There was no 
conclusive clinical evidence of hyperthyroidism in cats between 1970 and 1972. 
Geriatric cats examined between 1970 and 1972 were significantly (P < 0.001) younger 
(mean ±sd, 8.4 +4.0 years) than those seen between 1990 and 1992 (11.7 +3.3 years). 
Cats may now be living longer; the emergence of hyperthyroidism may be related in part 
to this increased longevity.
A pre-precipitated total T4 antibody radioimmunoassay kit and a free T4 
equilibrium dialysis kit were validated for use with cat serum The mean +sd (reference 
range) serum total T4 concentration in healthy cats (n = 50) was 26.00 +7.62 (10.75 - 
41.25) nmol/1. The serum free T4 concentration (n = 38) was 24.79 +8.33 (8.14 - 41.45) 
pmol/1. The calculated free T4 fraction was 0.10 +0.06 (range, 0.04 - 0.37) %.
In cats with non-thyroidal illnesses (n = 107), serum total T4 concentrations (mean 
+sd, 17.35 +8.49; range, 2.00 - 45.33 nmol/1) were significantly (P < 0.001) lower than 
in healthy cats. There was a significant (P < 0.001) inverse correlation between mortality 
and serum total T4 concentrations. Serum free T4 concentrations (mean +sd, 27.70 
+13.53; range 1.52 - 75.54 pmol/1) were not significantly (P > 0.05) different compared 
to healthy cats. Three cats (3.1 %) had serum free T4 concentrations below the reference 
range. Corresponding serum total T4 concentrations were also depressed. Twelve cats 
(12.2 %) had serum free T4 concentrations above the reference range. Corresponding 
serum total T4 concentrations tended to remain within the reference range. The 
calculated free T4 fraction in the sick cats (mean +sd, 0.24 +0.30; range, 0.06 - 2.10 %) 
was significantly (P < 0.001) elevated compared to healthy cats.
Serum total T4 concentrations (mean +sd, 164.02 +102.10; range, 39.69 - 575.57 
nmol/1) were significantly (P < 0.001) higher in hyperthyroid (n = 95) compared to 
healthy cats. The serum total T4 concentration was not diagnostically elevated in three 
(3.2 %) hyperthyroid cats. The specificity, sensitivity and efficiency of serum total T4 
estimations for diagnosing hyperthyroidism in this population were 100, 96.9 and 98.5 
%, respectively. Serum free T4 concentrations (mean +sd, 233.32 + 177.08; range, 46.88 
- 687.61 pmol/1) were significantly (P < 0.001) higher in hyperthyroid (n = 26) compared 
to healthy cats. The serum free T4 concentration was not diagnostically elevated in one 
(3.8 %) hyperthyroid cat. The specificity, sensitivity and efficiency of this test were 93.9,
96.2 and 94.4 %, respectively. There was a highly significant correlation (r = 0.92, P <
0.001) between serum total and free T4 concentrations in the healthy and hyperthyroid 
cats. There was no significant (P > 0.05) difference in free T4 fractions between 
hyperthyroid (mean +sd, 0.11 +0.04; range, 0.07 - 0.25 %) and healthy cats.
A simple method of 13 4  dose estimation was devised based on clinical severity of 
the thyrotoxicosis, serum total T4 concentration and size of goitre. The mean +sd dose 
of 13 l i  administered to 50 cats was 143 +24 MBq. The treatment was effective in 47 
(94 %) cats. There was no significant (P >0.05) difference in the outcome between cats 
in which 13 l l  was injected intravenously (n = 27) or subcutaneously (n = 23).
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CHAPTER 1 
INTRODUCTION
1.1 BACKGROUND
Interest in the field of small animal geriatrics or gerontology has recently increased 
(Goldston, 1989). Despite this, there are few reports detailing the categories of disease 
and their prevalence in the older cat. In 1968, Griffiths surveyed diseases affecting cats 
over eight years of age presented to 10 veterinary practices in a six month period. Given 
the major advances in feline medicine, the numerical increase in the cat population and 
the probable increase in the proportion of aged cats since 1968, this report is outdated. 
Notably, feline hyperthyroidism (thyrotoxicosis) was first definitively diagnosed in 1979 
by Cotter and by Peterson, Johnson & Andrews but was not known to exist prior to this 
date. The reasons for the emergence of hyperthyroidism remain obscure but may be 
related to a previous lack of awareness of the disease or to a longer average life span for 
cats (Peterson, Randolph & Mooney, 1994).
Since the emergence of feline hyperthyroidism as a common disease, there has been 
increasing interest in thyroid hormone concentrations and associated abnormalities in the 
cat. To date, the concentrations of circulating total (protein-bound and free) 3,5,3',5'- 
tetraiodothyronine (thyroxine (T4)) and total 3,5,3-triiodothyronine (T3) in euthyroid 
and hyperthyroid cats have been clearly defined (Peterson, Kintzer, Cavanagh, Fox, 
Ferguson, Johnson & Becker, 1983b; Thoday, Seth & Elton, 1984; Mooney, 1990; 
Thoday & Mooney, 1992). However, a paucity of information exists regarding 
circulating free T4 concentrations in euthyroid and hyperthyroid cats and in cats with 
non-thyroidal illnesses.
In humans, it is recommended that serum free T4 concentrations are measured by 
the techniques of equilibrium dialysis or ultrafiltration, but interpreted with caution if 
other methods are used (Ekins, 1985). Absolute serum free T4 concentrations are 
assessed either directly, or indirectly by measurement of the free T4 fraction and 
subsequent calculation from serum total T4 concentrations. Refetofif, Robin & Fang 
(1970) suggested that the serum free T4 concentration in warm blooded vertebrates is 
relatively constant despite variations in serum total T4 concentrations between species. 
This theory has generally been extrapolated for the cat but confirmed in only a small 
number of cases. Hays, Turrel & Broome (1988) estimated the free T4 fraction by 
equilibrium dialysis in five healthy cats but the absolute concentrations were not 
reported. Ferguson, Peterson & Nachreiner (1989) measured the absolute serum free T4 
concentration by equilibrium dialysis in 28 healthy cats, but the free T4 fraction was not 
calculated.
In man, the presence of severe non-thyroidal illness has a profound effect on 
circulating thyroid hormone concentrations (Wartofsky & Burman, 1982). Serum total 
T4 concentrations are markedly depressed, but serum free T4 concentrations generally
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remain within the reference range, are occasionally elevated but rarely depressed. Serum 
total T4 concentrations are also depressed in the presence of non-thyroidal illness in the 
dog (Ferguson, 1988). At the time of commencement of this study, there were no 
reports on the effect of non-thyroidal illness on serum total T4 concentrations in the cat. 
During the course of the study, Peterson & Gamble (1990) reported that serum total T4 
concentrations were depressed in cats with non-thyroidal diseases. However, there are 
no conclusive reports on the effect of illness on corresponding serum free T4 
concentrations.
A diagnosis of feline hyperthyroidism is confirmed by the demonstration of an 
elevated serum total T4 concentration. Occasionally hyperthyroid cats have serum total 
T4 concentrations below the diagnostic range (Peterson, Graves & Cavanagh, 1987). In 
humans, serum free T4 concentrations are more consistently elevated and provide a 
better indication of the degree of hyperthyroidism (Woeber, 1986). Ferguson, Peterson 
& Nachreiner (1989) measured serum free T4 concentration in 25 hyperthyroid cats and 
suggested that its measurement provided no additional information over measurement of 
serum total T4 concentrations alone. Hays, Turrel & Broome (1988) reported that the 
free T4 fraction is similar in healthy and hyperthyroid cats, although only six 
hyperthyroid cases were examined. There are no reports comparing serum free T4 
concentrations in hyperthyroid cats and cats presenting with non-thyroidal illness.
Hyperthyroidism is effectively treated by surgical thyroidectomy or the use of 
antithyroid drugs. However, administration of radioactive iodine is considered to be the 
safest, simplest and most effective method of controlling hyperthyroidism (Peterson & 
Turrel, 1986). The calculation of a therapeutic dose of radioactive iodine has previously 
relied on tracer kinetic studies and the use of sophisticated computerised nuclear 
medicine equipment. The administration of standard fixed doses, although applicable, 
have resulted in under or over treatment of a number of animals. Where the success of 
radioactive iodine therapy has been reported, it was recognised that the efficacy was 
often related to the size of the thyroid gland, circulating serum total T4 concentrations 
and clinical severity of the thyrotoxicosis. During the course of this study, Jones, 
Cayzer, Dillon & Smidt (1991) reported that the required dose of radioactive iodine for 
each cat could be effectively calculated from these parameters. However, although a 
grading system was provided for the size of the goitre and the clinical severity of the 
disease, no grading regimen was provided for serum total T4 concentrations, so that 
their work is difficult to reproduce. In addition, radioactive iodine has usually been 
administered intravenously, there are no studies reporting its efficacy when administered 
subcutaneously.
1.2 PROJECT AIMS
The present study was carried out against this background; the aims were as follows
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To assess the changing trends in diseases affecting geriatric cats, by 
establishment of a medical referral clinic dedicated to older cats, and by 
reviewing case records from a similar time period 20 years ago.
To determine if any animals exhibited clinical features consistent with a 
diagnosis of hyperthyroidism by a retrospective study of the feline case 
records.
To assess the possibility that the emergence of hyperthyroidism is age 
related by an analysis of the ages at which cats were presented.
To fully validate a recently developed equilibrium dialysis kit method 
for use with cat serum and to assess absolute serum free T4 
concentrations in healthy cats.
To calculate the free T4 fraction by measurement of corresponding 
serum total T4 concentrations, and thereby provide a complete 
standard base for subsequent comparison purposes.
To assess the alterations in serum total and free T4 concentrations and 
the calculated free T4 fraction in sick cats with a variety of non- 
thyroidal diseases.
To compare the efficiency of serum total and free T4 estimations for 
the diagnosis of hyperthyroidism, particularly in comparison to cats 
with non-thyroidal diseases.
To devise a simple and reproducible method of dose estimation for 
radioactive iodine therapy based on the clinical severity of the 
thyrotoxicosis, circulating total T4 concentration and size of goitre 
estimated by palpation.
To assess the efficacy of therapy comparing intravenous and 
subcutaneous routes of isotope administration.
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CHAPTER 2 
GENERAL MATERIALS AND METHODS
2.1 CLINICAL MATERIAL
The case material comprised a series of cats with a variety of medical illnesses referred 
by veterinary practitioners to the author at the Small Animal Clinic, University of 
Glasgow Veterinary School. Using the Jarrogate data-base system (University of 
Glasgow), each cat was assigned a case number with the inclusion of breed, sex, age, 
name and owner details. Relevant historical details were recorded and a full physical 
examination carried out. In almost all cases, blood was obtained by jugular venepuncture 
from conscious animals. The blood was collected into plain tubes for thyroid hormone 
assay, potassium ethylenediamine tetraacetic acid (EDTA) tubes for haematological 
examinations, lithium heparin tubes for routine biochemical and viral examinations and 
flouride oxalate tubes for glucose estimation. Haematological, biochemical and viral 
examinations were carried out within 24 hours of sampling. After clot retraction, serum 
was harvested by centrifugation and stored at -20°C for future thyroid hormone assay. 
Further diagnostic tests, including radiography, electrocardiography, ultrasonography 
and biopsy were carried out as necessary. A diagnosis was subsequently made based on 
these findings, and in relevant cases was supplemented by post-mortem examination.
2.2 HAEMATOLOGICAL PARAMETERS
A full blood count was obtained using an ABX Minos ST Vet (Roche) haematology 
analyser. Buffered saline was used as a diluent and potassium cyanide as a lysing agent 
as described by the manufacturer. The parameters evaluated included red and white cell 
and platelet counts, haemoglobin concentration and haematocrit. For the differential 
white cell count, blood films were fixed and stained with a standard May-Grunwald- 
Giemsa stain, and 200 cells counted under oil immersion microscopy.
2.3 BIOCHEMICAL PARAMETERS
Plasma concentrations of urea, creatinine, phosphate, cholesterol, bilirubin, alkaline 
phosphatase (AP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), 
lactate dehydrogenase (LDH) and glucose were measured using commercial reagent kits 
on a Cobas MIRA (Roche) clinical chemistry analyser. The commercial reagent kits, 
manufacturers and their methods are listed in Table 1.
Plasma concentrations of sodium and potassium were measured by atomic emission 
using a Flame Photometer 543 (Instrumentation Laboratories). Plasma concentrations of 
calcium and magnesium were measured by atomic absorption using an Atomic 
Absorption 257 Spectrophotometer (Instrumentation Laboratories). Plasma chloride
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concentrations were measured coulormetrically using a Chloride Meter 925 (Coming 
Limited).
Plasma total protein concentrations were measured by a modified biuret reaction 
with blank correction and albumin by a bromocresol green automated method on a 
Technicon Auto Analyser AAII (Technicon Instruments Corporation). Plasma globulin 
concentrations were estimated by subtraction of albumin from total protein 
concentrations.
Quabty assurance was guaranteed using commercially available control sera 
(Precipath U and Precipath EL, Boehringer Mannheim GmbH). Quabty control was 
monitored by the Scottish Quabty Assessment Scheme and UKEQAS for general clinical 
chemistry.
Serum total and free T4 concentrations were assayed as described in Chapter 4.
2.4 VIRAL EXAMINATIONS
Feline leukaemia virus (FeLV) status was assessed by the demonstration of p27 antigen 
using a commercial enzyme-linked immunosorbent assay (ELISA) (Petcheck FeLV 
antigen detection kit, IDEXX Laboratories). If positive, virus isolation in ceb culture 
was carried out using an in-house technique. Feline immunodeficiency virus (FIV) 
infection was based on demonstrating the presence of FIV-specific antibodies using a 
commercial ELISA (Petcheck FIV detection kit, IDEXX Laboratories). Samples were 
screened for feline coronovirus (FCoV) antibodies by an in-house indirect 
immunofluorescence assay.
2.5 STATISTICAL ANALYSES
AU statistical analyses, unless stated otherwise, were computed using the Statistix 
Version 4.0 (Analytical Software) package. This package was also used for the box and 
whisker plots. The level of significance was taken as P < 0.05.
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Parameter Reagent kit Method
Urea Unimate 5 UREA, Roche Enzymatic UV test with urease and 
glutamate-dehydrogenase
Creatinine TO 1-1927-02, Technicon Enzymatic UV test with picric acid
Phosphate Unimate 7 PHOS, Roche UV test with phosphomolybdate
Cholesterol Unimate 7 CHOL, Roche Enzymatic colorimetric test with 
cholesterol esterase, cholesterol oxidase 
and a peroxidase catalyzed indicator 
reaction
Bilirubin Bilirubin Test, Roche 4-sulfobenzenediazonium chloride 
(Jendrassik-Grof) reaction
AP Unimate 3 ALP DGKC, Roche Kinetic colorimetric test with 4- 
nitrophenyl phosphate
ALT Unimate 5 ALT, Roche Kinetic UV test with L-alanine and NADH
AST Unimate 5 AST, Roche Kinetic UV test with L-aspartate and 
NADH
LDH MA-KIT 10 LDH SFBC, Roche Kinetic UV test with pyruvate and NADH
Glucose Unimate 7 GLUC PAP, Roche Enzymatic colorimetric test with glucose 
oxidase and a peroxidase catalyzed 
indicator reaction
UV, ultraviolet
NADH, nicotinamide adenine dinucleotide
Table 1. Commercial reagent kits, manufacturers and methods used for analysing 
biochemical parameters on the Cobas MIRA (Roche) clinical chemistry analyser.
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CHAPTER 3
AN INVESTIGATION INTO DISEASES OF GERIATRIC CATS: 
CURRENT AND PREVIOUS TRENDS
3.1 LITERATURE REVIEW
The aged cat
Ageing in itself is not a disease, but is a normal and complex biological process resulting 
in the progressive reduction of an individuals ability to maintain homeostasis under 
internal physiological and external environmental stresses. This decreases the subject's 
viability, increases its vulnerability to disease and eventually causes its death (Goldston, 
1990).
In humans, the theory of ageing and attempts to retard its progress are important 
areas of research. There is a general consensus that ageing does not have a single cause, 
but is the result of a multitude of parallel and interacting processes that combine to 
ensure eventual decrepitude (Rusting, 1992). There are two main theories of ageing, 
both propose that these processes are genetically controlled (Partridge & Barton, 1993). 
The optimality explanation suggests that survival and fertility late in life are sacrificed for 
the sake of early reproduction and survival. The mutational explanation suggests that 
senescence has evolved because of a greater mutation load on the later, and less strongly 
selected, part of the life history (Partridge & Barton, 1993).
The internally controlled ageing process would eventually lead to death even in the 
absence of accidents, violence and infections. If ageing were retarded, this might delay 
much of the cancer, heart disease and other disabling conditions to which adults become 
increasingly vulnerable as they grow older (Rusting, 1992). The average person bom in 
an industrialised nation today can expect to five approximately 75 years, whereas for 
most of history, life expectancy was closer to 30 or 40 years (Rusting, 1992). This 
increase is not related to modification of the ageing process but to changes in the 
environment including improved nutrition and the ability to control major infectious 
diseases by sanitation, vaccines and therapeutic agents.
Similar factors have produced longevity changes in the domestic cat population. 
Improved veterinary care and more advanced preventive measures, balanced nutrition 
and responsible ownership means that pets on average live longer (Kitchell, 1989). There 
are few vital statistics for cats currently available. Flower (1931) reported average 
longevity in the cat to be 14 to 15 years and Mellen (1940) reported it as approximately 
14 years. Comfort (1956) investigating maximum ages reported 29 cats between 19 and 
35 years old and suggested the cat to be the longest lived of the small domestic animals 
living in exceptional cases for 25 to 30 years. Morris (1994) reported that one cat was 
known to live to be 36 years of age. Griffiths (1968) studied 608 cats of eight years of 
age or over and found a marked reduction in the number of survivors after nine years of 
age in males and 10 to 11 years in the female. The author concluded that as in most
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other species, the male cat is shorter-lived than the female. Morris (1994) reported a 
recent estimate indicating approximately 37 % of cats in the USA are over six years old. 
The cat population in the UK for 1993 was estimated at 7.05 million (Petfood 
Manufacturers Association Profile), thus about 2.6 million could be in excess of six 
years.
A recent survey undertaken by Diplomates of the American Colleges of Veterinary 
Internal Medicine, Veterinary Surgery, Veterinary Pathologists and the American Board 
of Veterinary Practitioners attempted to define the age at which cats were considered 
geriatric or most likely to suffer diseases associated with ageing (Goldston, 1990). The 
mean ± standard deviation (sd) age was reported as 11.88 +1.94 years. In the same 
survey the age at which dogs were considered geriatric varied depending on size but no 
such differentiation was noted for cats. However, Siamese cats were considered to have 
longer, and Persian cats shorter life spans. The survey also mentioned several other 
factors affecting longevity, although these factors were not differentiated by species and 
possible reasons were not included. Obese pets had a decreased longevity, and animals 
maintained strictly on balanced commercial diets lived longer than animals fed random 
table scraps. Feeding high fat and/or low fibre diets decreased life expectancy. Outdoor 
animals had shorter life expectancies than animals living indoors and neutered animals 
lived longer than entire animals. However, it is more practical to consider any animal 
over five years old at risk from age-associated changes or diseases with a definite age 
predisposition. Indeed Johnson & Mitzner (1989) in discussing the establishment of a 
geriatric programme in practice suggested that all pets over five or six years of age be 
selected as the nucleus of the programme.
The effects of ageing in the cat
There is limited information available regarding the normal physiological changes that 
occur in the aged dog and even less in the aged cat. Information is generally 
extrapolated from other species, primarily rats, mice and humans. The following 
description is largely taken from publications reviewing specific ageing changes of these 
species pertinent to, but rarely proven for the dog or cat (Mosier, 1981, 1989; Ross, 
1989; Goldston, 1990; Mooney, 1991, 1993). Where information is available on the cat 
or dog, it is added.
In humans, there is a curvilinear decline in the resting metabolic rate with 
advancing age (Poehlman, 1992). Both total daily energy expenditure and energy intake 
decline with age. However, they do not decline proportionally, giving rise to a distortion 
in energy balance characterised by obesity or excessive leanness (Poehlman, 1992). This 
has not been addressed in the cat but Morris (1994) suggested a similar pattern in this 
species. Thus, as the metabolic rate decreases, and activity is reduced, the caloric need is 
decreased by up to 40 % in the last one third of normal life span.
The proportion of body fat to lean body mass increases and muscle, bone and 
cartilage mass decreases. The capacity for thermoregulation decreases due in part to
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decreased heat production and to slow or less pronounced peripheral vasomotor 
reactions. Sensitivity to thirst decreases due a decrease in the number of osmoreceptors 
in the lateral superior hypothalamus and the development of arterio-capillary fibrosis. 
Sleep becomes more intermittent and the animal more restless. There is a loss of 
fastidiousness in excretory habits and a change in mental alertness. Generally there is a 
reduced reaction to stimuli and partial loss of the sensations (vision, hearing, taste and 
olfaction).
Few consistent age-related changes in the gastrointestinal system have been 
reported. Hepatic cell numbers decrease, together with a mild increase in fibrous tissue 
and fat accumulation. Hepatic function decreases and biliary and intestinal secretions 
decrease. There is a reduced rate of intestinal epithelial cell renewal. While these factors 
may suggest that the digestive system of older animals is less efficient, Morris (1994) 
argued that because of considerable reserve there may be no apparent loss of function 
unless seriously compromised.
The high incidence of atherosclerosis and hypertension contribute significantly to 
data on age-associated cardiovascular changes in humans. Since these are relatively 
uncommon in cats, Ross (1989) questioned the extrapolation of such data to the cat. 
Valtonen & Oksanen (1972) found that histopathological evidence of arteriosclerosis in 
45 (77.6 %) of 58 dogs correlated with age and with endocardiosis, but the latter is an 
infrequent problem in cats. Baroreflex activity, blood volume, blood pressure, cardiac 
output and circulation time are decreased in the aged dog (Dodman, Seeler & Court, 
1984). However, in the resting state, it is likely that heart function is not significantly 
different in the aged patient. If stressed, diminshed cardiovascular responsiveness to 
beta-adrenergic stimulation may become apparent (Maher & Rush, 1990).
Pulmonary function deteriorates progressively with increasing age in the dog 
(Dodman, Seeler & Court, 1984). This is attributable to physical changes that occur in 
both the lungs and chest wall. There is a decrease in lung elasticity, diffusion capacity, 
and pulmonary capillary blood volume (Robinson & Gillespie, 1973, 1975). Evaluation 
of thoracic radiographs of old dogs often reveals fibrosis, and bronchial and chondral 
cartilage calcification which presumably contribute to reduced ventilatory function 
(Dodman, Seeler & Court, 1984). There is an increase in the viscosity of lung secretions 
and a possible decrease in protective airway reflexes.
Renal changes associated with ageing are manifested by significant structural and 
functional alterations (Allen & Roudebush, 1990). The functional changes include 
decreased renal blood flow and glomerular filtration rate, a reduced ability to concentrate 
urine and to maintain sodium, water and acid-base homeostasis. There is an alteration in 
the distribution of vascular flow from the cortex towards the medulla. Structural changes 
include a decrease in the weight and volume of the kidney. The number of glomeruli 
decrease with an increasing percentage of sclerotic and abnormal glomeruli. The renal 
tubules decrease in number and proximal tubule volume and length decrease. 
Nephrosclerosis of varying severity, has been reported as a frequent morphologic
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abnormality of geriatric dogs without biochemical evidence of renal insufficiency 
(Cowgill & Spangler, 1981).
Immunocompetence declines with increasing age leading to a decreased ability to 
ward off infections and an increased incidence of immune-mediated diseases. The 
leucocyte response is reduced with decreased chemotaxis and phagocytosis. In addition, 
the immune system may be less able to perform surveillance and eradication of neoplastic 
clones of cells in the early stages of the disease, thus allowing tumours to become 
established (Kitchell, 1989). As a rule the incidence of cancer increases with age and in 
general this is true for the cat (Kitchell, 1989). However, the age distribution of 
lymphoreticular malignancies is bimodal because of a peak associated with the early 
onset of cancer in cats infected with FeLV (Schneider, 1983). In addition, a notable 
finding in cats is that approximately 80 % of tumours are malignant (Carpenter, 
Andrews, Holzworth, Averill, Harbison & Moore, 1987).
Age-related reproductive changes are unique in the cat. In comparison to other 
species, queens do not generally lose their ability to reproduce with age. However, after 
six years of age, reproductive efficiency of queens generally declines as measured by 
inter-oestrus interval, litter size, incidence of congenital defects and frequency of 
problems during parturition (Harman & Talbert, 1985). Tom cats appear to have a 
reproductive life at least as long as queens (Ross, 1989).
In general terms, ageing results in or occurs simultaneously with the progressive 
and irreversible loss of organ reserve, regenerative powers of organ function, and 
adaptability (Mosier, 1989). Morris (1994) summarised the ageing process as a loss of 
functional units: neurones in the nervous system, nephron numbers in the kidney, ciliated 
epithelial cells in the respiratory tract; bone mass decreases and the functional ability of 
individual units is decreased. In themselves these changes will ultimately lead to clinical 
disease. Moreover, in the aged patient overt organ failure can also be precipitated when 
the patient is in a poor state of nutrition, when the environment is changed or where 
stress, of any form, is applied (Mosier, 1989). Mosier (1981) stated that recovery from 
disease takes 24 additional hours for each five years of age.
Diseases of the aged cat
Several recent articles have focused specifically on diseases of the aged cat including 
renal failure (Rubin, 1989), hyperthyroidism (Meric, 1989), neoplasia (Kitchell, 1989; 
Gorman, 1990), chronic respiratory diseases (Ford, 1990), diabetes mellitus (Wol£ 
1989), and skin diseases (Halliwell, 1990). A contemporary edition of the Veterinary 
Clinics of North America focused entirely on geriatrics and gerontology (Goldston, 
1989). Any current textbook on diseases of the cat provides age predispositions if 
applicable. However, there is only one report surveying disease conditions affecting the 
older cat (Griffiths, 1968).
Griffiths' (1968) survey represented an analysis of 608 cats over eight years of age 
seen during a six month period in 10 practices in the UK Of these cats, 339 were male
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(314 castrated and 25 entire) and 263 were female (238 ovariohysterectomised and 25 
entire). Of the remaining six cases, the sex was not recorded. The preponderance of 
males was suggested to be due to the preference of so many people for male kittens. In 
all of the cases presented, a diagnosis was made on the basis of clinical examination or 
subsequently by post-mortem examination. The average age of the males which died or 
were euthanased in a terminal condition was 12 years and that of the females was 13 
years.
Neoplasia occurred in 72 cats. The incidence of all other conditions was reported 
for the remaining 536 cases excluding neoplasia. The commonest conditions 
encountered, other than neoplasia were those of the respiratory system (14 % of clinical 
cases), teeth and gums (12 %), skin (12 %) and ears (9 %). The actual numbers of cats in 
each of these categories were not recorded. These conditions had a respective mortality 
of 9, 2, 0 and 11 %. Trauma from various causes accounted for 50 (9 %) of the cases 
presented. The most common were wounds or abscesses caused by bites, and these were 
twice as frequent in the male (8 % of clinical cases) as in the female (4 %). All of these 
cases survived. In addition, injuries due to accidents were seen in 17 (3 %) cases. Of 
these nine were probably caused by road accidents and the associated mortality rate was 
24 %.
Disorders of the digestive tract were not considered to be a serious problem in the 
elderly cat. Only 21 (4 %) cases were presented, of which 14 were of constipation or 
colonic impaction. Diarrhoea was only noted in four cases and hairball and gastritis was 
diagnosed in three cases. All of these cats survived. Liver disease was noted in 12 (2 %) 
cats and was detected either by the presence of jaundice or on post-mortem examination. 
Nine (75 %) of these cases died or were euthanased. Nephritis was diagnosed in live 
animals in 23 cases and was certified as the primary cause of death in 23 further cases 
giving a total incidence of 9 %. A diagnosis of diabetes mellitus was made in only three 
cases (1 %). In one case, insulin therapy was instituted. One case was controlled by oral 
medication and the third case was presented in a terminal condition.
Twenty-five (5 %) cats were presented with nervous signs of which 10 were 
affected by "stroke", all of them over 10 years of age. Nine had paralytic conditions or 
paraplegia and six were affected with convulsions. Accurate diagnoses were not made 
and the associated mortality for this group was 63 %.
Neoplasia was the commonest cause of death in the survey. Investigation into the 
cause of death was possible in 138 cases, and neoplasia was implicated in 56 (41 %) 
cases. This represented more than twice the number of deaths due to nephritis (17 %), 
which was the next most common condition. In total, 72 neoplastic conditions were 
diagnosed giving an associated mortality for neoplasia of 77 %. The most common 
neoplastic condition was lymphosarcoma, accounting for 25 cases. None of these cases 
had been confirmed in the live animal. The remaining neoplasms were associated with 
the mouth and oropharynx (number of observations (n) = 12), liver (n = 8), ear (n = 6), 
digestive tract (n = 4), urogenital system (n = 2), mammary tissue (n = 6), labial
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granuloma (n = 2), bone (n = 1) and others (n = 6). No further details on these tumours 
were reported. The incidence of neoplastic conditions by age were 10 % in cats of eight 
years, 10 % in cats of nine to 11 years, 29 % in cats of 12 to 14 years and 29 % in cats 
of 15 years or over.
Advances in feline medicine
Since the survey reported by Griffiths in 1968, several advances have occurred in feline 
medicine. Ancillary diagnostic aids are now more widely and routinely available 
including haematology, blood biochemistry and radiography. The existence of FeLV and 
its relationship to disease was discovered prior to 1968 (Jarrett, Martin, Crighton, Dalton 
& Stewart, 1964a; Jarrett, Crawford, Martin & Davie, 1964b), but testing for its 
presence, now routinely made, was only rarely performed. Holzworth (1963) described 
a peculiar chronic fibrinous peritonitis with a definite predilection for cats. The condition 
now known as feline infectious peritionitis (FIP) was described as seen most often but 
not invariably in kittens and young cats, often affecting several cats in a household or 
cattery. In 1970, Ward described its relationship to FCoV infection. Although still 
considered primarily a disease of younger cats, any age of cat may be affected.
Two recent discoveries pertinent to the aged cat require special mention. The 
isolation of FIV was first reported by Pedersen, Ho, Brown & Yamamoto in 1987, in 
cats from a multiple-cat household that exhibited a syndrome similar to acquired 
immunodeficiency syndrome. FIV is not a new virus, since antibodies to FIV have been 
found in stored feline sera collected as early 1975 in the UK (Gruffydd-Jones, Hopper, 
Harbour & Lutz, 1988). The median age of clinically healthy FIV infected cats is three 
years but the median age of sick cats is 10 years (Shelton, Waltier, Connor & Grant 
1989). This reflects the relatively long latency period of FIV infection, which is thought 
to be between two and five years. Thus, FIV is considered to cause disease particularly 
in the older cat. In addition, male cats are more likely to be infected and infection in 
pedigree cats is less common than in cats of mixed breed (Hosie, Robertson & Jarrett, 
1989).
Hyperthyroidism was first diagnosed as a distinct clinical entity in 1979 by Cotter 
and by Peterson, Johnson & Andrews. A small number of anecdotal reports analysed 
retrospectively suggest that hyperthyroid cats may have existed prior to this date 
(Mooney, 1990). However, the frequency of diagnosis has increased dramatically since 
1979 (Scarlett, Moise & Rayl, 1988) and it is now accepted as the commonest endocrine 
disorder of domestic cats and one of the most frequently diagnosed disorders in small 
animal practice. In 1984 Peterson reported that one of every 300 cats presented to the 
Animal Medical Center, New York, irrespective of age or health status was 
hyperthyroid. Hyperthyroidism is a disease of aged cats and is seen almost exclusively in 
cats exceeding six years of age. The mean age at onset in the two largest series reported 
was 12.8 (Peterson et al., 1983b) and 13.0 years (Thoday & Mooney, 1992). Peterson,
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Randolph & Mooney (1994) reported that less than 5 % of cats are younger than 10 
years of age at the time of diagnosis.
The increased frequency with which hyperthyroidism is now diagnosed may reflect 
an actual increase in incidence, an increased awareness of the condition by veterinary 
practitioners, an increased average life span for cats or a combination of these factors. 
However, 7, 000 cats that had necropsies performed at the Animal Medical Center, New 
York during the 14 year period from 1970 to 1984 have been reviewed (Peterson & 
Ferguson, 1989a). An average of only 1.9 cats per year were found to have gross 
evidence of thyroid enlargement (caused by adenomatous hyperplasia, adenoma or 
carcinoma) in the period before 1977. Benign adenomatous hyperplasia affecting one or 
both thyroid lobes is now recognised as the most common pathological abnormality 
associated with the condition (Mooney, 1990). The aetiology of hyperthyroidism in cats 
remains obscure.
In humans, the two most important forms of hyperthyroidism are Graves' disease 
and toxic multinodular goitre. Graves' diseases is an immune-mediated disorder in which 
circulating antibodies mimic thyrotropin (thyroid stimulating hormone (TSH)), thereby 
promoting thyroid hormone production and secretion. Despite the pathological changes 
in hyperthyroid cats which resemble toxic nodular goitre (Peterson & Becker, 1983), 
attempts have been made to identify stimulating immunoglobulins. Thyroid stimulating 
immunoglobulins, as found in Graves' disease have not been found in hyperthyroid cats 
(Peterson, Livingstone & Brown, 1987; Kennedy, Thoday & Mooney, 1989). 
Adenomatous thyroid tissue removed from hyperthyroid cats and transplanted into 
thyroxine-treated nude mice retains its histopathological appearance and continues to 
grow and function. Similar results are found in human toxic nodular goitre (Peter, 
Gerber, Studer, Becker & Peterson, 1987). Thyroid cells from hyperthyroid cats 
cultured in TSH-free media also continue to grow and function (Peter, Gerber, Studer, 
Peterson, Becker & Groscurth, 1991). Thus neither hyperfunction nor growth of toxic 
goitres depend on extrathyroidal stimulators. These reports suggest that intrinsic 
alterations within the thyroid gland lead to autonomy of follicular growth and function 
and subsequently to the development of hyperplastic nodules, causing thyrotoxicosis 
(Peter et al., 1987, 1991). Increased titres of thyroid growth stimulating 
immunoglobulins have been identified in the sera from some hyperthyroid cats (Brown, 
Keating, Livingstone & Bullock, 1992). These autoantibodies stimulate thyroid growth 
but do not stimulate function and their precise role in hyperthyroidism is unclear. They 
may play a role in goitre formation. Thyroid function as indicated by in vivo serum total 
T4 concentrations did not differ in cats with increased titres of growth stimulating 
immunoglobulins compared to cats with no detectable titres (Brown et a l , 1992).
Scarlett Moise & Rayl (1988) attempted to identify possible risk factors for feline 
hyperthyroidism. A three to four-fold increased risk of developing hyperthyroidism was 
associated with regular treatment with flea sprays or powders, living strictly indoors and 
having reported exposure to lawn herbicides, fertilisers and pesticides. The greater the
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proportion of commercial canned foods in the diet, the greater the associated risk. Cats 
whose diets were half or more canned food had 3.4 times the risk of developing 
hyperthyroidism compared to those fed no canned food. Cats fed some, but less than 
half canned food had 1.6 times the risk of those fed no canned food. Non-Siamese cats 
were approximately 10 times more likely to develop hyperthyroidism than Siamese cats. 
This breed predisposition has not been reported elsewhere (Peterson et al., 1983b; 
Thoday & Mooney, 1992).
In humans, iodide administration is known to induce transient hyperthyroidism, the 
so-called Jod Basedow effect (Bravennan, 1986). Iodide-induced hyperthyroidism 
frequently follows iodide repletion in endemic iodine deficient areas and occurs most 
frequently in patients with pre-existing thyroid autonomous nodules. Potassium iodate 
was added to bread throughout Tasmania (an iodine deficient area) in 1966 as a 
prophylactic measure against endemic goitre. After this the incidence of thyrotoxicosis at 
the two thyroid clinics on the island more than doubled (Connolly, Vidor & Stewart, 
1970). Due to its transient nature, the Jod Basedow effect cannot explain the 
autonomous and progressive nature of feline hyperthyroidism. Despite this, several 
studies have examined the iodine content of cat foods in an attempt to implicate iodine in 
the cause or progression of hyperthyroidism. The iodine content of some commercial cat 
foods is up to 10 times recommended levels (Mumma, Rashid, Shane, Scarlett-Kranz, 
Hotchkiss, Eckerlin, Maylin, Lee, Rutzke, Gutenmann, Bache & Lisk, 1986). In another 
study, the iodine content of cat foods was found to vary more than 100-fold (Johnson, 
Ford, Tarttelin & Feek, 1992). Thus, certain foods are iodine deficient and some are 
excessive. Johnson et a l (1992) therefore suggested that wide fluctuations in iodine 
intake may eventually lead to thyroid dysfunction, particularly in individuals genetically 
or environmentally prone to thyroid disorders. The possible mechanisms involved were 
not addressed.
There is no doubt that iodine content plays a role in thyroid function in cats since 
serum free T4 concentrations, as measured by an analogue kit method, were found to be 
inversely correlated with urinary iodine excretion (Tarttelin, Johnson, Cooke, Ford & 
Feek, 1992). This study only examined the effect of feeding a fixed amount of iodine for 
two weeks and did not address if the results seen were permanent or temporary. 
Although not pertinent to the origin of hyperthyroidism, a change to a low iodine content 
diet had no effect on thyroid function tests in thyrotoxic cats (Peterson & Ferguson, 
1989a). Thus the role of iodine in the pathogenesis of hyperthyroidism remains unclear. 
Cats may be exposed to other goitrogenic compounds (e.g. phthalates) either through 
their diets or in the environment that could contribute to the development of 
adenomatous lesions in the thyroid gland. These may be of particular importance 
because such hydrocarbons are metabolised by glucuronidation, a metabolic pathway 
particularly slow in the cat (Ferguson & Peterson, 1990).
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More recent research is centred on the possible role of proto-oncogenes in the 
pathogenesis of hyperthyroidism (Ferguson & Peterson, 1990). Results have not yet been 
published.
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Griffiths (1968) surveyed disease conditions affecting cats over eight years of age. 
Despite the probable increase in the number of older cats presenting to veterinary 
surgeons today (Kitchell, 1989), there have been no recent reports on the prevalence of 
diseases in this population. This study was designed to assess the disease conditions 
affecting older cats in a referral population. A comparison with cats seen in a similar 
time period beginning in 1970 was made in order more clearly to assess changing trends 
in prevalence and their significance.
3.3 MATERIALS AND METHODS 
Clinical material (1990-1992)
Using the geriatric age criteria of Johnson & Mitzner (1989) local veterinary surgeons 
were invited to refer sick cats of over five years of age to the medical section of the 
Small Animal Clinic. The study was carried out between January 1990 and June 1992. 
Each case underwent a full physical examination and ancillary diagnostic aids as 
described in Chapter 2. A diagnosis was subsequently made based on these findings, and 
in relevant cases was confirmed or refuted by post-mortem examination.
Historical records of clinical material (1970-1972)
The case numbers for cats seen between January 1970 and June 1972 were obtained 
from the Clinic day books. Microfiches of these records were then examined.
Statistical analyses
The Mann Whitney U test was used for all statistical analyses. Survival time (the time 
from initial presentation to death or last-follow) was determined in the non-hyperthyroid 
cats. A life table was calculated to determine the probability of survival and the data 
used to plot a survival curve as described by Colton (1974). Such a method accounted 
for the cats entering the study at different times, for the different lengths of time 
observed and the unknown endpoints for some cats at the time of study termination.
3.3 RESULTS
Clinical material (1990-1992)
The relevant case numbers are listed in Appendix 2.
Between January 1990 and June 1992, 162 cats of five years of age or over were 
examined. The number of cats seen represented 19.4 % of the total number (853) of cats 
seen at the Small Animal Clinic over this time period.
This group consisted of 81 females (74 ovariohysterectomised, seven entire) and 
81 males (78 castrated, three entire). The majority of the cats were either domestic short
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(n = 131) or long (n = 10) haired; the remaining 21 (13.0 %) cats represented five other 
breeds: Siamese (n = 13), Persian (n = 4), British Blue (n = 2), Burmese (n = 1) and 
Birman (n = 1).
The ages for 160 of the cats are summarised in Table 2. Two cats were of 
unknown age but were known to be in excess of 10 years because of the length of time in 
the owners possession. There was no significant (P > 0.05) difference in the ages of the 
female compared with the male cats. The oldest cat, at 20 years of age, was a female.
Male Female All cats
n 80 80 160
Mean 11.4 11.6 11.5
sd 3.3 3.3 3.3
Minimum 5.0 5.0 5.0
1st quartile 8.5 9.0 9.0
Median 12.0 12.0 12.0
3rd quartile 14.0 14.0 14.0
Maximum 18.0 20.0 20.0
Table 2. Summary statistics of the ages (years) in the male, female and all geriatric cats 
grouped together, presented to the Small Animal Clinic between January 1990 and June 
1992.
Diseases affecting the geriatric cats (1990-1992)
In 83 (51.2 %) cats, the main diagnosis was hyperthyroidism The mean ±sd age at time 
of diagnosis in 82 of these cats where ages were known was 13.0 +2.2 years. Only five 
(6.0 %) cats were less than 10 years old. The number of hyperthyroid cats of different 
ages compared to the total population of cats are illustrated in Figure 1.
At the time of initial presentation, 16 (19.3 %) of these hyperthyroid cats had 
concurrent illnesses of significance. Seven (8.4 %) had clinical and radiographic 
evidence of congestive cardiac failure. Four (4.8 %) had clinical and biochemical 
evidence of renal failure. Three of these cats were euthanased and in one renal 
lymphosarcoma was found on post-mortem examination. Three (3.6 %) cats were 
positive for FeLV antigen (n = 2) and FIV antibodies (n = 1). One cat was euthanased 
because of constipation. A rectal stricture and a hepatic and pulmonary adenoma were 
found on post-mortem examination. The remaining cat was blind as a result of damage 
to the retinas caused by hypertension and was euthanased at the owners request.
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Figure 1. The number of cats diagnosed as hyperthyroid (hatched box) for different age 
categories compared to the total number of cats seen between January 1990 and June 
1992.
The diagnoses for the 79 non-hyperthyroid cats are illustrated in Figure 2.
The most common disease category other than hyperthyroidism was neoplasia seen 
in 17 (10.5 %) of all cats. Lymphosarcoma was suspected clinically in six (35.3 %) cats 
of this group and was subsequently confirmed at post-mortem examination in four of 
these animals. Thyroid carcinoma was diagnosed by biopsy or post-mortem examination 
in three (17.6 %) cats. One case each of pancreatic adenocarcinoma, nasal carcinoma, 
pyloric carcinoma and pulmonary adenocarcinoma were diagnosed. In the remaining 
four cases pulmonary, mediastinal, abdominal or hepatic neoplasia was suspected 
clinically and radiographically but further investigations were refused.
FeLV, FIV and FCoV related diseases were diagnosed in 13 (8.0 %) of the cats. 
One cat was positive for both FeLV and FIV, while five were positive for FIV only and 
three for FeLV only. The remaining four cats were suffering diseases associated with 
FCoV. One other cat presented with a thyroid carcinoma was found to be positive for 
FIV antibodies. This was not considered to be clinically significant at that time.
Chronic renal failure was diagnosed as the primary problem in six (3.7 %) cats. As 
a secondary illness it was diagnosed in six further cases. The prevalence of the remaining 
diseases seen was 3.1% (five cases) for cardiomyopathy (four hypertrophic and one 
dilated) and 2.5 % (four cases) for chronic enteropathy. Three (1.9 %) cases each of 
diabetes mellitus, chronic bronchopneumonia/feline asthma, chronic gingivitis, 
lymphocytic cholangiohepatitis and obesity were diagnosed. Two (1.2 %) cases each of 
chronic upper respiratory tract infections and hepatic lipidosis were diagnosed.
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Disease Category
SN, Systemic neoplasia
VI, Viral disease (FeLV, FIV, FCoV)
RF, Renal failure,
CM, Cardiomyopathy 
CE, Chronic enteropathy 
DM, Diabetes melhtus
CB, Chronic bronchopneumonia/feline asthma 
LC, Lymphocytic cholangitis 
CG, Chronic gingivitis 
O, Obesity
CU, Chronic upper respiratory tract infections 
HL, Hepatic lipidosis 
UN, Undiagnosed
MS, Miscellaneous (one case each of meningoencephalitis, primary Haemobartonella 
felis, primary hypokalaemia, ovarian follicular cysts, feline endocrine alopecia, 
hyperadrenocorticism (adrenal tumour), polyarthritis, pyothorax, behavioural change, 
cystitis, pyloric stenosis, oesophageal reflux and intestinal parasitism)
Figure 2. Diseases of non-hyperthyroid geriatric cats seen between January 1990 and 
June 1992.
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The survival curve for the non-hyperthyroid cats is illustrated in Figure 3. Thirty- 
one (39.2 %) cats died or were euthanased at the time, or within one month of 
presentation.
% Surviving
-------------- 3 ^
Months since diagnosis
Figure 3. Survival curve for the prognosis of the non-hyperthyroid geriatric cats 
presented during January 1990 and June 1992.
Clinical material (1970-1972)
The relevant case numbers are listed in Appendix 3.
Between January 1970 and June 1972, 480 entries for cats appeared in the day 
book. Sixty-three of these entries represented external samples or post-mortem material. 
Of the remaining 417 entries studied, 34 (8.2 %) records were missing, 62 (14.9 %) were 
of unknown age, 223 (53.5 %) cats were less than five years of age and 98 (23.5 %) 
were five years of age or older. Of the older cats, 57 (13.7 % of all cases) were referred 
as medical cases.
This group consisted of 21 females (nine ovariohysterectomised, 12 entire) and 34 
males (24 castrated, 10 entire). The cats were either domestic short (n = 39) or long (n 
= 1) haired; the remaining 17 (29.8 %) cats represented five other breeds: Siamese (n = 
12), Persian (n = 2), British Short Hair (n = 1), Burmese (n = 1) and Chinchilla (n = 1).
The ages for 55 of the cats were reported, but simply described as aged in the 
remaining two. The mean ±sd age at time of presentation was 8.35 +2.99 years. Thirty- 
eight (69.1 %) cats were less than 10 years of age. The oldest cat (a female) was 16.5 
years. There was no significant (P >0.05) difference in the ages of the female compared 
with the male cats. As a group, the cats were significantly (P < 0.001) younger than 
those seen between 1990 and 1992.
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Diseases affecting the geriatric cats (1970-1972)
The diagnoses for these cats are illustrated in Figure 4.
Neoplasia was the most common diagnosis made, accounting for 12 (21.1 %) 
cases. In nine cases these were confirmed on post-mortem examination as myeloid 
leukaemia (n -  3), lymphosarcoma (n = 2) and one case each of salivary gland 
carcinoma, squamous cell carcinoma of the oesophagus, bronchial carcinoma, and 
pancreatic/ovarian adenocarcinoma. Alimentary lymphosarcoma, mediastinal 
lymphosarcoma and oesaphageal carcinoma were suspected clinically in the remaining 
three cats.
Eleven (19.3 %) cats presented with signs of gastrointestinal disease (vomiting, 
diarrhoea, colitis or constipation) but a diagnosis was not made in any case. The next 
most common diseases were renal failure (n = 6, 8.8 %), urolithiasis (n = 4, 7.0 %) 
diabetes mellitus (n = 3, 5.3 %) aplastic anaemia (n = 2) and pharyngitis (n = 2, 3.5 %).
It was impossible to assess the reasons for presentation or diagnoses made from 
three case records. The remaining 14 cases were suffering a variety of illnesses. One 
cat, a seven year old ovariohysterectomised Siamese, presented with polyphagia, weight 
loss, sudden onset blindness, polydipsia, steatorrhoea, jaundice and palpable 
hepatomegaly. On post-mortem examination the animal was found to have chronic 
pancreatitis, hepatic fibrosis and pulmonary oedema.
3.5 DISCUSSION
In comparing the geriatric medical cases seen between the periods 1990 to 1992 and 
1970 to 1972 several interesting facts emerged. Approximately twice as many cats were 
presented to the Small Animal Clinic during the more recent period (1990 - 1992). A 
disproportionate increase was found in the number of geriatric medical cases presented, 
amounting to almost a three-fold increase. The cats presented 20 years ago were also 
significantly younger. These findings support suggestions that cats are now living longer 
(Kitchell, 1989).
In the survey reported by Griffiths in 1968, more male cats were presented than 
females. Whilst this was true in the cats seen between 1970 and 1972, equal numbers of 
male and female cats were presented between 1990 and 1992. Since Griffiths (1968) 
suggested that this may be due to the preference of cat owners for male kittens, this 
appears to be no longer true. By contrast to Griffiths (1968) report, where an increased 
longevity was noted for female cats, this was not found in either group of cats studied. 
However, the oldest cats seen in the 1970 and 1990 groups, were both females. 
Approximately 30 % of the 1970 cats were pedigree animals, whilst only 13 % of the 
1990 cats were pedigree. This is unlikely to reflect a decline in pedigree numbers in the 
cat population. Rather, it may reflect a greater tendency of pedigree cat owners to 
present their cats for referral which may no longer be the case.
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Number of cats
16
14 --------
12 ---------
10
8
6 --------
4 --------
2   --------
o  N LI U U U U U U - - - - - - - -  l
SN GD RF UO DM UN AA PS MS
Disease category
SN, Systemic neoplasia 
GD, Gastrointestinal disease 
RF, Renal failure 
UO, Urolithiasis 
DM, Diabetes mellitus 
UN, Undiagnosed 
AA, Aplastic anaemia 
PS, Pharyngitis
MS, Miscellaneous (one case each of multiple pulmonary thrombi, old diaphragmatic 
hernia with liver torsion, pneumonia with cystitis, periodontal disease, pyrexia of 
unknown origin, chronic pancreatitis with hepatic fibrosis and pulmonary oedema, 
septicaemia, primary Haemobartonella felis, fibrinous peritonitis, hepatic cirrhosis, 
pneumonia, hydrothorax, chronic bronchopneumonia with nephrosclerosis and 
glomerulonephritis, FeLV)
Figure 4. Diseases of the geriatric cats seen between January 1970 and June 1972.
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Hyperthyroidism was the most common disease seen in the current geriatric cats. 
The mean age at the time of diagnosis was similar to previous reports (Peterson et al., 
1983b; Thoday & Mooney, 1992). By contrast, hyperthyroidism was not diagnosed in 
any cat seen between 1970 and 1972. Since hyperthyroidism was not definitively 
diagnosed until 1979 (Cotter, 1979; Peterson, Johnson & Andrews, 1979), this could 
have been related to a lack of awareness of the disease. However, in retrospectively 
analysing the case records, only one cat was found to have historical and clinical features 
consistent with the presence of hyperthyroidism (Peterson et al., 1983b; Thoday & 
Mooney, 1992). This cat exhibited weight loss despite an increased appetite, polydisia, 
steatorrheoa and had suddenly become blind. However, on post-mortem examination 
most of these signs were explained by the finding of chronic pancreatitis. A thyroid 
abnormality was not reported and it is doubtful that the cat was hyperthyroid. 
Retrospective analyses of clinical case records for the presence of hyperthyroidism has 
not been reported previously. The findings of the present study compliment a study of 
post-mortem records which showed that thyroid abnormalities were rare prior to 1977 
(Peterson & Ferguson, 1989a). Thus, it would seem that hyperthyroidism has shown a 
true increase in incidence.
The study of the ages at which cats presented in both time periods may provide 
possible clues on the emergence of hyperthyroidism as a disease of significance. 
Between 1990 and 1992, hyperthyroidism was rare in cats less than 10 years old as has 
been reported previously (Peterson, Randolph & Mooney, 1994). Between 1970 and 
1972, over two thirds (n = 38) of the cats were less than 10 years of age. Thus 
hyperthyroidism may not be a new disease. The increased frequency with which it is 
currently diagnosed may be related to an increased longevity of cats. Indeed, Peter et a l 
(1987) suggested that the emergence of hyperplastic follicles in thyroid tissue may be an 
age related phenomenon. Whether extra-thyroidal stimuli enhance this progression 
remains unclear.
There was an increased prevalence with which viral infections were diagnosed 
between 1990 and 1992 compared to the earlier period. It is likely that between 1970 
and 1972 some of the diseases seen were viral-related. FeLV was discovered in 1964 
(Jarrett et al. 1964a, 1964b). FIV is known to have existed prior to its discovery in 1987 
(Pedersen et al., 1987; Gruflydd-Jones et al., 1988). A chronic fibrinous peritionitis was 
described by Holzworth in 1963, but its relationship to FCoV was not known until 
described by Ward in 1970. Thus, between 1970 and 1972, there was limited awareness 
of viral diseases and diagnostic tests were not yet, or rarely, available. There was only 
one case record from 1972 where FeLV status was recorded. By 1990 such testing had 
become routine. Because of the wide variety of clinical signs associated with FeLV and 
FIV related diseases (Hopper, Sparkes, Gruflydd-Jones, Crispin, Muir, Harbour & 
Stokes, 1989; Rojko & Hardy, 1994), it was impossible retrospectively to analyse which 
cats seen between 1970 and 1972 were likely candidates. However, one cat was found 
to have a fibrinous peritionitis which was presumably related to FCoV.
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Neoplastic diseases and renal failure remained common in both groups of cats 
studied. They were also the two most common causes of death in the survey of Griffiths 
(1968). In both groups of cats, lymphosarcoma was the most common neoplastic 
disease diagnosed and this finding resembles Griffiths survey in 1968. Diseases of a 
chronic nature were common in both the cats surveyed from 1990 and 1970.
Irrespective of disease, an accurate diagnosis in life was made more frequently in 
the period between 1990 and 1992. This again presumably reflects the increased number 
of ancillary diagnostic tests available and carried out. In addition, with the aid of these 
tests secondary problems unrelated to the primary diagnosis were often found. This is 
not surprising in the older animal because of the additional stress on organ systems, 
which as a result of the normal ageing process have a limited reserve capacity (Mosier, 
1989). The presence of a concurrent problem ultimately affected both prognosis and 
treatment options. This study confirms suggestions that a standard data-base for the 
assessment of diseases in geriatric animals should at least include haematological and full 
blood biochemical profiles (Mooney 1991; Mooney, 1993).
The survival prognosis for the non-hyperthyroid cats seen between 1990 and 1992 
was poor. There was a sharp decline in survival within the first month of presentation, 
followed by a slower decline and a further decrease by 30 months. This is not surprising 
in a referred population of cats. Referral is often based on specialisms in a particular 
institute. However, chronically and severely sick animals are often also referred because 
of better diagnostic and treatment facilities available at the referral institute. In addition, 
in this study, many owners opted for referral as a final attempt to do as much as possible 
for their animal.
The large number of hyperthyroid cats referred was related both to the expertise 
available and the establishment of a radioactive iodine unit for its treatment. Providing 
these cats had no concurrent illnesses, the prognosis was excellent. In accord with this, 
many of the cats were lost to adequate follow up after successful management by 
surgical thyroidectomy, antithyroid drug treatment or radioactive iodine administration. 
Survival data were therefore difficult to calculate.
By its very nature, a study using a referred population of animals cannot provide 
true disease prevalences. This study did not attempt to do so, but simply highlighted 
some changes that presumably reflect, at least in part, similar trends in disease in the 
wider feline geriatric population. In carrying out a similar survey on geriatric dogs, 
MacDougall & Barker (1984) suggested that although information from referral centres 
is biased towards particular research interests and expertise, such data reflects diseases of 
importance worthy of further study. More importantly, in the study presented here, the 
paucity of information on the geriatric cat became evident. Specifically, the current 
proportion of older cats, average longevity and disease prevalence in the wider feline 
population are unknown and deserve to be the subject of further study.
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CHAPTER 4
ASSESSMENT OF SERUM TOTAL AND FREE THYROXINE 
CONCENTRATIONS IN FELINE SERUM
4.1 LITERATURE REVIEW
An introduction to the thyroid hormones
Irrespective of species, the role of the thyroid gland is to produce iodinated derivatives 
of tyrosine, the thyroid hormones (Gorbman, 1986). Once released into the circulation 
the thyroid hormones are responsible for a variety of actions. In the adult vertebrate 
these actions differ from tissue to tissue as exemplified by enhancement of lipolytic 
activity in adipose tissue, modulation of gonadotropin secretion by the pituitary, 
maintenance of hair growth by the skin and stimulation of the sodium pump and 
glycolytic pathways leading to calorigenesis and oxidative phosphorylation in the liver, 
kidney and muscle. In addition, thyroid hormones alter the concentrations of certain 
neurotransmitters and their receptors in the brain and affect tissue metabolism of some 
drugs. They modulate the actions of other hormones through receptor interactions or 
alteration of transcriptional or translational events initiated by other hormones, and can 
regulate concentrations of their own receptors and, through transamination, their own 
metabolism (Shambaugh, 1986).
In man, a variety of iodothyronines, iodotyrosines, iodoproteins such as 
thyroglobulin and iodoalbumin and a small amount of inorganic iodide are released by the 
thyroid gland into the blood (Chopra, 1991). Only T4 and T3 are considered to have 
significant metabolic activity. T4 is the main secretory product of the thyroid gland. 
Despite this T3 is three to five times more potent than T4, and T4, although possessing 
inherent thyromimetic activity, is often considered to be a ''pro-hormone'1. In health, 
only 10 to 15 % of circulating T3 is secreted by the thyroid gland, the remainder being 
produced peripherally by (outer ring) 5'-deiodination of T4 (Braverman, Ingbar & 
Sterling, 1970; Chopra, 1991). Two isotypes of 5'-deiodinase (type I and type II) have 
been identified by differences in their substrate preference, degree of susceptibility to 
inhibition by propylthiouracil and response to physiological perturbations. The highest 
type I activity is found in the thyroid gland, liver and kidney. The type II enzyme 
appears to generate T3 for local use in organs such as the brain and brown adipose tissue 
(Kohrle, DieterHesch & Leonard, 1991).
In the dog, T4 is also the main secretory product of the thyroid gland, although 
smaller amounts of T3, 3,3',5'-L-triiodothyronine (reverse T3 (rT3)) and various 
deiodinated metabolites have been identified in venous effluent from the thyroid glands 
(Laurberg, 1978, 1980, 1981). In the cat, T4, rather than T3, is the main compound in 
thyroid venous plasma (Taurog, Porter & Thio, 1964). This is supported by a recent 
study of six healthy cats where thyroid secretion rates of 5.6 +1.2 ug/kg/day and 0.4 
±0.1 ug/kg/day for T4 and T3 respectively were found (Broome, Hays & Turrel, 1987).
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Up to 60 % of circulating T3 is produced from peripheral tissue monodeiodination of T4 
in the dog (Belshaw, Barandes, Becker & Berman, 1974) and a similar situation is 
thought to occur in the cat.
Overall control of thyroid hormone production is provided by a negative feedback 
mechanism of circulating T4 and T3 on thyrotropin releasing hormone (TRH) from the 
hypothalamus and TSH from the anterior pituitary. Peripheral conversion of T4 to T3 
may be autoregulated and is altered in iodine deficiency and in a variety of other 
pathological states (Nicoloff, 1986). Since T3 is the more metabolically active hormone, 
this mechanism may serve to maintain euthyroidism in the face of a low or a high serum 
T4 concentration. Such a mechanism may be responsible in part for the maintenance of 
normal circulating T3 concentrations when T4 concentrations are only mildly elevated in 
hyperthyroid cats, or when circulating T4 concentrations are markedly suppressed as 
during carbimazole therapy (Peterson et al., 1983b; Mooney, Thoday & Doxey, 1992a; 
Thoday & Mooney, 1992). T3 toxicosis, an elevated circulating T3 concentration, 
accompanied by a normal circulating T4 concentration, which has been described in man 
has not been described in the cat (Peterson et al., 1983b; Thoday & Mooney, 1992). 
Given this, in the cat the measurement of circulating T3 concentrations in isolation gives 
a less meaningful estimate of thyroid function than the study of circulating T4 
concentrations alone.
Transport of thyroxine within the circulation
Thyroid hormones are water-insoluble lipophilic compounds. In humans, their ability to 
circulate in plasma depends primarily on binding by specific binding proteins, thyroxine- 
binding globulin (TBG), thyroxine-binding prealbumin (TBPA) and by albumin itself. 
Less importantly, T4 may bind to certain lipoproteins and other minor transport 
hormones. These transport hormones have been reviewed in detail by Robbins (1991). 
The major fraction of T4 (approximately 70 %) is bound to TBG, a trace inter-alpha- 
globulin. It is the least abundant of the three major transport proteins, having a 
concentration of approximately 15 mg/1 in human plasma, but has an extremely high 
affinity for T4. In normal plasma, about one fourth of the TBG molecules contain T4. 
TBPA is more abundant than TBG, having a concentration of approximately 250 mg/1 in 
plasma. The affinity constant for the T4-TBPA interaction is intermediate between TBG 
and albumin, such that TBPA transports only about 10 % of the T4 in blood. Albumin is 
the most abundant protein in human plasma. Although very few albumin molecules carry 
T4, their high concentration results in the binding of approximately 15 to 20 % of the 
circulating T4. Compared to TBG, more T4 binding sites of TBPA and albumin remain 
unoccupied.
Larsson, Pettersson & Carlstrom (1985) attempted to isolate TBG and TBPA from 
canine serum utilising purification methods developed for the isolation of these proteins 
in humans. An analogue of human TBPA was found to exist in canine plasma, albeit
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migrating in the alpha-2 globulin region. TBG was also present in canine serum and 
reported to be the major T4 carrier. In addition, T4 was found to bind to albumin and, in 
equal amounts, to another protein migrating in the alpha-1 region, with both transport 
proteins showing low affinity but high capacity for T4. The relative distribution of T4 on 
these proteins at basal T4 concentrations were 60 % for TBG, 17 % for TBPA, 12 % for 
albumin and 11 % for the alpha-1 protein. Further characterisation of these proteins 
(Larsson, 1987) showed many similarities between human and canine TBPA with regard 
to tetrameric structure, microheterogeneity, extinction coefficient, molecular weight, and 
the concentration in plasma. Partial immunochemical identity between the two was also 
reported. However, canine TBG, migrating in the beta region, was of lower plasma 
concentration, and of higher molecular weight than human TBG and showed no 
immunochemical resemblance to this protein. Evidence was also presented that the 
previously unidentified T4-binding protein in the alpha-1 globulin region was the high 
density lipoprotein (HDL), HDL2 and in the pre-beta region, very low density 
lipoprotein (VLDL). TBG in the dog is not completely saturated until the circulating T4 
concentration is approximately 150 nmol/1, while the other serum proteins are virtually 
never saturated (Larsson, Pettersson & Carlstrom, 1985).
The isolation and identification of feline plasma thyroid hormone binding proteins 
have been reported. Larsson, Pettersson & Carlstrom (1985) identified albumin and 
TBPA, albeit migrating in a different direction to human TBPA, as the major T4 binding 
proteins but failed to identify TBG in the cat. Thoday (1986) reported that T4 was 
bound to albumin and to a protein migrating in the alpha- 1/alpha-2 globulin fraction 
although this had a lower affinity, capacity or concentration in plasma than human TBG.
Over 99 % of T4 circulating in human plasma is protein bound, while a small 
fraction of approximately 0.03 % is unbound or free (Woeber, 1986). Robbins & Rail 
(1957) initially proposed that protein binding functioned as a mechanism for retention of 
thyroxine in a fluid compartment, but that the bound hormone was an inactive form, 
whereas the free or unbound component was responsible for the actions of the hormone. 
However, Pardridge (1981) presented experimental evidence showing that single-pass 
organ uptake of hormone may exceed the free fraction; this suggests protein-mediated 
hormone uptake and that certain binding proteins may serve to distribute hormone to 
specific tissues. Despite these challenges it is usually accepted that the free fraction of 
T4 is metabolically active, while the protein bound fraction serves to restrict hormone 
availability to tissue sites of metabolism and disposal and to modulate the effects of 
alterations in T4 secretion or administration (Nicoloff, 1986).
In the dog, since the overall concentration and binding affinity of the binding 
proteins is lower, the total (protein-bound and free) T4 concentration is lower, the 
unbound or free T4 fraction is higher and hormone turnover more rapid than in man. 
The free T4 fraction in the dog has been variably estimated as 0.103 to 0.189 % (Furth, 
Becker, Nunez & Reid, 1968), 0.155 to 0.303 % (Refetoff  ^ Robin & Fang, 1970) and
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0.09 +(standard error of the mean (sem)) 0.003 % (Ferguson & Peterson, 1992). Given 
the higher free T4 fraction, absolute concentrations of free T4 are similar in dog and 
man. Indeed, it has been suggested that the free T4 concentration in warm blooded 
vertebrates is more constant than any other parameter of thyroid function despite 
variations in the nature and capacity of serum T4 binding proteins (Refetoff, Robin & 
Fang, 1970). A similar situation is thought to exist in the cat as in the dog, but there are 
few references to free T4 fractions in this species. Thoday (1990a) reported that the free 
T4 fraction ranged from 0.083 to 0.105 % in cats but further details were not provided. 
Hays, Turrel & Broome (1988) reported the mean ±sd free T4 fraction measured in five 
euthyroid cats as 0.057 +0.009 %.
Laboratory assessment of circulating thyroxine concentrations
Measurement of total and free circulating concentrations of T4 are now carried out 
routinely in human medicine, and most methods have been used in the cat.
Circulating total thyroxine concentrations
Measurement of the plasma protein-bound iodine (PBI) concentration was for many 
years the mainstay as an index of circulating T4 concentrations in man but this method is 
now of mere historic interest. The method relied on the fact that the iodine present in T4 
comprises 80 to 90 % of the total plasma iodine concentration. However, this assay was 
subject to spurious results in patients whose thyroids were secreting large quantities of 
iodoproteins and in those who had received large quantities of exogenous iodine in 
organic or inorganic form. The plasma butanolol-extractable iodine (BEI) concentration 
assay was developed in an attempt to overcome some of the limitations of the PBI test 
by increasing the specificity for T4, but was beset by similar problems. Such methods 
have been employed in the dog. However, the dog has plasma iodide concentrations 10 
to 20 times higher than human plasma, and this constitutes approximately one-third of 
the total PBI (Belshaw, Cooper & Becker, 1975; Belshaw, 1983). Preliminary data in 
the cat suggest a similar plasma iodide concentration (Peterson & Ferguson, 1989a). 
Thus PBI determinations are unsatisfactory indices of T4 concentrations in small 
animals.
The development of the competitive protein-binding displacement assay (CPBA) 
offered many advantages over PBI determination for T4 in human subjects. T4 
contained in an ethanol extract of the patient's serum competes with tracer T4 for binding 
to TBG in a standard dilute solution of pooled human serum Apart from the fact that 
the ethanol extraction step is time consuming, such assays are not easily adaptable to 
either the dog or cat because of the differences in concentration and affinity of TBG in 
the dog (Larsson, 1987) and the lack of TBG in the cat (Larsson, Pettersson & 
Carlstrom, 1985).
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There is no doubt that the development of a radioimmunoassay (RIA) system for 
the measurement of circulating insulin concentrations in humans revolutionised the study 
of hormones (Yalow & Berson, 1960). The method, using specific insulin antibodies and 
a radioactive ligand, was found to offer unprecedented specificity, sensitivity, precision 
and practicality, and was exploited by Chopra in 1972 to measure total T4 
concentrations. The principles behind the assays have been reviewed previously 
(Mooney, 1990). The analyte reacts with a specific antibody in the presence of a 
radiolabelled analyte. The labelled analyte is distributed between the antibody bound and 
free forms in a proportional manner to the non-labelled analyte. Following separation of 
the antibody bound radiolabelled analyte, and by comparison with an appropriate 
standard, the concentration of the test analyte can be interpolated.
Since the first description of the total T4 RIA, numerous kit methods have been 
developed commercially and are routinely used in most human laboratories. In addition, 
using the same principles, ELISA kits have been developed to avoid the use of 
radioactive ligands but the sensitivity of RIAs remains unequalled. It is recommended 
that reference ranges be determined for each kit method used in each laboratory. As 
discussed previously, total T4 concentrations are higher in humans than either dogs or 
cats. In general, typical serum total T4 concentrations vary between approximately 60 
and 140 nmol/1 in healthy euthyroid adult humans (Stockigt, 1991).
Measurements of circulating total T4 concentrations using RIAs have been 
reported in the cat since 1978 (Reap, Cass & Hightower, 1978). Some authors have 
recommended that standards be prepared in hormone free feline serum to minimise 
differences in the nature and concentrations of binding proteins between the standards 
and the samples (Peterson, Keene, Ferguson & Pipers, 1982; Hoenig & Ferguson, 1983; 
Thoday, Seth & Elton, 1984). In addition, optimisation of each reagent used in the 
assay has been recommended to ensure an assay response appropriate to the type of 
sample and the concentration range of interest, and to provide a consistent response in 
the face of mild variations in conditions (Thoday, Seth & Elton, 1984). However, such 
recommendations are expensive and time consuming to implement and it is generally 
accepted that kits designed for use with human serum or plasma are applicable in the cat 
once the assay is modified to allow for the measurement of the lower circulating total T4 
concentrations in this species. This generally involves the use of standards of a lower 
concentration than those provided in the kit simply by dilution of those already provided. 
In addition, each RIA system should be fully validated with regard to specificity, 
sensitivity, accuracy and precision to ensure reliability (Midgley, Niswender & Rebar, 
1969; Hunter, 1978). As with medical laboratories, each veterinary laboratory should 
determine its own reference range for the particular species in question.
A review of the measurement of total T4 concentrations in cats has been presented 
previously (Mooney, 1990). Despite the variations in techniques and methods used, the 
reference ranges for serum total T4 concentrations in healthy euthyroid cats, with few
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exceptions, tend to lie between 10 and 60 nmol/1. Thoday, Seth & Elton (1984) 
measured serum total T4 concentrations in 318 healthy cats ranging in age from four 
months to 13 years. Total T4 concentrations in both males and females tended to 
decrease until approximately five years of age and then increase again. For any given 
age, females and neutered females tended to have higher serum total T4 concentrations 
than males and neutered males. Animals living in the same environment had similar total 
T4 concentrations although it was not possible to differentiate between genetic and 
environmental effects for T4. Peterson & Gamble (1990) found no difference in total 
T4 concentrations between young and older cats.
The measurement of circulating total T4 concentrations reflects the concentration 
of hormone bound to the binding proteins, while the minute concentration of free 
hormone makes an insignificant contribution to the total (Toft, Campbell & Seth, 1981). 
As a consequence, changes in measured total T4 concentrations can occur in response to 
changes in the concentration and/or affinity of the binding proteins. In humans, most 
notable among these would be changes that occur in pregnancy, hereditary TBG excess 
or deficiency, therapy with certain drugs and non-thyroidal illness. Factors of 
importance to the cat are reviewed in Chapter 5.
Circulating free thyroxine concentrations
Despite the challenges of Pardridge (1981), the diagnostic value of free thyroid hormone 
concentrations has not been seriously questioned. Such measurements obviate the 
inherent errors arising from a reliance on serum total thyroid hormone concentrations 
particularly if the relationship between circulating total and free hormone concentration 
is disturbed, for example, when concentrations of binding proteins are abnormal, when 
autoantibodies directed against thyroid hormones exist in the circulation and when 
endogenous or exogenous competitors for protein binding are present (Ekins, 1985).
For many years in human medicine, there has been a reliance on the indirect and 
rather crude free T4 index (FTI) which provides an approximate indication of circulating 
free T4 concentrations by correcting total T4 concentrations for changes in serum 
binding protein concentrations. The calculation of the FTI involves measurement of the 
circulating total T4 concentration, and the correction factor is estimated by one of a 
variety of assays, collectively termed thyroid hormone (T4 or T3) uptake tests (THUT). 
Alternatively, TBG can be measured by immunoassay and a total T4 : TBG ratio 
calculated (Seth & Beckett, 1985). Both of these approaches yield a quantity 
correlating reasonably closely with circulating free T4 concentrations (Ekins, 1985). 
The FTI has been of value in the correct interpretation of serum total T4 concentrations 
when serum concentrations of TBG are mildly abnormal as during administration of 
oestrogen, and in pregnancy and genetic disturbances of TBG synthesis. However, the 
FTI has two main disadvantages. It is cumbersome and costly to perform and there is a 
greater probability of error implicit in the conduct of two separate and methodologically
Chapter 4 42
unrelated measurements (Ekins, 1985). The FTI has been shown to provide unreliable 
and low results in patients hospitalised for non-thyroidal illness in whom an additional 
diagnosis of hypothyroidism could have been considered (Chopra, Solomon, Hepner & 
Morgenstein, 1979a). Despite these problems the FTI is often measured and is still 
considered to be useful to experienced thyroidologists (Alexander, 1986) but has largely 
been replaced by direct methods of determining free T4 concentrations. In veterinary 
medicine, because of the differences in serum thyroid hormone binding proteins 
compared to man, the FTI is not a reliable indicator of free T4 concentrations and any 
studies must rely on the direct methods currently available.
There are three principal methods for directly measuring circulating free T4 
concentrations:
1. Equilibrium dialysis
2. Ultrafiltration
3. Direct immunoassay
Equilibrium dialysis and ultrafiltration are considered to be the "gold standard" or 
reference techniques by which other techniques are compared (Ekins, 1985). The 
problems associated with each of these techniques for the measurement of circulating 
free T4 concentrations in non-thyroidal illness are reviewed in more detail in Chapter 6.
1. Equilibrium dialysis relies on bringing the serum (the "dialysand") into contact 
with a buffer (the "dialysate"), the two being separated by a membrane permeable to free 
hormone and other small molecules but not to serum proteins responsible for hormone 
binding. As free hormone molecules pass through the membrane, there is a net 
dissociation of bound hormone restoring thermodynamic equilibrium throughout the 
system At the time of equilibrium, the free hormone concentration on both sides of the 
membrane will be identical. The free hormone concentration in the dialysate can be 
measured either directly by a sensitive RIA or indirectly by first measuring the total 
hormone concentration by RIA and then the fraction that appears in the dialysate, relying 
on radioactively labelled hormone initially introduced into the test sample. The second of 
these two techniques was originally developed by Sterling & Hegedus (1962). Minor 
problems associated with this indirect technique have been related to certain buffering 
salts and preservatives in the dialysate which affect the free T4 concentration. However, 
the major problem associated with this method has derived from the impurities present in 
the radiolabelled hormones used to measure the free fraction. Sterling & Brenner (1966) 
attempted to overcome or correct the problem of iodide contamination by the use of 
magnesium precipitation. However, even when freshly purified tracer is used the indirect 
method is fraught with radioiodide contamination problems. This is apparently due to 
photochemical deiodination of tracer T4 which occurs at body temperature during the 
incubation required to reach dialysis equilibrium (Nelson & Weiss, 1985). Thus, the 
results obtained by the indirect approach have tended to be artefactually raised (Ekins, 
1985).
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Direct dialysis measures free T4 concentrations by a sensitive RIA applied to the 
dialysate. This was originally developed by Ellis & Ekins (1973) in an attempt to avoid 
errors arising from the impurity of radioactive preparations employed in the more 
conventional methods. Although this proved to be a breakthrough in equilibrium dialysis 
techniques, it was not widely or routinely used in clinical laboratories because it was 
costly and technically demanding. Helenius & Liewendahl (1983) later devised a new 
and practical modification of the technique which proved to be analytically accurate, 
sensitive, reproducible, suitable for routine use in the clinical laboratory and, since the 
dialysis cell design permitted serial production, relatively inexpensive. The serum sample 
was diluted with buffer prior to dialysis but the free T4 concentration was found to be 
independent of dilution in the dialysis step for sera from healthy subjects, patients with 
non-thyroidal illness and subjects with abnormal values for TBG when dilutions of 1 : 5, 
1 : 20 and 1 : 55 were tested. Dilution of serum samples introduces an element of 
inaccuracy into the measurement of free hormone concentrations but, particularly in the 
case of T4, the magnitude of the error is relatively unimportant and therefore permissible 
(Ekins, 1985). However, if non-dialysable protein binding inhibitors, postulated to occur 
in non-thyroidal illness, are present in the serum, the effect of sample dilution may 
become important. If the effect of an inhibitor is dependent on its concentration, then 
dilution of serum would diminish inhibition resulting in increased protein binding and 
decreased free T4 concentrations. Thus in the study of Helenius & Liewendahl (1983), 
the negligible effect of dilution on serum free T4 concentrations in serum from healthy, 
euthyroid subjects was expected but was not expected in the serum from patients with 
non-thyroidal illness. By contrast, Nelson & Weiss (1985) using a similar technique, 
found that progressive dilution of serum (1 : 2 to 1 : 1024) from patients with non- 
thyroidal illness resulted in a progressive decrease in free T4 concentrations, similar to 
that induced by the addition of salicylates to normal sera, known inhibitors of T4 binding 
to serum proteins, providing evidence for the presence of a circulating inhibitors) of T4 
binding in non-thyroidal illness. The discrepancy between the studies of Helenius & 
Liewendahl (1983) and Nelson & Weiss (1985) may have arisen as a result of patient 
selection since in the latter study patients were specifically selected for both low serum 
total T4 concentrations but normal TBG concentrations. In addition, it may have been 
the result of the wider range of dilutions studied since individual results from these 
patients displayed wide variations in the dilution-induced fall in free T4 concentrations.
Nelson & Tomei (1988) designed a re-usable dialysis cell and a complex buffer, 
with which undiluted serum samples could be dialysed with minimal changes in their 
serum matrix, following which free T4 concentrations could be measured by a sensitive 
RIA. The dialysate buffer was designed to approximate the composition of a protein- 
free ultrafiltrate of normal human serum, at least for those compounds present in serum 
at a concentration of greater than or equal to 1 mmol/1, except that glucose was omitted 
and preservatives included. Equilibrium was achieved in 14 hours at 37°C but assay
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incubations were routinely performed for 16 to 18 hours to ensure measurement on the 
plateau of the time-response curve. To study intra-assay precision, a single normal 
serum pool was dialysed in 57 cells. The mean free T4 concentration was 19.31 pmol/1 
with a coefficient of variation (c.v.) of 5.3 %. A second normal serum pool was run in 
one dialysis cell per day on 57 different days over four months. The mean concentration 
was 23.17 pmol/1 with a c.v. of 6.9 %. A pool of dialysates with a mean concentration of
18.03 pmol/1 was similarly assayed in these latter 57 assays with a c.v. of 7.4 % 
suggesting that the dialysis step adds little to the variability of the results. Repeated 
freeze-thaw cycles, up to a maximum of 10, had no effect on serum free T4 
concentrations. The working range of the assay was 2.57 - 164.74 pmol/1. Using this 
method serum free T4 concentrations were found to be normal in individuals whose 
hyperthyroxinaemia was caused by increased T4 binding to serum proteins. More 
importantly, the method separated the patients with hypothyroxinaemia of non-thyroidal 
illness or hypothyroxinaemia of TBG deficiency from those with hypothyroidism, 
whether it was primary or central. Although the dialysis step increased the time and 
effort required to perform a free T4 estimation, the method was recommended as 
adaptable to routine clinical laboratory use, if made available as a kit procedure. This has 
recently been adapted by Nichols Institute Diagnostics as a kit designed for routine 
clinical laboratory use with single use dialysis cells.
2. Ultrafiltration is occasionally adopted as an alternative to dialysis to isolate the 
fluid compartment containing the unbound hormone (Schussler & Plager, 1967) but like 
most equilibrium dialysis methods is both too time consuming and cumbersome for 
routine use in the clinical laboratory.
3. Free hormone immunoassays rely on the fact that when an antibody is 
introduced into serum, the resulting occupancy of antibody binding sites reflects the free 
hormone concentration in the surrounding medium (Ekins, 1985). Free T4 assays 
require a high-affinity T4 antibody, which has to be used at a very low concentration in 
order to minimise inter- sample bias deriving from variable depletion of the protein-bound 
pool (Ekins, 1985). Three main RIA methods have been commercially exploited with 
varying degrees of success, namely the "labelled hormone antibody uptake" method, the 
"labelled hormone, back titration" technique and the "labelled analogue" approach. 
Techniques that use nonradioactive detection systems (chemiluminometric and 
fluorometric systems) are also available based on the same principles but similar pitfalls 
apply (Stockigt, 1991).
The labelled-hormone antibody uptake approach is similar to the traditional FTI 
methods since it involves the measurement of the total T4 concentration in the sample 
and the fraction of the hormone which binds to exogenous antibody. The method 
essentially depends upon labelling the serum pool with radiolabelled hormone at a 
(diluted) specific activity which can be calculated from the total T4 concentration. By 
measuring the amount of radiolabelled hormone bound to antibody, and with knowledge
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of its specific activity, the occupancy of antibody sites can be inferred. Using standards 
of known free hormone concentration, determined by dialysis or ultrafiltration 
techniques, a dose response curve can be constructed relating antibody occupancy to free 
T4 concentration. This method is available in kit form, marketed as Immophase by 
Coming. Controversy surrounded the original introduction of this kit since an incorrect 
procedure for the calculation of assay results had been adopted. Despite rectification of 
this problem, spurious results have been found in patients with non-thyroidal illness. 
Thus, the method has not gained widespread use.
The labelled-hormone, back titration method, often called the "two-step" RIA 
relies on incubation of the test serum with insolubilised antibody to which some of the 
free T4 is adsorbed, followed by removal of the serum and therefore any interfering 
substances and subsequent exposure of the antibody preparation to labelled hormone. 
During this second incubation stage, labelled material is bound to residual, unoccupied, 
antibody binding sites and excess label is then washed away. The bound label is thus 
inversely proportional to the original free T4 concentration of the test sample. Two 
separate and sequential steps are obligatory in such a technique to avoid any possible 
interaction of labelled hormone with serum protein binding sites. Although established 
by Ekins (1985) using antibody coupled to Sephadex particles, it was independently 
developed by Clinical Assays marketed as the Gamma-Coat two step RIA (Bayer & 
McDougall, 1980). Ekins (1985) reported that the major disadvantage of this method is 
its liability to drift because of difficulty ensuring that the timing of the sequential 
incubation and washing steps is maintained from one sample to another. This has been 
confirmed using a non-isotopic adaptation (Beckett, Ratcliffe, Chapman, Wu, Rae, Gow 
& Toft, 1990). Use of an antibody of low affinity will also result in a loss of precision, 
and may be an additional source of error in results obtained with commercial kits based 
on this principle (Ekins, 1985). However, despite such problems and although 
technically demanding because of the two steps involved, the validity of these kits has 
never been seriously questioned (Alexander, 1986).
The labelled hormone analogue or one step assay approach held the most promise 
of all the free hormone immunoassays but has been fraught with the most difficulties. 
The principle is based on a modification of the two step technique, but obviates the two- 
stage sequential incubation by use of a labelled hormone analogue. This analogue is in 
principle, totally unreactive with endogenous binding proteins but retains the ability to 
cross react against native hormone for antibody binding sites. The prototype was the 
Amerlex free T4 RIA (Amersham Corporation) first reported by Midgley & Wilkins 
(1980). There is no doubt that this method provides reliable results in euthyroidism, 
hyperthyroidism and hypothyroidism even when compared to equilibrium dialysis 
(Stockigt, De Garis, Csicsmann, Barlow, White & Hurley, 1981; Gow, Kellett, Toft & 
Beckett, 1985; Liewendahl, Mahonen, Tikanoja, Helenius, Turula & Valimaki, 1986). 
Expected results are also obtained during pregnancy (Ekins, 1985) and in other cases
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where there are only minor alterations in TBG concentrations (Beckett et al., 1990). 
However since its inception it has been clearly shown that spuriously elevated results are 
obtained in cases of familial euthyroid T4-excess, where T4 is abnormally bound to 
albumin. Apparently low results are found in patients with non-thyroidal illness using this 
assay and variable results occur when circulating thyroid autoantibodies are present 
(Stockigt et al., 1981; Byfield, Lalloz, Pearce & Himsworth, 1983). It is therefore clear 
that despite the manufacturers' assurances, T4 analogues are not entirely free but can 
bind to serum proteins and other interfering substances and binding competitors within 
the test sample (Ekins, 1985; Wilkins, Midgley & Barron, 1985). Indeed, the correlation 
of low albumin and free T4 concentrations as assessed by analogue methods suggest 
that these methods actually measure albumin bound T4 rather than free T4 itself 
(Stockigt, Stevens, White & Barlow, 1983; Csako, Zweig, Benson & Ruddel, 1987). 
These findings have led to the suggestion that analogue methods should not be used by 
diagnostic laboratories (Alexander, 1986).
A minidialysis-type free hormone immunoassay kit (Liquisol, Damon Diagnostics) 
has also been developed. This method uses nylon microcapsules containing T4 antibody. 
The microcapsules have pore sizes similar to dialysis tubing. Free T4 in the patients 
serum or standard enters the microcapsule and displaces radiolabelled T4 from the 
antibody. Since spurious results have been found in patients with non-thyroidal illness 
using this method, it has not gained widespread use.
Absolute circulating free T4 concentrations in healthy adult humans tend to vary 
between 10 and 40 pmol/1 although it is recommended that each laboratory determine its 
own reference range.
Given the similarity in absolute circulating free T4 concentrations between species 
(Refetoff, Robin & Fang, 1970) methods for determination of free T4 concentrations in 
humans do not have to be modified for use with cat serum. However, as with total T4 
assays each should be validated and a reference range determined by each individual 
laboratory. There are few reports on the measurement of circulating free T4 
concentrations in healthy euthyroid cats. Hays, Turrel & Broome (1988) used the 
equilibrium dialysis method of Sterling & Brenner (1966) to measure the free T4 fraction 
in five healthy cats. Further details and absolute concentrations were not reported. 
Ferguson, Peterson & Nachreiner (1989) measured serum free T4 concentrations in 28 
healthy cats using unspecified equilibrium dialysis and direct RIA methods. The RIA was 
identified as an analogue kit method (Magic free T4, Ciba Coming Diagnostics) by 
Refsal, Nachreiner, Stein, Currigan, Zendel & Thacker (1991). The mean ±sd 
concentration for free T4 was 20.4 ±11.1 pmol/1 by equilibrium dialysis and 23.9 ±5.8 
pmol/1 by direct RIA. As compared to equilibrium dialysis, the direct RIA tended to 
overestimate free T4 concentrations in the low normal range while underestimating 
values in the higher range. Further details of assay methodologies were not provided. 
Sparkes, Jones, Gruffydd-Jones & Walker (1991) measured serum free T4
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concentrations in 13 healthy cats on 31 occasions using an analogue RIA (Amerlex-M, 
Amersham International). The mean ±sd free T4 concentration was 10.0 ±3.0 pmol/1 
with a range of 3.8 to 15.1 pmol/1. The assay had a sensitivity of 0.4 pmol/1 and was 
frilly validated for use in cats by demonstration of hormone recovery, parallelism studies 
and interassay reproducibility, although further details were not provided. The authors 
did not comment on the apparently low values of free T4 obtained. A reference range of
10 to 25 pmol/1 for serum free T4 concentrations using the same kit method has also 
been reported (Jones et al., 1991).
Refsal et a l (1991) are the only workers to report on the validation of a direct free 
T4 analogue RIA (Magic free T4, Ciba Coming Diagnostics) for use with cat serum. 
The reported laboratory reference range for healthy cats was 12 to 36 pmol/1. The mean 
±sd free T4 concentration as measured in four healthy cats was 28.3 ±5.6 pmol/1. The 
assay protocol provided by the manufacturer was not changed. The sensitivity of the 
assay, defined as the calculated concentration 2sd below the total specific binding (using
11 duplicate measurements of the 0 standard) was 0.8 pmol/1. Two pools of feline serum 
were diluted in phosphate buffered saline solution with 0.1 % gelatin (4 : 1, 1 : 2 and 1 : 
4). The recovery rate of expected values was 110, 117 and 109 %, respectively. 
However, when the same pools of feline serum were diluted (10 : 1, 5 : 1, 4 : 1, 1 : 2, 
and 1 : 4) in the supplied human 0 standard, the recovery of expected values was 80, 76, 
74, 57 and 46 % showing a lack of dilutional parallelism. This was not considered 
surprising, since serum binding proteins differ significantly between the cat and humans 
and the assay was designed specifically for use with human serum. When repeated 
measurements were performed on feline serum pools with mean free T4 concentrations 
of 16.1 and 44.9 pmol/1, the intra-assay c.v. over 10 assays was 4.3 and 9.6 %, 
respectively and the interassay c.v. over 10 assays was 7.3 and 7.2 %, respectively. A 
comparison was made between this assay and a direct equilibrium dialysis kit method 
(Nichols Institute Diagnostics) using 30 samples from hyperthyroid cats or cats with 
non-thyroidal illnesses. Individual values were not reported. The correlation of the 
results was 0.90. The regression coefficient was 0.44 and the y-intercept was 6.4 
(differing from 0 at P = 0.089). Absolute concentrations were reported to differ between 
the two methods, but relative ranking of the results was similar.
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4.2 INTRODUCTION
The free hormone hypothesis, proposed by Robbins & Rail (1957), suggested that it was 
the free or unbound fraction of a circulating hormone that was available to tissues and 
therefore metabolically active. Although this theory has been disputed by some workers 
on the basis of experimental evidence (Pardridge, 1981), it is generally accepted that the 
concentration of free T4 in serum is a more reliable indicator of thyroid function than 
that of total hormone taken alone. Despite this, controversy surrounds certain methods 
currently available for determination of serum free T4 concentrations in man. To date, 
equilibrium dialysis or ultrafiltration techniques are theoretically the most reliable 
methods considered as "gold standards" by which other methods are compared (Ekins, 
1985).
Despite the frequency of thyroid disease in the cat, there are few reports on the 
measurement of free T4 concentrations in this species (Hays, Turrel & Broome, 1988; 
Ferguson, Peterson & Nachreiner, 1989; Thoday, 1990a; Jones et al., 1991; Refsal et 
al., 1991; Sparkes et al., 1991). In the majority of the studies commercial analogue kit 
methods have been used (Ferguson, Peterson & Nachreiner, 1989; Jones et al., 1991; 
Refsal et al., 1991; Sparkes et al., 1991). This chapter describes the validation of two 
assays, for the measurement of total and free T4 concentrations respectively in feline 
serum, the latter using a direct equilibrium dialysis kit method. The results from a series 
of healthy euthyroid cats are presented and provide a basis for comparison with T4 
concentrations in both feline hyperthyroidism and cats with non-thyroidal illness.
4.3 MATERIALS AND METHODS 
Serum total and free thyroxine assays
Serum total T4 concentrations were measured using a liquid phase pre-precipitated 
antibody RIA kit (Gamma-B T4, ImmunoDiagnostic Systems Limited). The materials 
provided with the kit included seven standards prepared in 1 ml horse serum at 
concentrations of 0, 25, 50, 100, 150, 200 and 300 nmol/1, one vial of 12^I-T4 
(radioactive count < 110  kilo Becquerel (kBq) per vial), one vial of pre-precipitated 
sheep anti-T4 and one vial of assay buffer of sufficient volume to allow the assay of 41 
samples in duplicate per standard curve. Prior to routine use, to increase the range of the 
assay, the 25 nmol/1 standard was diluted 1:1 with the 0 standard resulting in an 
additional standard of 12.5 nmol/1. All reagents, standards and samples were allowed to 
come to room temperature and mixed by repeated inversion prior to use. All standards 
and samples were assayed in duplicate in labelled 12 x 75 mm polystyrene tubes 
(Sarstedt) as follows;
1. 25 ul of each standard or sample was added to appropriately labelled
tubes. 25 ul of 0 standard was added to non-specific binding (NSB) tubes.
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2. 200 ul of 125I-T4 was added to all tubes including two additional tubes 
set aside as total counts (TC).
3. 500 ul T4 antiserum complex was added to all tubes except the TC and 
NSB tubes. 500 ul assay buffer was added to the NSB tubes.
4. Each tube was vortexed gently and incubated in a water bath at 37 +2°C 
for between 20 and 25 minutes.
5. All tubes were then centrifuged at 1500 g for 20 minutes.
6. The tubes were decanted, drained and blotted on a pad of absorbent paper.
7. All tubes were counted in an auto gamma counter (Packard Cobra n, 
Packard Instrument Company) for 60 seconds.
8. The concentrations of samples were extrapolated from the standard curve 
using a four parameter logit-log model (SAS Immunoassay Program 632014,
P R. Edwards).
9. Within sample errors outwith the range were rejected and the samples re­
assayed.
Free T4 concentrations were measured using a direct equilibrium dialysis kit 
method (Catalog #40-2210, Nichols Institute Diagnostics). The materials provided with 
the kit included 40 single use Nelson Dialysis cells (patent pending), one vial of dialysis 
buffer, 100 anti-T4 coated tubes, one vial ^^I-T4 solution (radioactive count < 370 
kBq), 1 vial wash solution concentrate, six lyophilised standards at concentrations of 0, 
3.60, 8.24, 21.88, 55.34 and 128.70 pmol/1 and two lyophilised controls of known 
concentration. The standards, controls and wash solution required reconstitution prior 
to use. Each kit contained materials of sufficient number or volume to assay 38 samples. 
All reagents, standards, controls and samples were allowed to come to room temperature 
prior to use and assayed as follows;
1. The dialysis cells were separated into the dialysate vial and membrane 
cylinder and labelled.
2. 2.4 ml dialysis buffer was pipetted into each dialysate vial and the 
membrane cylinder reinserted.
3. 200 ul control or sample was pipetted into the membrane cylinder. The 
standards were not dialysed.
4. Each dialysis cell was individually sealed with Parafilm and incubated at 37 
±0.5°C for between 16 and 18 hours in a dry heat incubator.
5. The membrane cylinders were immediately removed and discarded and the 
dialysates allowed to come to room temperature prior to RIA.
6. Anti-T4 coated tubes were labelled in duplicate together with two 12 x 75 
mm polystyrene tubes (Sarstedt) as TC tubes.
7. 800 ul of each standard or dialysate was pipetted in duplicate into the 
appropriately labelled tubes.
8. 50 ul of the 125j_t4 solution was added to each tube.
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9. All tubes were vortexed and incubated in a water bath at 37 +0.5°C for 3 
hours.
10. All tubes, except the TC, were washed twice by dispensing 2.0 ml of the 
working wash solution into each tube and completely decanting the liquid 
from each tube.
11. All tubes were counted in the gamma counter for 60 seconds and the 
data treated as for the total T4 assay.
Validation of assays for determination of total and free thyroxine concentrations in 
feline serum
To assess the reliability of the assays for use with feline serum, both were frilly validated 
with regard to specificity, sensitivity, precision and where appropriate, accuracy.
Specificity
To ensure specificity for the hormone to be measured, inhibition curves produced by 
serial dilutions of serum were compared to that produced by the standard solutions for 
parallelism. For the total T4 assay, serum obtained from a hyperthyroid cat was diluted 
1:1.25, 1:1.56, 1:2.34, 1:3.52, 1:5.27, 1:7.91, 1:11.87 and 1:17.80 with hormone-free 
serum. This hormone-free serum was prepared from pooled feline serum using the anion 
exchange method described by Salter (1979) and modified for use with cat serum by 
Thoday, Seth & Elton (1984). For the free T4 assay, serum from a hyperthyroid cat 
was diluted 1:2, 1:4, 1:8 and 1:16 with hormone-free serum prior to the dialysis 
procedure. The extent of cross reactivity for chemically similar substances was assessed 
by the kit manufacturers.
Sensitivity
For both the total and free T4 assays, the detection limit was calculated as the 
concentration corresponding to the mean minus lsd of the 0 standard.
Precision and drift
For the total T4 assay, low, medium and high pools were included in each assay. The 
medium pool was prepared from healthy cat serum and the low pool from this by dilution 
with hormone-free feline serum. The high pool was prepared from hyperthyroid cat 
serum. The medium pool was assayed repeatedly in one assay to calculate intra-assay 
precision. The low, medium and high pools were included at the beginning of each assay 
to calculate the interassay precision. In addition, the low, medium and high pools were 
placed at the beginning and end of the assay over four assays to calculate drift.
For the free T4 assay, medium and high pools were included in each assay. The 
medium pool was prepared from healthy cat serum and the high pool from hyperthyroid 
cat serum. The medium pool was assayed repeatedly, incorporating the dialysis step
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each time, to calculate intra-assay precision. The medium and high pools were included 
at the beginning of each dialysis and assay run to calculate interassay precision. In 
addition, the medium pool was placed at the end of one assay to estimate drift.
Each pool was stored at -20°C in aliquots of 0.5 ml to avoid repeated freeze/thaw 
cycles.
Accuracy
For the total T4 assay accuracy was assessed by determining the recovery of known 
amounts of T4 added to feline serum with endogenous hormone concentrations in the 
low (hormone-free serum), medium (prepared from healthy cat serum) and high 
(prepared from hyperthyroid cat serum) end of the reference range. A nominal 1 mmol/1 
T4 solution was prepared by dissolving 88.9 mg (formula weight 888.9) of L-thyroxine 
sodium salt pentahydrate crystalline (T2126, Sigma Chemical Company Limited) in 100 
ml of a 1:1 propylene glycol: distilled water solution, adjusted to pH 9.0 by the dropwise 
addition of a 1 molar sodium hydroxide solution. The concentration of this solution was 
checked spectrophotometrically and found to have a concentration of 0.85 mmol/1. This 
solution was sequentially diluted in barbitone buffer (pH 8.6), such that the addition of 
30 ul to 1.0 ml of test serum increased the concentration by 24.7 nmol/1. The per cent 
thyroid hormone recovery was calculated from the equation;
(Concentration of hormone found-Endogenous hormone concentrationlx 100 
Concentration of hormone added 
The recovery test used for assessing accuracy could not be applied to the free T4 
assay. As an alternative, the accuracy of the method itself was assessed by assaying the 
two quality control samples supplied with each kit. These contained T4 lyophilised in a 
protein matrix with 0.1% sodium azide and required reconstitution with distilled water 
prior to use.
Clinical material
Blood samples were obtained from a series of healthy cats and stored as described in 
Chapter 2, until required for assay. These healthy animals were being sampled for FeLV, 
FIV and/or FCoV antibody titres either routinely as adults prior to mating, as kittens 
prior to rehoming or because of contact with a cat known to have a viral related illness.
4.4 RESULTS
Results of the validation methods for the total and free thyroxine assays 
Specificity
The results of the parallel studies are presented in Tables 3 and 4.
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Sample Observed concentration Expected concentration % Observed/Expected
Undiluted 261.13
Diluted 1: 1.25 194.36 208.90 93.04
1 1.56 153.25 167.12 91.70
1 2.34 102.44 111.42 91.94
1 3.52 71.46 74.28 96.20
1 5.27 48.03 49.52 97.00
1 7.91 33.64 33.01 101.91
1 11.87 27.69 22.01 125.81
1 17.80 16.82 14.67 114.66
Mean ±sd 101.53 ±12.37
Table 3. The observed and expected concentrations of total thyroxine 
hyperthyroid cat serum serially diluted with hormone-free feline 
concentrations are expressed in nmol/1.
in a sample of 
serum All
Sample Observed concentration Expected concentration % Observed/Expected
Undiluted 231.80
Diluted 1: 2 94.10 115.90 81.19
1: 4 56.14 57.95 96.88
1: 8 26.58 28.98 91.73
1:16 14.97 14.89 100.64
Mean ±sd 92.61 ±8.44
Table 4. The observed and expected free thyroxine concentrations in a sample of 
hyperthyroid cat serum serially diluted with hormone-free feline serum All 
concentrations are expressed in pmol/1.
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For both assays, cross reactivity data were provided by the manufacturers. For the 
total T4 assay, these were 1.4 % for rT3, 0.02 % for T3 and <0.01 % for 3,,5'-diiodo-L- 
thyronine, 3,-iodo-L-thyronine, phenytoin, phenylbutazone, sodium salicylate and o- 
acetylsalicylic acid. For the free T4 assay, these were 0.044 % for D-T4, 0.005 % for 
T3, DL-T3 and 3-iodo-L-thyronine, 0.0036 % for rT3, 0.001 % for 3,5'-diiodo-L- 
thyronine and 0 % for aspirin, sodium- salicylate, phenylbutazone and 5,5- 
diphenylhydantoin.
Sensitivity
For the total T4 assay, the detection limit, calculated over five assays, was always less 
than 2.00 nmol/1 (range; 0.23 - 1.81 nmol/1). Any concentrations below this were 
arbitrarily defined as 2.00 nmol/1 for statistical analyses.
For the free T4 assay, the detection limit, calculated over six assays, was always 
less than 1.00 pmol/1 (range; 0.10 - 0.72 pmol/1). Any concentrations below this were 
arbitrarily defined as 1.00 pmol/1 for statistical analyses.
Precision and drift
The results from which data on precision and drift were calculated are presented in 
Appendices 4, 5, 6 and 7.
For the total T4 assay, the medium pool was assayed 20 times within one assay 
resulting in an intra-assay c.v. of 6.48 % (mean +sd; 30.33 +1.96 nmol/1). For the free 
T4 assay, the medium pool was assayed 10 times within one assay resulting in an intra- 
assay c.v. of 8.48 % (mean +sd; 24.02 +2.04 pmol/1).
For the total T4 assay, the interassay c.v. for the low, medium and high pools over 
14 assays were 9.60 % (mean +sd; 16.09 +1.54 nmol/1), 8.94 % (mean +sd; 33.01 +2.95 
nmol/1) and 5.64 % (mean +sd; 153.51 +8.65 nmol/1), respectively. There was no 
evidence of drift (P > 0.05) as assessed by Student's t test on pools placed at the 
beginning and end of a run over four assays. For the free T4 assay, the inter-assay c.v. 
for the medium and high pools over six and five assays respectively, were 16.01 % (mean 
+sd; 26.20 +4.19 pmol/1) and 13.03 % (mean +sd; 131.91 +17.18 pmol/1). In one assay, 
the medium pool was placed at the beginning and end of the run with results of 26.32 
and 25.33 pmol/L, respectively.
Accuracy
The results from which data on accuracy were calculated are presented in Appendices 8 
and 9.
The mean +sd recovery for the total T4 assay was 99.82 +10.48 %. For the free 
T4 assay, the supplied quality control samples fell within the expected target ranges for 
each assay, respectively.
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Serum total and free thyroxine concentrations in healthy cats
These results are detailed in Appendix 10 and summarised in Table 5.
The mean ±sd age of the 50 healthy cats in which circulating total T4 
concentrations were determined was 4.5 ±3.6 years (range; 0.08 - 14.0 years). Thirty- 
five cats were domestic short haired, the remainder being pedigree animals of various 
breeds. Twenty-five animals were male (17 castrated, eight entire) and 25 were female 
(13 ovariohysterectomised, 12 entire). Serum free T4 concentrations were determined in 
38 of these animals aged between 0.08 and 14.0 years (mean ±sd; 4.14 ±3.17 years). 
This group consisted of 20 male (14 castrated, six entire) and 18 female (10 
ovariohysterectomised, eight entire) animals; 24 were domestic short-haired and the 
remainder were pedigree animals. In the remaining 12 animals, an inadequate volume of 
serum was available to measure both total and free T4 concentrations. The free T4 
fraction, expressed as a percentage, was determined from the serum total and 
corresponding free T4 concentration.
The reference ranges for serum total and free T4 concentrations were calculated as 
the mean ±2sd and were 10.75 - 41.25 nmol/1 and 8.14 - 41.45 pmol/1, respectively.
Total T4 (nmol/1) Free T4 (pmol/1) % free T4 fraction
n 50 38 38
Mean 26.00 24.79 0.10
sd 7.62 8.33 0.06
Minimum 11.67 6.63 0.04
1st quartile 20.72 19.52 0.08
Median 26.60 23.88 0.09
3rd quartile 31.37 29.76 0.12
Maximum 44.33 47.72 0.37
Table 5. Summary statistics of serum total and free thyroxine (T4) concentrations and 
free T4 fractions in healthy cats.
4.5 DISCUSSION
The total and free T4 assays were easy to use and readily adaptable for routine 
application in a clinical laboratory. The free T4 assay was more time consuming because 
of the dialysis step, a larger volume of serum was required (200 ul compared to 50 ul for
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a total T4 determination) and was approximately three times more expensive than a total 
T4 estimation. Modification of the total T4 assay to include a low standard of 12.5 
nmol/1 introduced a potential dilutional error into the standard curve, but this drawback 
was outweighed by the benefits in measuring the lower total T4 concentrations in the cat 
compared to man.
The results of the validation studies were considered to be adequate to excellent. 
Data on specificity for T4 were provided by the respective manufacturers and avoided 
the expense and time involved in their determination. The results of the inhibition curves 
for both total and free T4 in feline serum were parallel to their respective standard 
curves, and confirmed that the assays were specific for human and feline T4. The 
sensitivity (detection limit) of an assay, defined as that concentration which can be 
distinguished from zero with a stated degree of probability can be evaluated using a 
variety of techniques (Midgley, Niswender & Rebar, 1969; Hunter, 1978). The most 
common method is to determine the concentration corresponding to the mean ±2sd of 
replicate measurements of the 0 standard or the lowest value that can be distinguished 
from 0 at the 95 % confidence limit. Some workers consider it more accurate to report 
the detection limits of an assay as the lowest and the highest standards (Thoday, 1986). 
However, this limits the range of an assay and computerised methods of curve fitting are 
adept at extrapolating concentrations below or above these confines. In both assays used 
here, the sensitivity for each assay run was calculated by the computer programme as the 
concentration corresponding to the mean ±lsd of the 0 standard. This is perhaps an 
overestimation of the sensitivity, but the arbitrary definition of a concentration that 
always exceeded this limit was considered to overcome this problem. The sensitivity of
2.00 nmol/1 for the total T4 assay was the same figure as that reported by Sparkes et al. 
(1991) using the same kit method. For the free T4 assay, the sensitivity of 1.00 pmol/1 
was similar to that of 1.93 pmol/1 reported by the manufacturers, which was itself an 
improvement on the higher concentration of 2.57 pmol/1 reported for the prototype 
(Nelson & Tomei, 1988).
In RIAs precision is considered adequate if the intra-assay c.v. is between 5 and 10 
% and the interassay c.v. between 8 and 15 % (Hunter, 1978). The intra-assay c.v.'s of 
6.48 and 8.48 % for the respective medium pools used in the total and free T4 assays 
were therefore excellent. The interassay c.v.'s for the low, medium and high pools in the 
total T4 assay and the high pool in the free T4 assay were below 15 % and were 
therefore also considered adequate. The interassay c.v. for the medium pool in the free 
T4 assay was slightly higher at 16.01 %. However, given the two steps (dialysis and 
RIA) for this assay and that calculations were made over six assay runs only, this c.v. 
was felt to be acceptable. The lack of drift calculated over four assay runs for the total 
T4 assay was reassuring, since the time for completion of an assay run was less than 3 
hours. Drift was not considered to be as great a potential problem for the free T4 assay,
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because of the long incubation periods, but the placement of a medium pool at the 
beginning and end of one assay run revealed no significant difference.
Accuracy in a hormone RIA is usually considered adequate if the recovery of 
known amounts of added hormone is between 80 and 120 % (Thoday, 1986). The 
accuracy (mean ±sd; 99.8+10.5 %) of the total T4 assay was therefore excellent, even 
when individual results over the low, medium and high end of the standard curve were 
examined. Accuracy was impossible to determine for the free T4 assay, because free T4 
concentrations depend both on the quantity of T4 added and on the affinity and amount 
of binding proteins present in the sample. However, the fact that the external quality 
control samples fell within their respective expected values suggested that the assay itself 
was working adequately.
The use of this equilibrium dialysis method for the measurement of circulating free 
T4 concentrations in healthy, euthyroid cats is unique in feline medicine. As in man 
(Ekins, 1975), it could be considered the "gold standard" by which other techniques are 
compared. The measurement of corresponding total and free T4 concentrations and the 
subsequent calculation of the free T4 fraction contributes greatly to our hitherto 
inadequate knowledge of these parameters in cats. The reference range for serum total 
T4 concentrations in healthy euthyroid cats of 10.75 to 41.25 nmol/1, was similar to 
previous reports (Mooney, 1990). The reference range of 8.14 to 41.45 pmol/1 with a 
mean +sd of 24.79 +8.33 for serum free T4 concentrations in healthy cats supports the 
premise of Refetoff, Robin & Fang (1970) that absolute free T4 concentrations are 
similar in all vertebrate species. This range resembles that reported by Ferguson, 
Peterson & Nachreiner (1989) and Refsal et al. (1991) who used equilibrium dialysis and 
the Magic Free T4 analogue RIA. These similarities are not unexpected since the results 
for free T4 concentrations in healthy adult humans tend to be similar whether using 
equilibrium dialysis and direct immunoassays (Stockigt et al., 1981; Gow et al., 1985; 
Liewendahl et al., 1986). However, the low reference range values for the Amerlex-M 
free T4 analogue kit method reported for cats (Jones et al., 1991; Sparkes et al., 1991) 
are inexplicable. The properties of feline thyroid hormone binding proteins may invalidate 
an assay essentially optimised for use with human serum containing TBG and there are 
no reports comparing this kit with any other method in cats. Five unspecified analogue 
RIA's were used to measure free T4 concentrations in 15 healthy dogs and, compared to 
results obtained by equilibrium dialysis, the concentrations found were significantly lower 
(Montgomery, Nelson, Ferguson & Feldman, 1991). The results of free T4 
concentrations measured by analogue RIA in any species should therefore be viewed 
with circumspection.
The calculated mean +sd free T4 fraction of 0.10 +0.06 % confirms previous 
expectations (Peterson & Ferguson, 1989a) and is essentially similar to the unspecified 
reports of Thoday (1990a) and the results obtained in five healthy cats reported by Hays, 
Turrel & Broome (1988). The results are also similar to those reported for the dog
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(Furth et al., 1968; Refetof£ Robin & Fang, 1970; Ferguson & Peterson, 1992). Thus, in 
the cat it can conclusively be said that circulating total T4 concentrations are lower, the 
free T4 fraction is higher but that circulating free T4 concentrations are similar to those 
reported in man.
This study therefore provides a basis upon which the effect of hyperthyroidism and 
non-thyroidal illness on circulating total and free T4 concentrations can be evaluated. In 
addition, it identifies areas where further study might be fruitful. For example, a 
comparison may now be made between analogue methods and equilibrium dialysis in the 
measurement of circulating free T4 concentrations. Moreover, assessments of the effects 
of age, sex, breed and environment on circulating free T4 concentrations in cats, which 
were not carried out due to the small population size in this study, can now be envisaged.
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CHAPTER 5
THE EFFECT OF NON-THYROID AL ILLNESS ON SERUM TOTAL 
THYROXINE CONCENTRATIONS
5.1 LITERATURE REVIEW
A brief introduction to illness and endocrine status
A variety of non-thyroidal illnesses are known to have a profound effect on serum 
thyroid hormone concentrations in humans who have no apparent intrinsic thyroid 
disease (Nicolofif & LoPresti, 1991). Alterations also occur in the dog (Ferguson, 1988). 
More recent investigations suggest similar effects in the cat (Peterson & Gamble, 1990). 
Virtually any illness is capable of such effects. However in humans, these alterations 
usually occur in association with several other systemic hormonal responses. These 
include reductions in circulating insulin-like growth factors, gonadotropin and sex 
hormone concentrations and increases in serum adrenocorticotropin hormone (ACTH) 
and cortisol concentrations. Experimentally, administration of cytokines (interferons, 
interleukins and tumour necrosis factor) produce the characteristic features of illness 
such as fever and leucocyte responses, as well as the endocrine alterations (Nicoloff & 
LoPresti, 1991). It has therefore been suggested that changes in thyroid hormone 
concentrations should be viewed as a part of a coordinated systemic response to illness 
that involves both the immune and the endocrine systems.
The following review will concentrate on the effect of illness on total thyroid 
hormone concentrations in humans, the dog and the cat. A more detailed review of the 
effect of illness on serum free T4 concentrations is presented in Chapter 6.
The effect of illness on serum thyroid hormone concentrations in man
In humans, there are two major and distinct thyroid hormone responses in the face of 
illness. The first, and more common of the two, is associated with a depression of 
serum total and free T3 concentrations with normal or near-normal serum TSH and total 
and free T4 concentrations. This is termed the "low T3 state", often coined the 
"euthyroid sick syndrome" (Wartofsky & Burman, 1982). The second syndrome is 
associated with a depression of both serum T3 and total T4 concentrations and is termed 
the "low T4 state of medical illness" (Wartofsky & Burman, 1982).
The low triiodothyronine state
A variety of illnesses are associated with the low T3 state and include chronic starvation 
or malnutrition, diabetes mellitus, chronic illnesses and certain renal and hepatic diseases. 
In one study, 70 % of hospitalised patients studied had depressed serum total T3 
concentrations (Bermudez, Surks & Oppenheimer, 1975). The decrease in serum T3 
concentrations is roughly related to the severity of the disease (Chopra, Hershman, 
Pardridge & Nicoloff, 1983).
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The underlying mechanism of the low T3 state is a reduction in or impairment of, 
the peripheral conversion of T4 to T3 (Vagenakis, Portnay, O'Brian, Rudolph, Arky, 
Ingbar & Braverman, 1977; Faber, Thomsen, Lumholtz, Kirkegaard, Siersbaek-Nielsen 
& Friis, 1981; Kaptein, Robinson, Grieb & Nicoloff  ^ 1982a). In healthy individuals, the 
major route of T4 disposal is by 5'- and 5-deiodination producing T3 and rT3, 
respectively (Nicoloff 1986). In non-thyroidal illness, serum total T3 concentrations are 
reduced while serum rT3 are reciprocally elevated and the fraction of T4 metabolism 
accounted for by the combined T3 and rT3 production is reduced (Chopra et al., 1983). 
This is primarily due to reduced T3 production, since production of rT3 remains 
relatively constant (Faber et al., 1981; Kaptein et al., 1982a; Chopra et al., 1983; 
LoPresti, Gray & Nicoloff 1991). Thus, the increased serum concentrations of rT3 
appear to be a result of reduced clearance rather than increased production (LoPresti, 
Gray & Nicoloff 1991). A unifying explanation would be inhibition of the 5'-deiodinase 
enzyme responsible both for T3 production and clearance of rT3 to its less iodinated 
metabolites (Wartofsky & Burman, 1982). However, there are no substantiated reports 
of such inhibition. The accounting gap in T4 disposal suggests that another metabolite of 
T4 is formed as an alternative and possibly diverting pathway. Such an alternative 
pathway has not yet been identified.
Serum TSH concentrations are usually normal in non-thyroidal illness (Wartofsky 
& Burman, 1982). Various explanations have been advanced for the failure of the 
pituitary to increase TSH production and secretion in response to the low serum T3 
concentrations of non-thyroidal illness. The normal serum T4 concentrations coupled 
with the particularly active type II 5'-deiodinating system in the pituitary, which may not 
be inhibited by illness, may compensate for reduced circulating T3 concentrations 
(Utiger, 1980; Bacci, Schussler & Kaplan, 1982). A lowering of the "setpoint" about 
which serum thyroid hormone concentrations regulate TSH secretion has been suggested 
(Utiger, 1980). An alternative explanation is that the stress of illness can inhibit pituitary 
TSH secretion, thereby preventing the expected response. Bacci, Schussler & Kaplan 
(1982) found that during the recovery phase of non-thyroidal illness, the mean serum 
concentration of TSH in 41 patients was significantly higher than in both healthy patients 
and the same patients during the acute stage of the illness. During this stage serum 
concentrations of T3 remained depressed, albeit higher than during the acute stage of the 
illness. The reappearance of the T3-dependent negative feedback suggested alleviation 
of stress inhibition of pituitary TSH secretion. Serum TSH concentrations during the 
recovery phase of the illness were negatively correlated with both total and free T3 but 
less strongly correlated with total T4. The negative effect of total T4 was presumably 
due to a positive correlation found between serum total T4 and total T3 concentrations. 
There was no negative correlation between serum TSH and free T4 concentrations. 
Thus, T3 was the predominant stimulus to TSH secretion during recovery from non- 
thyroidal illness. The authors reported that in general, the serum concentrations of TSH 
found in the recovery phase were lower than those of hypothyroid patients with primary
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hypothyroidism and similar serum total T3 concentrations. This may have been due to 
the persistence of some degree of stress inhibition. In the same study in contrast to the 
findings in patients that survived, serum TSH concentrations did not increase in 22 
patients that died. An elevated serum TSH concentration could therefore be viewed as a 
favourable prognostic sign. A variety of hormones and peptides inhibit TSH and TRH 
secretion and are secreted in response to stress. These include cortisol, dopamine, 
growth hormone, opiate peptides, somatostatin and cholecystokinin (Chopra et al.,
1983).
Apart from low serum concentrations of T3, affected patients have no other 
biochemical or clinical features classically associated with hypothyroidism Utiger (1980) 
argued that since administration of T3 during fasting resulted in increased urinary 
excretion of nitrogen, including 3-methyl-histidine, an indicator of muscle breakdown, 
the reduced T3 production of illness and fasting would result in conservation of muscle 
and perhaps other protein. Decreased T3 production could also result in a decreased 
rate of oxygen consumption, substrate utilisation and various other catabolic processes. 
Utiger (1980) therefore concluded that the low T3 state is metabolically protective and a 
beneficial adaptation to illness in man.
The low thyroxine state
Both serum total T4 and T3 concentrations are depressed in acute and severe illnesses. 
Decreased serum total T4 concentrations are not as common as decreased serum total 
T3 concentrations. In one study, while 68 % of 195 patients requiring intensive medical 
therapy had decreased serum total T3 concentrations, only 43 % had decreased serum 
total T4 concentrations (Kaptein, Weiner, Robinson, Wheeler & Nicoloff 1982b). A 
continuum of changes probably extends from patients with mild illnesses and the low T3 
state, to critically ill patients who have the low T4 state of medical illness (Nicoloff & 
LoPresti, 1991). The time required from transition from one to the other is presumably 
dependent on the progression of the illness itself.
Patients with the low T4 state of medical illness are not considered to be 
hypothyroid. Serum TSH concentrations are usually normal compared to the elevated 
concentrations seen in primary thyroid failure (Chopra et a l ,  1983). Thus, the low T4 
state may be due to a reduction in T4 secretion by the thyroid gland as a consequence of 
either secondary or tertiary hypothyroidism However, serum free T4 concentrations, 
measured by the gold standard techniques of equilibrium dialysis or ultrafiltration, are 
usually normal (Chopra et al., 1983). T4 production rates in non-thyroidal illness are 
also normal (Kaptein, Grieb, Spencer, Wheeler & Nicoloff, 1981a). In addition, T4 
therapy in non-thyroidal illness is not beneficial. Brent & Hershman (1986) treated 23 
severely ill patients with T4. This treatment resulted in rapid normalisation of serum T4 
concentrations. Serum T3 concentrations remained depressed, rT3 concentrations 
increased and TSH concentrations were suppressed. Survival was not improved. The 
authors concluded that, by inhibiting TSH secretion, T4 treatment may suppress an
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important mechanism for normalisation of thyroid function during recovery (Bacci, 
Schussler & Kaplan, 1982).
Marked increases in the serum free fraction of T4 occur in non-thyroidal illness. In 
addition, kinetic data of T4 metabolism in non-thyroidal illness have revealed an 
increased metabolic clearance rate and fractional catabolic rate, analogous to euthyroid 
patients with low serum concentrations of TBG (Kaptein et a l ,  1981a, 1982a). 
However, immunoassayable serum TBG concentrations in affected patients are normal or 
only minimally reduced (Kaptein et a l,  1981a, 1982a). Thus, the major cause of reduced 
serum total T4 concentrations is an acquired defect in which the binding of T4 to serum 
proteins is altered. In both of these studies, an impairment of extravascular T4 binding 
was apparent, which may have been the result of a common factor (Kaptein et a l,  1981a, 
1982a).
Several studies have suggested that a substance is released during illness which 
inhibits T4 binding to serum proteins, although this is controversial. Chopra, Teco, 
Nguyen & Solomon (1979b) were the first authors to demonstrate the existence of a 
non-dialysable inhibitor in non-thyroidal illness. There was a smaller decrease or an 
actual increase in the dialysable fraction of T4 when sera from sick patients were added 
to pooled normal serum, as compared to a decrease when normal sera were added. The 
inhibitor was either an immunoglobulin M (IgM) antibody, an immune complex with 
IgM, or a substance that shares with IgM several physicochemical and antigenic 
characteristics. However, in another study, although the existence of a non-ultrafiltrable 
inhibitor was confirmed, it was neither rT3 nor an immunoglobulin (Woeber & Maddux,
1981). The discrepancy in these results may have been the result of different 
methodologies. Oppenheimer, Schwartz, Mariash & Kaiser (1982) also reported the 
existence of an inhibitor of serum protein binding which was not readily dialysable but 
which could not be identified with any immunoglobulin fraction. Homogenates of 
extrathyroidal tissue of patients with non-thyroidal illness and extrathyroidal tissue of 
healthy rats contained an inhibitor of protein binding similar to the serum inhibitor 
(Chopra, Solomon, Teco & Eisenberg, 1982). These authors suggested that the inhibitor 
may leak into the circulation during illness. Subsequently, a simple, sensitive, rapid and 
precise competitive ligand binding assay was putatively developed for the measurement 
of the thyroid hormone binding inhibitor in serum and extrathyroidal tissues (Chopra, 
Huang, Hurd, Beredo & Solomon, 1984). In this study, the inhibitor was found to be 
associated with a lipid moiety, several fatty acids, particularly oleic and linoleic acids, 
being candidates, with the small intestine as a potent source of the inhibitor. In accord 
with this, in vitro studies with oleic acid suggest it may be an important inhibitor in non- 
thyroidal illness (Chopra, Huang, Solomon, Chaudhuri & Teco, 1986). In contrast with 
these reports, Mendel, Laughton, McMahon & Cavalieri (1991) failed to find evidence of 
an inhibitor of T4 to serum binding proteins in non-thyroidal illness. Mixtures of sera 
from 111 sick patients with a pool of normal sera yielded free T4 fractions predicted 
from the law of mass action without assuming the presence of an inhibitor. These
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authors suggested that in previous reports, evidence for the presence of an inhibitor may 
have been the result of heparin (used to keep intrarterial lines patent) in the sera or the 
failure to select normal sera with a low triglyceride concentration leading to in vitro 
generation of free fatty acids. The authors do conclude however, that irreversible 
inhibitors of binding indistinguishable from altered affinities of the binding proteins may 
be present in non-thyroidal illness. An alternative and plausible explanation for the low 
serum total T4 concentrations could be the presence of desialylated TBG which is 
immunoreactive but has a low affinity for T4 (Mendel et al., 1991).
Although the physiological significance of the low T4 state remains unknown an 
intriguing and important aspect is its use as a prognostic indicator (Chopra et a l , 1983). 
Slag, Morley, Elson, Crowson, Nuttall & Shafer (1981a) reported subnormal serum total 
T4 concentrations in 22% of 84 patients admitted to an intensive care unit. An initial 
serum total T4 concentration of less than 38.61 nmol/1 was correlated with 84 % 
mortality, a concentration of 38.61 to 64.35 nmol/1 with 50 % mortality while only 15 % 
of patients with reference range serum total T4 concentrations died. In the same study, 
the predictive value of low serum total T3 concentrations was poor. A more detailed 
study of the predictive value of altered thyroid hormone parameters was subsequently 
reported by Kaptein et a l  (1982b). Decreased serum total T4 concentrations had the 
highest correlation with mortality (P < 0.001) and correctly predicted outcome in 70 % 
of patients. Other thyroid hormone indices, including total T3, T3UT, FTI and the free 
T4 fraction, correlated with total T4 and did not contribute independently to prediction 
accuracy. Seventy-five patients with nadir serum total T4 concentrations below 38.61 
nmol/1 were also studied. In these patients only an increased free T4 fraction was found 
to correlate significantly with mortality and correctly predicted outcome in 67 % of 
survivors and 65 % of non-survivors. If a circulating inhibitor of T4 binding is present in 
non-thyroidal illness, the extent of the impaired binding would appear to reflect the 
severity of the disease state and explain the relationship between decreased serum total 
T4 concentrations, the increased free T4 fraction and mortality (Kaptein et a l , 1982b).
Miscellaneous states
Most patients with non-thyroidal illness present with either the low T3 or low T4 state. 
However, several variants can occur. Chronic renal disease and the nephrotic syndrome 
result in a unique response since serum rT3 concentrations do not increase as serum total 
T3 concentrations decrease (Wartofsky & Burman, 1982; Nicoloff & LoPresti, 1991). 
This is probably due to failure of rT3 clearance rates to slow as they do in other non- 
thyroidal illnesses. Circumstantial evidence suggests that a circulating factor, possibly 
increased parathormone concentrations, may play a role (Nicoloff & LoPresti, 1991). 
Non-thyroidal illness may also lead to hyperthyroxinaemia (proportionate increments in 
circulating total T4 and T3) due to acquired TBG excess (Borst, Eil & Burman, 1983). 
This effect most commonly occurs in patients with infectious hepatitis, chronic active 
hepatitis, and primary biliary cirrhosis (Borst, Eil & Burman, 1983; Nicoloff & LoPresti,
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1991). The hepatocellular damage in these disorders may cause leakage of excessive 
amounts of TBG into the circulation or increased hepatocyte TBG synthesis (Borst, Eil 
& Burman, 1983; Nicoloff & LoPresti, 1991). There may also be discharge of hepatic 
stores of T4 (Nicoloff & LoPresti, 1991). Elevated serum total T4 concentrations with 
normal total T3 concentrations can also occur, presumably due to decreased 
extrathyroidal metabolism of T4 (Gavin, Rosenthal & Cavalieri, 1979; Borst, Eil & 
Burman, 1983). Such patients are difficult to differentiate from hyperthyroid patients 
with concurrent illnesses and depressed serum total T3 concentrations.
A variety of drugs are also capable of altering circulating thyroid hormone 
concentrations (Wenzel, 1981; Wartofsky & Burman, 1982; Borst, Eil & Burman, 1983). 
Most notable are the effects of endogenous or exogenous glucocorticoids. These 
hormones inhibit serum thyroid hormone protein binding, peripheral conversion of T4 to 
T3, and suppress both basal and TRH-stimulated TSH release (Wartofsky & Burman,
1982).
The effect of illness on serum thyroid hormone concentrations in the dog
In the dog fasting, non-thyroidal illness and drug administration are known to affect 
serum total thyroid hormone concentrations. As in man, these effects complicate the 
diagnosis of hypothyroidism, a common disease in the dog. In an intensive care unit, 
almost all dogs (numbers unspecified) had serum total T4 and T3 concentrations below 
the reference range and approximately half had undetectable concentrations (Ferguson, 
1988). However, there are notable differences in the pattern of thyroid hormone changes 
between man and the dog.
In contrast to the situation in humans, a two week period of fasting in the dog was 
associated with a decrease in serum total T3, but unchanged serum total T4 and rT3 
concentrations (deBruijne, Altszuler, Hampshire, Visser & Hackeng, 1981). Laurberg & 
Boye (1984) similarly found that fasting was associated with a pronounced decrease in 
serum total T3 but a slight decrease in serum total T4 and rT3 concentrations. The 
absence of increased serum rT3 concentrations may be related to the dog's resistance to 
the development of ketosis during fasting (deBruijne et a l,  1981).
Spontaneous hyperadrenocorticism has a profound effect on circulating thyroid 
hormone concentrations. Serum total T4 and T3 concentrations were measured in a 
series of 102 dogs with untreated hyperadrenocorticism (Peterson, Ferguson, Kintzer & 
Drucker, 1984a). Mean serum total T4 and T3 concentrations were significantly (P < 
0.001) decreased compared to healthy dogs. Serum total T4 and T3 concentrations were 
below the reference range in 58 (57 %) and 53 (52 %) affected dogs, respectively. 
Forty-two of the dogs had both decreased serum total T4 and T3 concentrations, 16 had 
decreased total T4 alone and 11 had decreased total T3 alone. Twenty dogs were 
evaluated after successful treatment when there was a significant increase in serum total 
T4 and T3 concentrations. A TSH stimulation test was performed in 22 additional dogs 
with hyperadrenocorticism In these animals both basal and post-TSH serum total T4
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concentrations were significantly (P < 0.01) lower than in healthy animals. To examine 
the possible mechanisms involved, serum free T4 (by equilibrium dialysis) and rT3 
concentrations were subsequently measured in 42 dogs (Ferguson & Peterson, 1992). 
The mean free T4 fraction was significantly higher (P < 0.001) in affected dogs 
suggesting reduced serum thyroid hormone binding. However, despite the high free T4 
fraction, absolute serum free T4 concentrations were significantly (P < 0.001) lower in 
the dogs with hyperadrenocorticism. The mean serum rT3 concentration, measured in 
23 dogs with this disease was also significantly (P < 0.001) lower compared to healthy 
controls. The authors concluded that inhibition of peripheral 5'-deiodination of T4 is not 
a predominant feature of chronic glucocorticoid excess in the dog. Suppression of 
pituitary TSH secretion may play the major role in the alterations of serum thyroid 
hormone concentrations in spontaneous hyperadrenocorticism in the dog (Ferguson & 
Peterson, 1992). By contrast, acute doses of glucocorticoids are associated with minimal 
changes in serum total T4 concentrations, while serum total T3 concentrations are 
depressed and rT3 increased. These findings are suggestive of 5'-deiodination inhibition 
(Woltz, Thompson, Kemppainen, Munnell & Lorenz, 1983; Laurberg & Boye, 1984).
Larsson (1987) measured serum concentrations of total T4, T3 and rT3 in 35 dogs 
with hepatic disease, 31 dogs with renal disease, 22 dogs with diabetes mellitus and 40 
dogs with spontaneous hyperadrenocorticism. Elevated concentrations of serum rT3 
were found in all illnesses except hyperadrenocorticism. Significantly depressed serum 
total T3 concentrations were not found in any disease, while elevated concentrations 
were found in diabetes mellitus. Depressed serum total T4 concentrations were common. 
The mean serum total T4 was markedly depressed and serum TBPA concentrations 
subnormal in the patients with renal disease. The elevated circulating concentrations of 
T3 found in dogs with diabetes mellitus have not been explained. In another study of six 
dogs with diabetes mellitus, basal serum concentrations of total T4 and T3 were 
essentially normal although the T4 response to TSH administration was blunted 
(Gosselin, Capen, Martin & Targowski, 1980). Peterson & Ferguson (1989a) observed 
subnormal concentrations of both serum total T4 and T3 concentrations in uncontrolled 
diabetic ketoacidosis and suggested this may reflect the severity of the disease. These 
authors also studied 16 dogs with chronic renal disease. Subnormal serum total T4 
concentrations were found in 14 animals, and four of these had undetectable 
concentrations. Most of the dogs had depressed serum total T3 but elevated serum rT3 
concentrations. Elevated serum concentrations of both serum total T4 and T3 can occur 
in obese dogs (Gosselin et al., 1980).
The estimation of serum total T4 concentrations is useful as a prognostic indicator 
in humans (Slag et a l , 1981a; Kaptein et a l ,  1982b). Serum total T4 concentrations are 
frequently depressed by non-thyroidal illness in the dog. However, there are no 
conclusive reports evaluating the correlation between the degree of suppression, severity 
of illness and subsequent mortality in this species.
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The effect of illness on serum thyroid hormone concentrations in the cat
There is only one report detailing the effect of non-thyroidal illness on serum thyroid 
hormone concentrations in the cat. Peterson & Gamble (1990) measured serum total T4 
concentrations in a series of 494 cats with a variety of illnesses and a group of 156 
healthy cats. The sick cats ranged in age from one to 24 years (mean ±sd, 12.6 ±3.6 
years). The various categories of disease included renal failure (n = 128), diabetes 
mellitus (n = 37), congestive heart failure (n = 27), systemic neoplasia (n = 34), focal 
neoplasia (n = 44), hepatic disease (n = 26), inflammatory bowel disease (n = 23), 
inflammatory pulmonary disease (n = 17), miscellaneous disorders (n = 79) and 
undiagnosed disease (n = 79). The cats were allotted to groups on the basis of severity 
of illness (i.e. mild (n = 107), moderate (n = 244) and severe (n = 143)) and also 
outcome (i.e. lived (n = 371), died (n = 29) or euthanased (n = 94)). The sick cats had 
significantly (P < 0.001) lower serum total T4 concentrations than healthy controls. 
Mean serum total T4 concentrations were lowest in cats with diabetes mellitus (10.5 
±11.1 nmol/1), hepatopathy (10.8 ±7.6 nmol/1), renal failure (12.3 ±8.4 nmol/1) and 
systemic neoplasia (12.6 ±9.1 nmol/1). The percentage of cats with serum total T4 
concentrations below 10.0 nmol/1 was highest in diabetes mellitus (59 %), hepatopathy 
(54 %), renal failure (48 %) and systemic neoplasia (41 %). By contrast serum total T4 
concentrations were minimally affected by focal neoplasia, since only 4 % had values 
below the reference range. There was also a significant decrease in serum total T4 
concentrations from healthy cats through those with mild (mean ±sd, 21.3 ±6.8 nmol/1), 
moderate (14.8 ±8.1 nmol/1) and severe (6.5 ±5.8 nmol/1) illnesses. The differences in 
serum total T4 concentrations between the various disease categories was almost entirely 
attributable to the severity of the disease. Serum total T4 concentrations in the cats that 
died (mean ±sd, 7.8 ±9.8 nmol/1), or were euthanased (10.0 ±7.0 nmol/1) were 
significantly (P < 0.001) lower than in those cats that survived (15.2 ±8.8 nmol/1). Of the 
sick cats with low (less than 10.0 nmol/1) serum total T4 concentrations (n = 182), 41 % 
died or were euthanased. By contrast, only 20 % of the cats (n = 201) with low normal 
(10.0 - 20.0 nmol/1) and 7 % of the 111 cats with normal (20.0 - 50.0 nmol/1) serum total 
T4 concentrations died or were euthanased.
In this study, the presence or absence of palpable goitre was recorded in the sick 
cats and a comparison made of their respective serum total T4 concentrations. This is 
addressed in more detail in Chapter 7.
There is only one report on the effect of specific drug therapy on thyroid function 
in healthy cats (Peterson & Ferguson, 1989b). In eight healthy cats, an 
immunosuppressive dose of prednisone (10 mg/cat) was injected intramuscularly, 
followed 24 hours later by a repository subcutaneous injection of methylprednisolone 
acetate (20 mg/cat). There was a significant (P < 0.004) decrease in serum total T4 
concentrations from a mean ±sd of 15.4 ±3.1 nmol/1 to 8.0 ±2.2 nmol/1, 24 hours after 
injection of prednisone. When retested one and two weeks later (after injection of the 
methylprednisolone acetate), the serum total T4 concentrations of 14.2 ±7.1 and 17.3
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+7.1 nmol/1, respectively were not significantly different from the pre-treatment values. 
Thus, an immunosuppressive dose of glucocorticoids acutely depresses serum total T4 
concentrations, but a standard dose of methylprednisolone acetate has no detectable 
effect.
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Non-thyroidal illness in both man and the dog is capable of suppressing serum total 
thyroid hormone concentrations often to levels indistinguishable from those exhibited in 
hypothyroid patients (Wartofsky & Burman, 1982; Kaptein et al. 1982b; Chopra et al. 
1983; Peterson et a l,  1984a; Larssen, 1987; Ferguson, 1988, Peterson & Ferguson, 
1989a; Nicoloff & LoPresti, 1991). There is only one report of the effect of non- 
thyroidal illness on thyroid hormone concentrations in the cat (Peterson & Gamble, 
1990). In this study only serum total T4 concentrations were measured and were found 
to be significantly depressed in ill cats. The present study was designed to attempt to 
both corroborate these results and to establish a data base for further studies on the 
possible mechanisms involved.
5. MATERIALS AND METHODS
Clinical material
The case material comprised a series of 76 sick geriatric cats referred to Glasgow 
University Small Animal Hospital. Thirty-seven were female (33 ovariohysterectomised, 
four entire) and 39 were male (37 castrated, two entire). They ranged in age from 5.0 to 
20.0 years with a mean ±sd of 10.1 ±3.6 years. Fifty-eight of the cats were either 
domestic short (n = 54) or long (n= 4) haired; the remaining cats represented four other 
breeds Siamese (n = 12), Persian (n = 3), British Blue (n = 2) and Birman (n = 1). In 
each case, a diagnosis of a non-thyroidal illness was made as described in Chapter 2. 
Most of these cats form part of the survey detailed in Chapter 3.
In addition, 31 younger sick cats were included in this study. Seven were female 
(five ovariohysterectomised, two entire) and 24 were male (20 castrated, four entire). 
They ranged in age from 0.5 to 4.5 years with a mean ±sd of 2.4 ±1.3 years. Twenty- 
two of the cats were either domestic short (n = 19) or long (n = 3) haired; the remainder 
were Persian (n = 4), Siamese (n = 2), Burmese (n = 2) and Devon Rex (n = 1). A 
diagnosis of a non-thyroidal illness was made using the same criteria as for the older cats.
The healthy cats in which serum total T4 concentrations were measured for 
comparison purposes are described in Chapter 4.
Estimation of serum total thyroxine concentrations
At the time of initial presentation a serum sample from each case was stored as described 
in Chapter 2, until required for assay. Serum total T4 concentrations were measured as 
described in Chapter 4.
Statistical analyses
The Mann Whitney U test was used for all statistical analyses.
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Serum total thyroxine concentrations in sick cats
These results are detailed in Appendix 11 and summarised in Table 6.
There was no significant difference (P > 0.05) in the serum total T4 concentrations 
between the geriatric and young sick cats. These data were therefore grouped together 
for future analyses.
Only two sick cats had serum total T4 values (43.77 and 45.33 nmol/1) exceeding 
the reference range (10.75 - 41.25 nmol/1) but were less than 3 sds from reference mean 
(48.87 nmol/1). Neither of the cats were severely ill. One (case number 114861) was 
mildly hypokalaemic after a period of anorexia of undetermined cause, while the other 
(case number 117989) was suffering recurrent vomiting as a result of mild congenital 
pyloric stenosis. There were no clinical features of thyrotoxicosis apparent in either 
animal and both cats remained healthy after treatment for follow-up periods of two years. 
The next highest value was 33.51 nmol/1.
Comparison of serum total thyroxine concentrations in sick and healthy cats
Serum total T4 concentrations were significantly (P < 0.001) lower in the sick cats 
compared to the healthy controls (mean ±sd, 26.00 ±7.62; reference range, 10.75 - 41.25 
nmol/l)(Figure 5).
Outcome of illness compared to serum total T4 concentrations in sick cats
These data are summarised in Table 7.
There was a significant difference (P < 0.001) in the serum total T4 concentrations 
in those cats that died or required euthanasia (n = 49) compared to those that remained 
alive (n = 58) (Figure 6). In 40 cases (82 %) the cats died or were euthanased at the 
time of initial presentation, hospitalisation or shortly afterwards. When the time to 
euthanasia was delayed, this was a result of owners refusing this option or because 
attempted treatment failed. There was only one cat (case number 114769) with a serum 
total T4 concentration as low as 2.00 nmol/1 that survived. This cat was suffering from a 
protein-losing nephropathy.
The mortality of the cats associated with different serum total T4 concentrations is 
presented in Figure 7. The overall mortality of the 107 cats was 46%, and ranged from 
83 % in cats with serum total T4 concentrations less than 5.00 nmol/1 to 20 % in cats 
with concentrations of greater than 25.00 nmol/1. Thirty-nine cats with serum total T4 
concentrations of less than or equal to 20 nmol/1 died or were euthanased, representing a 
mortality of 56% in this group. Ten cats with serum total T4 concentrations greater than 
20 nmol/1 died or were euthanased, representing a mortality of 27 %.
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Geriatric Young Geriatric and young
n 76 31 107
Mean 17.65 16.62 17.35
sd 8.14 9.39 8.49
Minimum 2.00 2.00 2.00
1st quartile 12.01 9.65 11.68
Median 17.50 17.96 17.68
3rd quartile 22.81 24.19 22.95
Maximum 45.33 31.39 45.33
Table 6. Summary statistics of serum total thyroxine (T4) concentrations (nmol/1) in 
geriatric cats, young cats and both geriatric and young cats grouped together. These 
cats were suffering from a variety of non-thyroidal illnesses.
ALIVE DEAD
n 58 49
Mean 20.29 13.87
sd 8.01 7.76
Minimum 2.00 2.00
1st quartile 15.53 8.97
Median 19.94 13.33
3rd quartile 23.59 19.97
Maximum 45.33 28.23
Table 7. Summary statistics of serum total thyroxine concentrations (nmol/1) in cats that 
remained alive, or required euthanasia or died as a direct result of their illnesses.
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HEALTHY SICK
Health status
Figure 5. Box and whisker plot of serum total thyroxine (T4) concentrations in 50 
healthy and 107 sick cats. The box encloses the middle half of the data and is bisected by 
a line representing the median. The whiskers represent the range of typical values. 
Possible outliers are represented by * and represent values from case numbers 114861 
and 117989. There are no probable outliers.
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1
ALIVE DEAD
Outcome
Figure 6. Box and whisker plot of serum total thyroxine (T4) concentrations in 58 sick 
cats that remained alive and 49 cats that died or required euthanasia as a direct result of 
their illnesses. The box encloses the middle half of the data and is bisected by a line 
representing the median. The whiskers represent the range of typical values. Possible 
outliers are represented by * and represent values from case numbers 114861 and 
117989 (high) and 114769 (low). There are no probable outliers.
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Figure 7. The relationship of mortality to serum total thyroxine (T4) concentrations in 
107 cats with a variety of non-thyroidal illnesses. The number of cats which died or 
were euthanased are depicted in parentheses.
5.5 DISCUSSION
These results are in agreement with those of Peterson & Gamble (1990) confirming that 
the presence of non-thyroidal illness has a profound effect on depressing circulating total 
T4 concentrations in the cat. In contrast to their study, the cats were not allocated to 
groups based on the disease category or severity of the illness. This was due to the 
smaller number of cases (107 versus 494) examined and the existence of many categories 
with few cases. However, the two cats with the highest serum total T4 concentrations 
were considered to be the least clinically ill, one recovering from an unknown illness and 
one suffering congenital pyloric stenosis. Their total T4 concentrations exceeded the 
reference range. It could be argued that, contrary to the clinical evidence, they were 
hyperthyroid. However, the serum total T4 values of these two cats did not exceed three 
sds from the reference mean, a value which has been suggested to differentiate 
hyperthyroid cats from the small number of healthy animals with elevated results (Turrel, 
Feldman, Hays & Homof, 1984). Peterson & Gamble (1990) reported that all of the 
high outlying serum total T4 concentrations occurred in the sick cats with palpable 
goitre. A small number of these animals subsequently were known to develop overt 
hyperthyroidism However, in the two cats of the present study, goitre was not palpable 
and hyperthyroidism did not subsequently develop in either animal.
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In this study the inverse correlation between mortality and serum total T4 
concentrations is similar to that found in humans (Kaptein et a l , 1982b). This could be 
viewed as an alternative way of assessing severity of illness since cats that die or are 
euthanased are most likely to be severely ill. This was certainly true in the study 
presented here. The significantly decreased serum total T4 concentrations in the cats that 
died or were euthanased compared to those that survived was therefore expected. Only 
one cat that survived had a serum total T4 concentration at the lower limit of detection. 
Although initially surprising, this cat was severely hypoproteinaemic and the results can 
therefore be explained. As suggested by Peterson & Gamble (1990) this study confirms 
the value of serum total T4 measurements as a prognostic indicator in sick cats.
Neither this study nor that of Peterson & Gamble (1990) specifically addressed the 
possibility of serum total T4 concentrations increasing as the cats recover from ill-health. 
Although likely, since the decline in serum total T4 concentrations is related to the 
severity of illness rather than the specific disease category, this needs to be addressed.
A criticism of this study is the failure to age match the healthy controls (mean ±sd,
4.5 ±3.6 years) to the sick cats, the majority being in excess of 5 years. Since 1986, 
obtaining reference values from healthy cats requires Home Office licensing and the 
healthy cats used in this study were being bled for other reasons. Controlling for age was 
therefore impossible. In the study by Peterson & Gamble (1990) the sick cats were also 
significantly older than the healthy controls. However, they analysed the serum total T4 
concentrations in the healthy group according to age and found no significant difference 
between young and old cats. Thoday, Seth and Elton (1984) reported that serum total 
T4 concentrations varied significantly with age in 318 cats ranging from 4 months to 13 
years, but mean serum total T4 concentrations decreased in cats greater than 5 years and 
then increased rather than decreasing. In addition, in the present study there was no 
significant difference in serum total T4 concentrations in the sick cats less than 5 years 
compared to those greater than 5 years. This suggests that the effect of illness is greater 
than any putative effect(s) of age.
The frequency with which serum total T4 concentrations are depressed in sick cats 
suggests that, as in the dog, the low T4 state of medical illness is more common than in 
humans (Ferguson, 1988; Kaptein et a l , 1982b). Further investigations are required to 
determine if serum total T3 concentrations are also depressed as they are in humans 
(Nicoloff & LoPresti, 1991). The mechanisms involved in depressing serum total T4 
concentrations warrant further investigation. The low circulating total T4 concentrations 
could be the result of decreased thyroid hormone production due to suppressed TSH 
secretion, as they are in spontaneous hyperadrenocorticism in dogs (Ferguson & 
Peterson, 1992). If such is the case, serum free T4 concentrations would be decreased. 
If circulating binding inhibitors were present in sick cats as suggested in humans (Chopra 
et al., 1979b; Woeber & Maddux, 1981; Oppenheimer et a l , 1982; Chopra et a l ,  1982,
1984), the serum T4 fraction would be increased. These questions are addressed in 
Chapter 6 by measurement of serum free T4 concentrations in affected cats.
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CHAPTER 6
THE EFFECT OF NON-THYROID AL ILLNESS ON SERUM FREE 
THYROXINE CONCENTRATIONS
6.1 LITERATURE REVIEW 
General Introduction
While non-thyroidal illness profoundly depresses serum total T4 concentrations in man, 
controversy surrounds its effect on serum free T4 concentrations. This controversy 
reflects the variety of methods available for measurement of circulating free T4 
concentrations (reviewed in Chapter 4). The effect of a variety of non-thyroidal illnesses 
on serum free T4 concentrations in the dog have been reported but the results must be 
examined critically with regard to the assay methods used. There is a paucity of reports 
on the effect of non-thyroidal illness on serum free T4 concentrations in the cat.
The effect of illness on serum free thyroxine concentrations in man
A variety of methods are used for measuring serum free T4 concentrations. The 
principles of the methods are reviewed in Chapter 4. In assessing the validity of 
commercial kit methods, the results obtained should be compared to the reference 
techniques of equilibrium dialysis or ultrafiltration (Ekins, 1985).
Non-analogue kit methods
Serum free T4 concentrations were measured using a labelled-hormone antibody uptake 
RIA method (Immophase, Coming) in 35 euthyroid patients (Chopra, Van Herle, Teco 
& Nguyen, 1980). These patients were hospitalised for a variety of non-thyroidal 
illnesses. Twenty-four of the patients had serum total T4 concentrations within, while 11 
had concentrations below the reference range. The reference range for serum free T4 
concentrations was established using samples from 32 euthyroid, healthy subjects (mean 
±sd, 21.36 ±5.15 pmol/1; range, 13.51 - 35.39 pmol/1). Serum free T4 concentrations 
were within the reference range in all but three of the 24 patients with reference range 
total T4 concentrations. In one patient, the serum free T4 concentration was just below 
the reference range at 12.23 pmol/1, while in the remaining two, the values were clearly 
subnormal at 10.30 pmol/1 each. The mean serum free T4 concentration in this group 
(17.63 pmol/1) was slightly, but significantly (P < 0.01), lower than the reference mean. 
Serum free T4 concentrations were within the reference range in only five of the 11 
patients with subreference range serum total T4 concentrations. Values were below the 
reference range in the remaining six patients (range, 6.82 - 12.87 pmol/1). The mean 
serum free T4 concentration in these 11 patients (12.87 pmol/1) was significantly (P < 
0.001) lower than the reference mean.
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Serum free T4 concentrations were also measured by these workers using the 
equilibrium dialysis technique of Sterling & Brenner (1966). In 32 euthyroid patients, the 
mean ±sd serum free T4 concentration was 29.60 +6.31 pmol/1 (reference range, 18.40 - 
40.80 pmol/1). The mean free T4 concentrations of 89.83 pmol/1 and 46.33 pmol/1 in the 
sick patients with either reference range or subnormal serum total T4 concentrations 
respectively were significantly (P < 0.001 and P < 0.02, respectively) higher than the 
reference mean. The mean free T4 fractions of 0.11 and 0.12 % were higher than that of 
euthyroid patients (0.03 %). In the nine patients with low serum free T4 concentrations 
by RIA, these values were usually within or above the reference range by equilibrium 
dialysis. In one case, the serum free T4 concentration was below the reference range 
using both techniques of measurement. The correlation between serum free T4 
concentrations as measured by RIA and equilibrium dialysis was low (r = 0.32). The 
authors concluded that serum free T4 concentrations as measured by this RIA technique 
would not serve as an appropriate sole test of thyroid status in the presence of non- 
thyroidal illness. In addition, they suggested that the high serum free T4 concentrations 
found by the dialysis method may be related to the putative non-dialysable binding 
inhibitors of non-thyroidal illness (Chopra et al., 1979b).
Kaptein, MacIntyre, Weiner, Spencer & Nicoloff (1981b) evaluated three different 
methods of serum free T4 estimation in a series of 14 healthy subjects and 26 sick and 16 
hypothyroid patients who had comparable serum total T4 concentrations. Serum free T4 
concentrations were measured by equilibrium dialysis using the method of Sterling & 
Brenner (1966) with purification of the tracer before and after dialysis, a labelled- 
hormone, back titration kit method (GammaCoat Two Step Free T4, Clinical Assays), a 
microencapsulated antibody kit method (Liquisol, Damon Diagnostics) and the 
Immophase kit. In sick patients with total T4 concentrations less than 38.61 nmol/1 
(reference range, 64.35 - 154.44 nmol/1) (n = 9), only the serum free T4 concentrations 
measured by equilibrium dialysis (mean ±sem, 30.89 +6.45 pmol/1) and the GammaCoat 
kit (18.02 +6.45 pmol/l) were similar to the concentrations in healthy subjects (mean 
±sem, 29.60 +1.29 and 15.44 +1.29 pmol/1, respectively). All of these values were 
therefore significantly higher (P > 0.01 in each case) than those of the corresponding 
hypothyroid patients. Serum free T4 concentrations as measured by the Liquisol and 
Immophase kits (mean ±sem, 7.72 +1.29 and 6.45 ±1.29, respectively) were significantly 
(P < 0.001 in each case) lower than in healthy patients (mean ±sem, 25.74 +1.29 and
20.59 +1.29 pmol/1, respectively) and were similar to those exhibited by the 
corresponding group of hypothyroid patients. In patients with serum total T4 
concentrations between 38.61 and 64.35 nmol/1 (n = 7), only the serum free T4 
concentrations measured by equilibrium dialysis (mean +sem, 30.89 ±5.15 pmol/1) and 
the GammaCoat kit (23.17 ±3.86 pmol/1) were similar to euthyroid patients and therefore 
significantly (P < 0.025 and P < 0.01, respectively) higher than those of hypothyroid 
patients. Serum free T4 concentrations as measured by the Liquisol and Immophase kits 
(mean ±sem, 18.02 ±2.57 and 12.87 ±1.29, respectively) were significantly (P < 0.001
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and P < 0.025, respectively) lower than healthy subjects and similar to those exhibited by 
the corresponding group of hypothyroid patients. In the patients with reference range 
serum total T4 concentrations (n = 10), serum free T4 concentrations by equilibrium 
dialysis were significantly (P < 0.025) higher (mean +sem, 41.18 + 3.86 pmol/1) than the 
healthy controls. Similarly, the results by the GammaCoat kit (mean +sem, 23.17 +2.57 
pmol/1) were also significantly (P > 0.025) higher than in the healthy subjects The 
results were significantly (P < 0.001) lower using the Immophase kit (mean +sem, 15.44 
±1.29 pmol/1) but similar using the Liquisol kit (25.74 +1.29 pmol/1) than in the healthy 
controls. In summary, taking all sick patients together serum free T4 concentrations 
were below the reference range in three (11.5 %) patients by equilibrium dialysis, two 
(7.7 %) patients by the GammaCoat kit, 19 (73.1 %) patients by the Immophase kit and 
14 (53.8 %) patients by the Liquisol kit. Serum free T4 concentrations were above the 
reference range in seven (26.9 %) patients by equilibrium dialysis and six (23.1 %) by the 
GammaCoat kit. The results for the Immophase kit are therefore similar to the report of 
Chopra et a l  (1980). The authors do not comment on the discrepancy between results 
of the equilibrium dialysis values in their study and the higher values in the study of 
Chopra et al. (1980). This may be related to the tracer purification technique used by 
Kaptein et al. (1981b), but which was not specified by Chopra et a l  (1980). 
Radioiodide contamination may artefactually raise values in indirect equilibrium dialysis 
(Ekins, 1985). Differences in patient selection may have also played a role.
Similar results using the Immophase kit have been reported by Slag, Morley, Elson, 
Labrosse, Crowson, Nuttall & Shafer (1981b). Serum free T4 concentrations were 
measured in 20 critically ill patients with serum total T4 concentrations below 64.35 
nmol/1 and another 65 ill patients with normal serum total T4 concentrations (> 64.35 
nmol/1). The serum free T4 concentrations in both groups (mean +sd, 12.36 +0.90 and
20.59 +0.64 pmol/1, respectively) were significantly (P < 0.001 and P < 0.01, 
respectively) lower than the concentrations in 35 euthyroid subjects (mean +sd, 23.17 
+0.77 pmol/1). The mean +sd serum free T4 concentration of 13.64 +1.02 pmol/1 in the 
patients with low serum total thyroxine concentrations measured using the GammaCoat 
kit method was similar to that of 12.10 +0.77 pmol/1 in the healthy subjects. However, 
the value of 16.47 +0.64 pmol/1 was slightly and significantly (P < 0.001) higher in the 
patients with serum total T4 concentrations above 64.35 nmol/1 compared with the 
healthy subjects. This confirms the results of Kaptein et a l  (1981b). In addition, the 
mean +sd (15.83 +1.02 pmol/1) serum free T4 concentration measured using the Liquisol 
kit in the patients with low serum total T4 concentrations was similar to that of 14.16 
+0.64 pmol/1 in the control group. In the second group of patients using the latter kit 
method, the serum free T4 concentrations were significantly (P < 0.01) higher (mean 
±sd, 19.31 + 0.77 pmol/1) than in the healthy controls. These results are in contrast to 
the previous report but may reflect the lower mean of 14.16 pmol/1 in the healthy 
controls compared to that of 25.74 pmol/1 reported by Kaptein et al (1981b). Free T4 
concentrations were also measured in this study by equilibrium dialysis using an organic
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anion exchange resin. The values were significantly (P < 0.01) lower in the patients with 
low serum total T4 concentrations than in the healthy patients (mean +sd, 11.20 +1.29 
and 16.73 +1.03 pmol/1, respectively (reference range, 7.72 - 25.74 pmol/1)) and slightly 
but not significantly higher (mean +sd, 27.03 +2.57 pmol/1) in the patients with normal 
serum total T4 concentrations. The differences between these results and those of 
Kaptein et al. (1981b) presumably reflect the different methodologies and/or patient 
selection. There was little or no correlation (r = 0.05 - 0.33) between equilibrium 
dialysis and the kit methods.
Melmed, Geola, Reed, Pekary, Park & Hershman (1982) also compared these 
three kit methods with equilibrium dialysis and found comparable results to those of 
Chopra et al. (1980) and Kaptein et al. (1981b). Fourteen patients admitted to a medical 
intensive care unit were studied. These patients had serum total T4 concentrations 
below 64.35 nmol/1. In addition, 13 patients with chronic liver disease and 32 patients 
with renal failure were studied. Serum total T4 concentrations were below the reference 
range in 46 and 31 % of these patients, respectively. Serum free T4 concentrations were 
measured by equihbrium dialysis (Sterling & Brenner, 1966) and the Liquisol, 
Immophase and GammaCoat kit methods. Each of the three groups of patients had a 
high proportion of low values for the dialysable free T4 concentration; six (43 %) 
critically ill, three (23 %) liver and three (9 %) renal patients. Since a similar equilibrium 
dialysis technique to that of Chopra et al. (1980) was used the higher proportion of low 
values in the critically ill group may reflect the small numbers of patients in this category 
in both studies. The means in each group were significantly (P < 0.01) lower than for 
healthy controls. Using the GammaCoat kit, four (29 %) critically ill patients had low 
serum free T4 concentrations and the mean value was significantly (P < 0.01) lower than 
for healthy controls. The difference between this and the study of Kaptein et a l  (1981b) 
may again reflect patient selection. None of the hepatic patients and two (6 %) renal 
patients had low serum free T4 concentrations. As in the study of Kaptein et al. 
(1981b), a high proportion (n = 6 (10.2 %)) of elevated values were found with this kit. 
When free T4 concentrations were measured using the Immophase kit, all of the critically 
ill, 10 (77 %) of the liver and 24 (75 %) of the renal patients had low values 
indistinguishable from those exhibited by a group of hypothyroid patients (n = 20). 
Free T4 concentrations were measured using the Liquisol kit; four (29 %) of the 
critically ill group, two (15 %) of the liver group and 10 (31 %) of the renal group had 
values below the reference range. The mean value of the critically ill group was 
significantly (P < 0.01) lower than that of healthy patients. However, using this kit only 
50 % of the hypothyroid patients had serum free T4 concentrations below the reference 
range compared to 95 to 100 % using the other methods. One value was actually above 
the reference range. The results for the Immophase and Liquisol kits in sick patients are 
therefore essentially similar to those of Kaptein et a l  (1981b).
Thus based on these reports, the GammaCoat kit method appears to be the most 
reliable for measuring serum free T4 concentrations in non-thyroidal illness yielding
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results usually comparable to those of equilibrium dialysis. However, conflicting reports 
on the values obtained with this kit are apparent. This may be due to differences in 
patient selection but suggests that none of these assays are entirely satisfactory for 
assessing serum free T4 concentrations in non-thyroidal illness.
Analogue kit methods
Stockigt et al. (1981) assessed the recently introduced Amerlex (Amersham) free T4 kit 
method in a series of 14 critically ill patients selected for low serum concentrations of 
total T4 ( < 55 nmol/1) and serum free T4 concentrations within the reference range as 
assessed by equilibrium dialysis using the technique of Sterling & Brenner (1966). Serum 
free T4 concentrations assessed by the Amerlex kit (mean +sd 6.5 +2.0 pmol/1) were 
significantly (P < 0.001) lower than those in 15 healthy patients (mean +sd, 17.0 +2.0 
pmol/1). Serum binding of the labelled analogue was evaluated by dextran-charcoal 
separation which suggested that binding correlated directly with prealbumin 
concentration. Further studies with purified prealbumin diluted in buffer showed dose- 
dependent binding of labelled analogue. Subsequently the Amerlex kit was assessed in 
patients with hereditary analbuminaemia and familial dysalbuminaemic 
hyperthyroxinaemia (Stockigt et al., 1983) and gave spuriously low and high values for 
free T4, respectively. This study suggested that the analogue binds to albumin. In then- 
previous publication, albumin contamination and not prealbumin was responsible for the 
binding (Stockigt et a l,  1983).
After the introduction of the Amerlex kit, several similar kits were marketed 
adopting different (and usually unspecified) analogues, separation systems, and methods 
of standardisation. Within the category of non-thyroidal illness, these kits could give 
varying results. In 40 patients with critical non-thyroidal illness, serum free T4 
concentrations measured using two analogue kit methods (Amerlex Free T4, Amersham; 
GammaCoat One Step Free T4, Clinical Assays) correctly identified only 17 and 16 
respectively as euthyroid (Waud, Chan, Drew, Oropeza, Sucupira, Scheinen, Garrison, 
Mayo, Taylor, Stem, Graham, Coyle, Niebyl & Wagner, 1983). The remaining values 
were within the hypothyroid range. Further details were reported by Chan, Waud, 
Taylor, Stem, Drew, Oropeza & Sucupira (1983). In the 40 patients the mean serum 
total T4 concentration was approximately half the mean value for euthyroid patients. 
Both free T4 assays gave similar results (mean +sd, 8.62 +5.28 pmol/1; reference range, 
8.75 - 23.12 pmol/1 (Amerlex) and 8.11 +6.44 pmol/1; reference range, 9.00 - 25.74 
pmol/1 (GammaCoat)). By contrast, in 25 of the patients, serum free T4 concentrations 
as measured by equilibrium dialysis were usually within the reference range (mean +sd, 
17.89 +12.36 pmol/1; reference range 12.87 - 29.60 pmol/1). Two values (8 %) were 
above and 4 (16 %) were below the reference range. As in previous reports (Chopra et 
al., 1980; Kaptein et a l,  1981b; Slag et al., 1981b; Melmed et a l,  1982), serum free T4 
concentrations measured using a labelled-hormone, back titration kit method
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(GammaCoat Two Step Free T4, Clinical Assays) were more comparable to equilibrium 
dialysis (mean +sd, 15.83 +8.75 pmol/1; reference range, 9.00 - 25.74 pmol/1).
Despite the similarity between the Amerlex and GammaCoat analogue kits, other 
kit methods have been found to give different results (Gow et al., 1985). Two groups of 
patients with non-thyroidal illness were studied: 39 patients from a general medical ward 
and 36 patients with renal failure undergoing dialysis treatment. All of these patients had 
reference range serum TSH concentrations, but 28 and 67 % of serum total T4 
concentrations were below the reference range in each group, respectively. Five kits 
were compared: Amerlex and Amerlex-M (Amersham), Becton-Dickinson (Becton 
Dickinson), Coat-A-Count (Diagnostic Products) and Magic Free T4 (Coming). The 
Amerlex-M kit contained the same analogue and standards as the Amerlex kit but 
involved magnetic separation rather than centrifugation. Many patients were found to 
have serum free T4 concentrations below the reference range. In the medical patients the 
number of values below the reference range were 4 (10 %) by Amerlex and Amerlex-M, 
7 (18 %) by Becton-Dickinson, 9 (23 %) by Coat-A-Count and 7 (18 %) by Magic Free 
T4. In the renal patients, these values were 24 (67 %) by Amerlex and Amerlex-M, 30 
(83 %) by Becton-Dickinson, 26 (72 %) by Coat-A-Count and 29 (81 %) by Magic Free 
T4. Thus the least number of low values were obtained with the Amerlex and Amerlex- 
M kits.
Csako et a l  (1987) further evaluated several kit methods in 82 patients with non- 
thyroidal illness and compared the results with serum albumin concentrations. The 
patients were classified as having reference range serum total T4 and T3 concentrations 
(Group 1, n = 22), low total T3 concentrations (Group 2, n = 37) and both low total T4 
and T3 concentrations (Group 3, n = 23). The kits evaluated were Amerlex, 
GammaCoat one step and Coat-A-Count and results were compared with equilibrium 
dialysis. Euthyroid (n = 26) and Group 1 patients had similar serum free T4 
concentrations and none were below the reference range. In turn, 24 to 30 % of Group 
2 and 61 to 74 % of Group 3 patients had subnormal serum free T4 concentrations 
assessed by the kit methods. By contrast, 46 % of Group 2 patients exhibited high serum 
free T4 concentrations by equilibrium dialysis but there were no subnormal values in 
either group. The albumin concentration was subnormal more often in Group 1 patients 
than in healthy controls. Group 2 patients revealed greater numbers of subnormal 
albumin concentrations and all of the Group 3 patients had abnormally low 
concentrations. Using previously established correlations the serum free T4 
concentrations were corrected for albumin. The results with all techniques were 
unchanged by this correction in healthy and Group 1 patients. By contrast, in Group 2 
and 3, after correction for albumin, almost all of the formerly low serum free T4 
concentrations assessed by analogue RIAs became normal. This study indicates that 
albumin-dependence often is responsible for the falsely low free T4 values obtained with 
analogue kit methods confirming preliminary reports (Stockigt et a l , 1981, 1983).
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Given this albumin dependence, several manufacturers attempted to improve the 
analogue RIA systems by adding binding blocker(s) that chemically inhibit(s) the 
analogue-albumin interaction. Two of these improved kits (Amerlex-M and Coat-A- 
Count) were assessed in 79 patients with nonthyroidal illness and compared to results 
obtained by ultrafiltration (Konno, Hirokawa, Tsuji, Hagiwara, Taguchi, Murakami & 
Taguchi (1989). Eight (10.1 %) patients had subnormal serum free T4 concentrations as 
assessed by ultrafiltration, 29 (37.2 %) by Amerlex-M and 19 (33.3 %) by Coat-A- 
Count. The possible influence of thyroid hormone binding protein (TBG, albumin and 
TBPA) concentrations on these results were studied. Serum free T4 concentrations by 
ultrafiltration were independent of the concentrations of these binding proteins (r = - 
0.031 - 0.160, n = 79, P > 0.05). Amerlex-M free T4 concentrations correlated with 
albumin (r = 0.491, n = 78, P < 0.001) and TBG (r = 0.250, P < 0.05), but not with 
TBPA. Coat-A-Count free T4 concentrations also correlated with TBG (r = 0.636, n = 
57, P < 0.001), but not with TBPA and albumin concentrations. The falsely low free T4 
concentrations with Coat-A-Count were largely found in patients with the low T4 state 
where serum TBG concentrations were reduced. The low values with Amerlex-M were 
found in the low T3 and low T4 states where albumin concentrations were reduced. The 
kit manufacturers did not supply data on the concentrations of blockers used in the kits. 
Thus, the authors suggested that the effect of the binding blockers depends on their 
concentration and in excess could possibly disrupt T4-TBG binding. There was no 
correlation with serum free T4 concentrations measured by ultrafiltration and oleic acid 
(a putative binding inhibitor (Chopra et al., 1986)) concentrations. This does not 
exclude the possible involvement of other substances which could interfere with T4 
binding in non-thyroidal illness. In this study mathematically calculated circulating free 
T4 concentrations correlated with serum TBG concentrations. By correcting for an 
altered binding constant of TBG, there was a closer agreement between calculated serum 
free T4 concentrations and those obtained by ultrafiltration. The dependence of the 
calculated values on serum TBG concentrations was then lost. This suggests that the 
binding affinity of TBG in non-thyroidal illness is altered as has since been reported 
elsewhere (Mendel et al., 1991).
Taken together, it is clear from these reports that analogue kit methods are 
inadequate for the measurement of serum free T4 concentrations in the presence of non- 
thyroidal illness. Although the problem appears to he with the analogues used, it is 
possible that the serum dilution inherent in the method may be an additional source of 
error (Nelson & Weiss, 1985).
Equilibrium dialysis and ultrafiltration
Despite equilibrium dialysis and ultrafiltration being considered as the gold standard 
techniques for measurement of serum free T4 concentrations, Ekins (1985) has identified 
several problems inherent with various methods. These were reviewed in Chapter 4, and
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included in particular, problems with tracer purification with indirect equilibrium dialysis 
and falsely low values in non-thyroidal illness if dilution of serum was involved.
In the above studies when equilibrium dialysis or ultrafiltration were used, serum 
free T4 concentrations were usually within or above the respective reference ranges. 
Occasionally, values were depressed particularly if corresponding total T4 values were 
markedly depressed. For the most part indirect equilibrium dialysis techniques were used 
which also involved dilution of serum samples. Surks, Hupart, Pan & Shapiro (1988) 
compared serum free T4 concentrations in 29 critically ill patients as measured by 
ultrafiltration and equilibrium dialysis. The ultrafiltration technique involved minimal 
dilution of serum and careful chromatographic purification of tracer T4 in the 
ultrafiltrate. An indirect equilibrium dialysis technique involving serum dilution was used 
(Oppenheimer, Squef, Surks & Hauer, 1963). The mean serum free T4 concentration by 
ultrafiltration was not significantly different between the sick patients and 12 healthy 
controls (mean ±sem, 34.7 +7.6 and 22.7 +1.5 pmol/1, respectively. The mean serum 
free T4 concentration by equilibrium dialysis was also not significantly different between 
the sick and healthy patients (mean +sem, 45.3 +5.1 and 31.0 +0.9 pmol/1, respectively). 
Free T4 values were higher when determined by equilibrium dialysis but there was an 
excellent correlation with ultrafiltration (r = 0.84, P < 0.001). In patients with serum 
total T4 concentrations greater than 40 nmol/1 (n = 20), the serum free T4 concentrations 
were either within or above the reference range. In patients with serum total T4 
concentrations below 40 nmol/1 (n = 9), the serum free T4 concentrations were either 
within or more rarely above the reference range. Occasionally in this group serum free 
T4 concentrations were just below the reference range (one (11.1 %) value by 
ultrafiltration and two (22.2 %) values by equilibrium dialysis), but these values were 
always higher than those exhibited by hypothyroid patients (n = 7). However, the mean 
serum free T4 concentrations by ultrafiltration or equilibrium dialysis (mean +sem, 19.4 
+3.9 and 27.1 +6.5 pmol/1, respectively) was not significantly different from the control 
group. In total, seven (24.3 %) values were above and one (3.4 %) value below the 
reference range by ultrafiltration and 10 (34.5 %) values were above and two (6.9 %) 
below the reference range by equilibrium dialysis. The discrepancy between this report 
and those above (Chopra et a l,  1980; Kaptein et a l,  1981b; Slag et a l ,  1981b; Melmed 
et a l,  1982; Chan et a l ,  1983) could be related to dialysis tubing, buffer constituents, 
factor of dilution or other technical factors (Surks et a l,  1988). Since the results were 
comparable using equilibrium dialysis and ultrafiltration which involved minimal sample 
dilution and maximal tracer purification, the former could therefore be considered an 
accurate technique (Surks et a l,  1988).
Using a similar ultrafiltration technique Faber, Kirkegaard, Rasmussen, Westh, 
Busch-Sorensen & Jensen (1987) reported comparable results to those of Surks et al 
(1988). Serum free T4 concentrations were measured in 34 critically ill patients and did 
not differ from values in healthy patients (numbers not reported). One value (2.9 %) was 
above and one below the reference range. By contrast, ill patients treated with dopamine
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(known to suppress TSH concentrations) had significantly lower serum free T4 
concentrations. The authors concluded that any reports where serum free T4 
concentrations are significantly reduced in the presence of non-thyroidal illness should be 
interpreted with caution.
A direct equilibrium dialysis method eliminates the need for adding radiolabelled 
tracer to the serum sample before dialysis, thereby eliminating the need for tracer 
purification steps. Theoretically it is therefore more accurate than any indirect technique 
(Ekins, 1985). Helenius and Liewendahl (1983) measured serum free T4 concentrations 
in 33 sick patients with low circulating T3 and high rT3 concentrations using an indirect 
equilibrium dialysis technique. The mean serum free T4 concentration was significantly 
(P < 0.001) higher in the sick patients compared with 40 healthy euthyroid subjects 
(mean ±sd, 26.5 +12.3 and 15.1 +3.0 pmol/1, respectively). The patients were divided 
into two groups. Group 1 (n = 20) had normal serum total T4 concentrations, although 
the mean value was lower than for healthy controls and Group 2 (n = 13) had values 
below 60 nmol/1. Serum free T4 concentrations remained significantly higher compared 
to the healthy controls in Group 1 (mean +sd, 31.1 +12.3 pmol/1) but were not 
significantly different in Group 2 (mean +sd, 19.4 +8.6 pmol/1). The reference range for 
serum free T4 concentrations was defined as the mean +2sd and was 9.1 to 21.1 pmol/1. 
Thus, 14 (70 %) values in Group 1 and two (15.4 %) values in Group 2 were above the 
reference range. There were no values below the reference range. Compared to this 
equilibrium dialysis method, conflicting results were obtained using two analogue 
(Amerlex and GammaCoat) and two non-analogue (Liquisol and Immophase) kits. The 
authors suggested the observed increases in circulating free T4 concentrations correlated 
well with the possible existence of hormone binding inhibitors. The higher values in sick 
patients compared to the values in the patients studied by Surks et al. (1988) presumably 
reflect differences in patient selection.
The method of Helenius and Liewendahl (1983) involved dilution of samples. The 
serum free T4 concentrations were independent of dilution in sick patients when dilutions 
of 1 : 5 to 1 : 55 were tested. However, using a similar dialysis technique Nelson & 
Weiss (1985) found a marked dilutional effect in serum from sick patients. Thus, Nelson 
& Tomei (1988) used a direct dialysis method involving minimal dilution of serum 
samples. Twenty-seven sick patients with the low T4 state of medical illness were 
studied. The serum total T4 concentrations ranged from less than 6.45 to 61.78 nmol/1. 
The serum free T4 concentrations were within the reference range in most subjects. One 
(3.7 %) patient had an elevated serum free T4 concentration (45.05 pmol/1; reference 
range, 10.30-34.75 pmol/1). Three (11.1 %) patients had a serum T4 concentration at 
the lower limit of the reference range.
Thus, of the various techniques, apparently the most accurate results have been 
obtained using the untrafiltration technique of Faber et al. (1987) and Surks et al. (1988) 
and the direct dialysis technique of Nelson & Tomei (1988).
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The effect of illness on serum free thyroxine concentrations in the dog
Montgomery et al (1991) compared five analogue free T4 assays (manufacturers 
unidentified) which used magnetic separation (A and B) or antibody coated tubes (C, D 
and E) with results of indirect equilibrium dialysis. Dogs were classified as healthy (n = 
15), hypothyroid (n = 11), or euthyroid with hyperadrenocorticism (n = 11) 
megaoesophagus (n = 4), hypercholesterolaemia/hypoalbuminaemia (n = 9) and obesity 
(n = 3). These classifications were based on history, clinical examination, results of 
biochemical analyses and TSH stimulation testing, requirement for T4 replacement 
therapy and additional, but unspecified, diagnostic tests where necessary. In the healthy 
dogs the mean (±sd) serum free T4 concentrations were consistently lower with the 
analogue RIAs (A, 10 +4; B, 18 +5; C, 12 ±5; D, 17 ±6 and E, 5 +1 pmol/1) compared to 
equihbrium dialysis (26 +12 pmol/1). A similar trend was reported to occur in the 
presence of non-thyroidal illness. Comparably low results between equihbrium dialysis 
and the analogue RIAs were found in hypothyroidism There was a significant 
correlation between equihbrium dialysis and each of the RIA systems (r = 0.85-0.91, P < 
0.001 in each case) in healthy dogs. When ah dogs were evaluated, a significant 
correlation was only found between equihbrium dialysis and systems A (r = 0.39, P < 
0.002) and C (r = 0.50, P < 0.001). Accuracy in assessing thyroid gland function was 
defined as hypothyroid dogs with positive test results and euthyroid dogs with negative 
test results over ah dogs tested. Accuracy was 0.91 with equihbrium dialysis, 0.71 with 
system A, 0.65 with system B, 0.71 with system C, 0.78 with system D and 0.75 with 
system E. It is difficult to interpret the effect of non-thyroidal illness on serum free T4 
concentrations from this study since actual values were not reported. However, from the 
accuracy studies, it would seem that serum free T4 concentrations have a tendency to be 
low in non-thyroidal illness when assessed by analogue assays but not by equihbrium 
dialysis, similar to the situation in man.
Nelson, Ihle, Feldman & Bottoms (1991) measured serum free T4 concentrations 
in 59 euthyroid dogs with dermatopathy (n = 38) or concurrent illnesses (n = 21) and 
compared the results to those obtained in euthyroid, healthy (n = 62) and hypothyroid 
dogs (n = 51). An analogue RIA system was used which contained thyroid hormone 
binding blockers (Diagnostic Products). From this report it is difficult to conclude the 
effects of non-thyroidal illness on serum free T4 concentrations. Dogs with a peripheral 
neuropathy or hyperadrenocorticism had serum free T4 values that were not significantly 
different from hypothyroid dogs. However, serum total T4 values between these dogs 
were also similar. In the remaining sick dogs serum free and total T4 concentrations 
differed significantly, in the same direction, from those in hypothyroid dogs. Thus, it is 
likely that the free T4 assay was not giving a true circulating free T4 concentration, but 
rather reflected the total T4 concentration.
Ferguson and Peterson (1992) studied serum free T4 concentrations in a series of 
42 dogs with hyperadrenocorticism using an indirect equihbrium dialysis technique.
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Since glucocorticoids have specific effects on functional thyroid status, which may differ 
from the effects of other illnesses, this study was previously reviewed in Chapter 5.
The effect of illness on serum free thyroxine concentrations in the cat
There is only one report which mentions the assessment of serum free T4 concentrations 
in sick cats. As part of a study designed to assess the value of the T3 suppression test in 
the diagnosis of hyperthyroidism Refsal et al  (1991) included 23 cats with a variety of 
non-thyroidal illnesses. However, serum total T4 concentrations in these cats were 
within the reference range (12 - 49 nmol/1) and were not significantly different from 
those in four healthy controls (mean +sd, 27.9 +10.3 and 25.7 ±11.1 nmol/1, 
respectively). Serum free T4 concentrations were measured using an analogue RIA kit 
(Magic Free T4, Coming). Serum free T4 concentrations in these cats were within the 
reference range (12-36 pmol/1) and were not significantly different from those in four 
healthy controls (mean +sd, 21.7 +5.4 and 28.3 +5.6 pmol/1, respectively). The authors 
mention that a comparison was made using this RIA system and a direct dialysis 
technique (Nichols Institute Diagnostics). This is addressed in Chapter 4.
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Despite the known effects of non-thyroidal illness in suppressing circulating total T4 
concentrations in cats (Peterson & Gamble, 1990) there are no conclusive reports on its 
possible effects on corresponding free T4 concentrations. To date, it has been assumed 
that, as in man, serum free T4 concentrations are essentially normal and the animals 
euthyroid. Given the wide range of commercial kit methods applicable to the 
measurement of serum free T4 concentrations in man and their increasing use in 
veterinary laboratories, such reports are likely to be made in the near future. However, 
these kit methods frequently produce erroneous results in humans and should be 
compared to the gold standard techniques of equihbrium dialysis or ultrafiltration (Ekins,
1985). This study was designed to assess circulating free T4 concentrations in sick cats, 
where serum total T4 concentrations were known to be depressed. An equihbrium 
dialysis technique was used in order both to provide more accurate results and to 
establish a data-base with which other techniques could be compared.
6.3 MATERIALS AND METHODS 
Clinical Material
The case material comprised 67 of the sick geriatric cats described in Chapter 5. Thirty- 
three were female (29 ovariohysterectomised, four entire) and 34 were male (32 
castrated, two entire). They ranged in age from 5.0 to 20.0 years with a mean +sd of
10.2 +3.7 years. Fifty of the cats were either domestic short (n = 47) or long (n = 3) 
haired; the remaining cats represented four other breeds: Siamese (n = 11), Persian (n = 
3), British Blue (n = 2) and Birman (n = 1).
In addition, the 31 sick younger cats described in Chapter 5 were included.
The healthy cats used for comparison purposes are those described in Chapter 4.
Estimation of serum free thyroxine concentrations
At the time of initial presentation a serum sample from each case was stored as described 
in Chapter 2, until required for assay. Serum free T4 concentrations were measured as 
described in Chapter 4. The free T4 fraction, expressed as a percentage, was determined 
from the serum free and corresponding total T4 concentration (Chapter 5).
Statistical analyses
The Mann Whitney U test was used for all statistical purposes.
6.4 RESULTS
Serum free thyroxine concentrations in sick cats
These results are detailed in Appendix 11 and summarised in Table 8.
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There was no significant difference (P > 0.05) in the serum free T4 concentration 
between the geriatric and young sick cats. These data were therefore grouped together 
for future analyses.
Geriatric Young Geriatric and young
n 67 31 98
Mean 27.71 27.67 27.70
sd 13.91 12.89 13.53
Minimum 8.45 1.52 1.52
1st quartile 19.04 22.05 19.62
Median 25.08 24.59 24.95
3rd quartile 33.29 33.57 33.36
Maximum 75.54 62.31 75.54
Table 8. Summary statistics of serum free thyroxine (T4) concentrations (pmol/1) in 
geriatric cats, young cats and both geriatric and young cats grouped together. These 
cats were suffering from a variety of non-thyroidal illnesses.
Serum free T4 concentrations were within the reference range (8.14 - 41.45 
pmol/1) for healthy cats in 83 (84.7 %) of the 98 sick cats.
Three cats (3.1 %) had serum free T4 concentrations below the reference range. 
These concentrations of 6.85 (case number 116330), 4.06 (case number 117268) and 
1.52 (case number 114584) pmol/1 corresponded to serum total T4 values of 2.00, 2.89 
and 2.00 nmol/1 respectively, all markedly below the reference range (10.75 - 41.25 
nmol/1). Two of these cats died and one was euthanased as a result of their illnesses. In 
the remaining cats with serum total T4 values below the reference range (n = 18), 
corresponding serum free T4 concentrations were either within (n = 16), or above (n = 
2), the reference range.
Twelve cats (12.2 %) had serum free T4 concentrations above the reference range, 
but in only six (6.1 %) were these values greater than 3 sds from the reference mean 
(49.78 pmol/1). These concentrations of 75.54 (case number 113929), 75.31 (case 
number 113235), 70.84 (case number 110531), 62.31 (case number 114049), 55.08 
(case number 116128), 51.34 (case number 115485) pmol/1 corresponded to serum total 
T4 concentrations of 22.12, 15.62, 16.16, 17.82, 15.07 and 10.03 nmol/1, respectively.
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Five of the serum total T4 concentrations were within the reference range, while the 
remaining value was just below the reference range.
The calculated free T4 fraction in sick cats
These results are detailed in Appendix 11 and summarised in Table 9.
Geriatric Young Geriatric and young
n 67 31 98
Mean 0.20 0.32 0.24
sd 0.15 0.48 0.30
Minimum 0.06 0.06 0.06
1st quartile 0.10 0.10 0.10
Median 0.14 0.14 0.14
3rd quartile 0.21 0.34 0.24
Maximum 0.82 2.01 2.10
Table 9. Summary statistics of the calculated free thyroxine (T4) fraction (%) in geriatric 
cats, young cats and both geriatric and young cats grouped together. These cats were 
suffering from a variety of non-thyroidal illnesses
There was no significant difference (P > 0.05) in the calculated free T4 fraction 
(%) between the geriatric and young sick cats. These data were therefore grouped 
together for future analyses.
The five highest values (range, 0.74 - 2.10 %) occurred in cats (case numbers, 
113701, 114769, 115950, 115953, 119282) with serum free T4 concentrations (range, 
14.86 - 42.06 pmol/1) either within (n = 4), or above (n = 1), the reference range. 
Corresponding serum total T4 concentrations (range, 2.00 - 4.64 nmol/1) were all below 
the reference range. Four (80 %) of these cats died. The one surviving cat (case 
number, 114769) was suffering from a protein-losing nephropathy.
The next six highest values (range, 0.45 - 0.59 %) occurred in cats (case numbers 
109212, 110531, 113235, 114854, 115449, 115485) with serum free T4 concentrations 
(range, 33.57 - 75.34 pmol/1) either within (n = 3), or above (n = 3) the reference range. 
Corresponding serum total T4 concentrations (range, 4.37 - 16.16 nmol/1) were either
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within the low end or below the reference range. Four (67 %) of these cats died or were 
euthanased as a result of their illnesses.
In the remaining cats (n = 87), the free T4 fraction range from 0.06 to 0.39 %. 
Thirty-seven (43 %) died or were euthanased as result of their illnesses.
Comparison of serum free thyroxine concentrations in sick and healthy cats.
There was no significant difference (P > 0.05) in the serum free T4 concentrations 
between the sick and healthy cats (mean ±sd, 24.79 ±8.33; reference range, 8.14 - 41.45 
pmol/1) (Figure 8).
There was no significant (P > 0.05 in each case) difference in the serum free T4 
concentrations in cats with corresponding serum total T4 concentrations within (mean 
±sd, 28.73 ±13.60 pmol/1, n = 77), or below (mean ±sd, 23.93 ±12.92 pmol/1, n = 21), 
the reference range and the healthy cats.
The calculated free T4 fraction was significantly (P < 0.001) higher in the sick cats 
compared with the healthy controls (mean ±sd, 0.10 ±0.06; range, 0.04 - 0.37 %) 
(Figure 9).
In comparing the results between the healthy and sick cats two notable results 
occurred in the healthy animals. Cat number 5 had a serum free T4 concentration of 
47.72 pmol/1, a serum total T4 concentration of 12.94 nmol/1 and a calculated free T4 
fraction of 0.37 %. The next highest free T4 concentration was 41.38 pmol/1. Cat 
number 3 had a serum free T4 fraction of 0.24 %, corresponding to a serum free T4 
concentration of 30.51 pmol/1 and a serum total T4 concentration of 12.50 nmol/1. The 
next highest serum free T4 fraction was 0.18 %.
6.5 DISCUSSION
The equihbrium dialysis technique used in this study eliminated the need to add 
radiolabelled tracer T4 to the serum sample before dialysis, thereby eliminating the need 
for tracer purification steps and its associated problems (Ekins, 1985). In addition, 
minimal serum dilution was involved. Sample dilution disturbs the concentration of 
hormone binding inhibitors which may be present in non-thyroidal illness, thereby 
artefactually decreasing serum free T4 concentrations (Ekins, 1985).
The serum free T4 concentrations in the cats with non-thyroidal illness were 
comparable with values in human patients where ultrafiltration of undiluted serum (Faber 
et al., 1987; Surks et al., 1988) or a similar equihbrium dialysis technique was used 
(Nelson & Tomei, 1988). In these human studies, serum free T4 concentrations were 
not significantly different in sick compared to healthy patients even when serum total T4 
concentrations were markedly depressed as was found in the cats presented here. This 
provides evidence that euthyroidism is maintained in sick cats despite suppressed 
circulating total T4 concentrations. Consequently, and as expected, the calculated free 
T4 fraction was elevated in these cats.
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Figure 8 . Box and whisker plot of serum free thyroxine (T4) concentrations in 38 
healthy and 98 sick cats. The box encloses the middle half of the data and is bisected by a 
line representing the median. The whiskers represent the range of typical values. Possible 
outliers are represented by * and represent values from cat number 5 (healthy) and case 
numbers 110531, 114049 and 116128 (sick). Probable outliers are represented by 0 and 
represent values from case numbers 113235 and 113929.
Chapter 6 90
HEALTHY SICK
Health status
Figure 9. Box and whisker plot of the calculated serum free thyroxine (T4) fraction (%) 
in 38 healthy and 98 sick cats. The box encloses the middle half of the data and is 
bisected by a line representing the median. The whiskers represent the range of typical 
values. Possible outliers are represented by * and represent values from cat number 3 
(healthy) and case numbers 109212, 110531, 113235, 114854, 115449 and 115485 
(sick). Probable outliers are represented by 0 and represent values from cat number 5 
(healthy) and case numbers 113701, 114769, 115950, 115953, 119282.
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In man, elevated serum free T4 concentrations have been found in 24.5 % of 29 
and 2.9 % of 34 patients with non-thyroidal diseases as estimated by ultrafiltration (Faber 
et a l , 1987; Surks et a l ,  1988) and 3.7 % of 27 patients as estimated by equihbrium 
dialysis (Nelson & Tomei, 1988). Of the cats studied here, 12 (12.2 %) had elevated 
serum free T4 concentrations. As in humans (Surks et a l,  1988), these values tended to 
correspond to reference range serum total T4 concentrations. The biological 
consequences of elevated circulating free T4 concentrations in sick human patients are 
unclear (Tibaldi & Surks, 1985). Such consequences remain unclear in the cat.
Three (3.1 %) cats had serum free T4 concentrations below the reference range 
whereas in humans using the same equihbrium dialysis technique none were found 
(Nelson & Tomei, 1988). Although every attempt was made to measure serum free T4 
concentrations in the cats before treatment had commenced, there was no control over 
possible drug therapy prior to referral. It was therefore possible that in these three cats, 
drugs (in particular glucocorticoids) known to suppress circulating serum total T4, TSH 
and free T4 concentrations were administered prior to referral (Wartofsky & Burman, 
1982; Peterson & Ferguson, 1989b; Ferguson & Peterson, 1992).
Since TBG does not exist in the cat (Larsson, Pettersson & Carlstrom, 1985; 
Thoday, 1986), alterations in TBG binding capacity or affinity (Konno et a l ,  1989; 
Mendel et a l,  1991) could not explain the results presented. A more plausible 
explanation for the low total T4 concentrations, normal or high free T4 concentrations 
and the elevated free T4 fraction seen in the sick cats would be the presence of serum 
protein binding inhibitors as suggested in humans (Chopra et a l ,  1979b; Woeber & 
Maddux, 1981; Oppenheimer etal., 1982; Chopra et a l,  1982, 1984, 1986). Since this 
premise remains controversial in humans, the cat can now be viewed as an appropriate 
model for further investigation of the possible mechanisms involved.
There are no substantiated reports on the use of this equihbrium dialysis technique 
in healthy or in sick cats. However, in the report of Refsal et a l  (1991) where the 
technique was briefly mentioned, no problems were highlighted. In addition, Ferguson 
(1994) also briefly mentions its use in the dog where its accuracy was virtually identical 
to that of indirect tracer equihbrium dialysis. The serum samples used in the present 
study were frozen and thawed prior to analysis. No studies on the effect of freeze/thaw 
cycles were carried out. However, using human serum, values for free T4 were not 
altered by 10 freeze-thaw cycles (Nelson & Tomei, 1988).
As in the study of serum total T4 concentrations (Chapter 5), it was impossible to 
age match the sick cats and healthy controls. However, there was no significant 
difference in the serum free T4 concentrations or calculated free T4 fraction between the 
sick cats less than five and those in excess of five years of age.
Ah but one of the cats with the five highest free T4 fractions died or were 
euthanased as result of their illnesses. The cat that survived was suffering from a 
protein-losing nephropathy, was severely hypoproteinaemic and the markedly elevated 
free T4 fraction is therefore easily explainable. Four of the cats with the next six highest
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free T4 fractions also died. This resulted in a mortality rate of 73 % for the cats with 
high outlying values, compared to a mortality of 43 % in the remaining cats. In humans 
with markedly depressed serum total T4 concentrations, an increased free T4 fraction 
was found to correlate significantly with mortality and contribute to prediction accuracy 
(Kaptein et a l,  1982b). From the results of the present study, a similar situation appears 
to exist in the cat. Thus, the likelihood of a cat dying or requiring euthanasia increases as 
the serum total T4 concentration decreases, particularly if the free T4 fraction is 
elevated.
The unusual results found in the healthy cats are interesting. In the two cases with 
the highest free T4 fractions and either normal or slightly elevated serum free T4 
concentrations, the corresponding serum total T4 concentrations were within the low 
end of the reference range. These cats were classified as healthy on the basis of history 
and lull clinical examination. Their results were highlighted as outliers and were similar 
to those found in the sick cats. It is thus possible that they were subclinically ill. 
Measurement of these three parameters in a larger group of healthy cats may prove to be 
a useful adjunct to physical examination in the assessment of health status.
In dogs, as in cats, the low T4 state appears to be a common response to illness 
(Larsson, 1987; Ferguson, 1988). It is therefore probable that dogs exhibit a similar 
serum free T4 response in illness to that found in the cats in this study. Hypothyroidism 
is a common disease of dogs (Peterson & Ferguson, 1989a) but commercial free T4 
analogue methods are largely incapable of separating hypothyroidism from non-thyroidal 
illness (Montgomery et a l ,  1991). It is therefore possible that this equilibrium dialysis 
technique may be more accurate in diagnosing hypothyroidism in the dog and would 
obviate the need for either dynamic TRH or TSH stimulation tests. In the cat, 
hypothyroidism is extremely rare (Peterson, Randolph & Mooney, 1994) and an accurate 
test for its diagnosis is not so frequently required. However, feline hyperthyroidism is 
common (Peterson, 1984; Thoday & Mooney, 1992) and usually diagnosed on the basis 
of a single serum total T4 concentration. Since serum free T4 concentrations, as 
measured by equihbrium dialysis were occasionally elevated in cats with non-thyroidal 
illness, this test may not be as accurate in confirming a diagnosis of hyperthyroidism 
This issue is addressed in Chapter 7.
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CHAPTER 7
SERUM FREE THYROXINE CONCENTRATIONS IN HYPERTHYROID 
CATS AND ITS VALUE AS A DIAGNOSTIC TEST
7.1 LITERATURE REVIEW
Circulating thyroid hormone concentrations in hyperthyroid humans
Typically in thyrotoxicosis, serum total T4 and T3 concentrations are elevated (Larsen, 
1972). In this study, serum total T4 concentrations averaged about 2.5 times the 
reference mean, whereas serum total T3 concentrations averaged 4.5 times the reference 
mean. Thus, there is a relative greater overproduction of T3 than of T4 in this disease. 
Since T3 is produced within the thyroid gland and peripherally from monodeiodination of 
T4, the increase could arise from either source. However, in hyperthyroidism, peripheral 
production of T3 contributes only 40 to 50 % to the T3 pool, compared to 85 to 90 % in 
euthyroid individuals (Abuid & Larsen, 1974). Thus, the ratio of T3 to T4 in thyroid 
secretion is increased in hyperthyroidism There are two possible mechanisms by which 
this occurs (Larsen, 1986). Studies of thyroglobulin isolated from the thyroid glands of 
patients with Graves' disease show that there is an increase in the ratio of T3 to T4 that is 
independent of iodine content (Izumi & Larsen, 1977). Secondly, the activity of a T4 5'- 
deiodinase present in thyroid tissue, has been reported to be enhanced in hyperthyroidism 
(Ishii, Inada, Tanaka, Mashio, Naito, Nishikawa & Imura, 1981).
It has been estimated that from 3 to 6 % of all patients with untreated 
hyperthyroidism have T3 toxicosis (Medeiros-Neto, 1986). Serum T3 but not T4 
concentrations are elevated in affected patients. This syndrome is more common in 
iodine deficient areas. Most untreated patients with this syndrome progress 
spontaneously to conventional hyperthyroidism with elevated circulating concentrations 
of both T3 and T4.
Rarely, patients with hyperthyroidism have elevated serum total T4 concentrations 
but reference range serum total T3 concentrations (Gavin, Rosenthal & Cavalieri, 1979). 
Such patients are usually suffering from severe concurrent non-thyroidal diseases and 
presumably peripheral production of T3 is inhibited. These individuals must be 
distinguished from sick euthyroid patients with isolated T4 hyperthyroxinaemia (Gavin, 
Rosenthal & Cavalieri, 1979; Borst, Eil & Burman, 1983).
Severe concurrent illnesses may also affect serum total T4 concentrations in 
hyperthyroid individuals. Lum, Kaptein & Nicoloff (1983) measured serum total T4 and 
T3 concentrations in four hyperthyroid patients with concurrent diabetic ketoacidosis, 
myocardial infarction, fulminant hepatitis or bacterial pneumonia. In all four patients, 
serum total T4 and T3 concentrations were either within or below the reference range. In 
two patients that survived serum total T4 and T3 concentrations increased into the 
thyrotoxic range in association with clinical improvement of the non-thyroidal illness. In
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the two patients who died serum total T4 and T3 concentrations remained depressed or 
decreased during the terminal phase of the illness.
When serum total T4 concentrations are increased in hyperthyroidism, the 
concentration of free T4 is disproportionately increased (Woeber, 1986). This is related, 
in part, to the relative saturation of binding sites in plasma proteins by the excessive total 
concentration of T4 (Woeber, 1986). However, Inada & Sterling (1967) reported that 
subnormal concentrations of TBG, and possibly TBPA, may be additional factors. T4 
regulation of TBG synthesis has been studied in a continuous cell culture line of Rhesus 
monkey hepatocarcinoma cells (Gershengom, Glinoer, Fox & Robbins, 1976). At 
physiological or lower concentrations of T4, TBG production was enhanced. At higher 
T4 concentrations, TBG production was decreased. This suggests that thyroid hormones 
can regulate the synthesis of their major transport proteins. If such a situation exists in 
humans, measurement of circulating free T4 concentrations ought to be a more sensitive 
test for the diagnosis of hyperthyroidism In addition, the degree of hyperthyroidism is 
related to circulating free and not total T4 concentrations.
Measurement of serum free T4 concentrations may also be of benefit in 
hyperthyroid patients with severe concurrent illnesses. Lum, Kaptein & Nicoloff (1983) 
measured serum free T4 concentrations, by equihbrium dialysis, in three hyperthyroid 
patients with severe concurrent non-thyroidal diseases and associated depression of 
serum total T4 concentrations. In two of these patients, the serum free T4 
concentrations were diagnosticahy elevated.
Circulating total thyroid hormone concentrations in hyperthyroid cats
Elevated basal serum total thyroid hormone concentrations are the biochemical hallmark 
of feline hyperthyroidism Compared to humans, serum total T3 concentrations are not 
as consistently elevated in thyrotoxic cats. In the first large series of 131 hyperthyroid 
cats reported (Peterson et al 1983b), the mean serum total T3 concentration was 
approximately nine times the reference mean. The mean serum total T4 concentration 
was approximately seven times the reference mean. However, serum total T3 
concentrations were within the reference range in four animals (3 %), while serum total 
T4 concentrations were above the reference range in all cases. In the largest series of 
126 hyperthyroid cats studied in the United Kingdom (Thoday & Mooney, 1992), 11 of 
122 (9 %) cats had serum total T3 concentrations within the reference range. In all 125 
cases where serum total T4 concentrations were measured the values exceeded three sds 
from the reference mean. This value has been suggested by Turrell et al  (1984) as a 
basis for differentiating hyperthyroid animals from the small number of healthy 
individuals with serum total T4 concentrations above the reference range. In a later 
report by Broussard & Peterson (1993), the changes in clinical and laboratory findings of 
202 hyperthyroid cats diagnosed between 1982 and 1992 were compared to the study of 
Peterson et al  (1983b). The serum total T3 concentrations were within the reference 
range in 29 % of the cases. In such cases serum total T4 concentrations were only
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marginally elevated (Peterson et al  1983b; Thoday & Mooney, 1992). These cats are 
usually mildly hyperthyroid but the effect of concurrent non-thyroidal illness on 
depressing serum total T3 concentrations may play a role in a small number of cases 
(Thoday & Mooney, 1992). Broussard & Peterson (1993) concluded that the higher 
prevalence of reference range serum total T3 concentrations in their study was related to 
earlier diagnosis or the inclusion of a population of mildly affected cats which previously 
would not have been tested. It is likely that serum total T3 concentrations would increase 
into the thyrotoxic range if the disorder were allowed to progress untreated (Peterson et 
a l,  1983b). Determination of serum total T4 is therefore of greater diagnostic value than 
determination of serum total T3 concentrations alone.
Serum total T4 concentrations are elevated in most hyperthyroid cats with a 
maximum concentration up to 19 times the upper limit of the reference range (Thoday & 
Mooney, 1992). Broussard & Peterson (1993) found that 2 % of their cats had reference 
range serum total T4 concentrations as compared to none in the earlier study of Peterson 
et a l  (1983b). This suggests that serum total T4 concentrations may not be 
diagnostically elevated in cases of early or mild hyperthyroidism
Peterson, Graves & Cavanagh (1987) measured serum total T4 concentrations 
hourly for 10 hours in 14 hyperthyroid cats and daily for 15 days in seven of these cases. 
The cats were selected because of the presence of a relatively mild hyperthyroid state. 
During the 10 hour sampling period, the individual c.v. for serum total T4 concentrations 
from the 14 cats (range, 6.4 - 22.6 %; mean +sd, 12.0 +4.8 %) was higher than the 
intra-assay c.v. of 5.1 %. Three of the cats had mean serum total T4 concentrations 
(47.62, 50.19 and 50.19 nmol/1) within the reference range (10.30 - 51.48 nmol/1). Of 
the 10 hourly determinations, five cats had from one to eight values within the reference 
range. When serum total T4 concentrations were averaged for each sampling time, there 
was no significant fluctuation in values over the 10 hour period. The times at which the 
lowest and highest values occurred were extremely variable among individual cats. 
During the 15 day sampling period, the individual c.v. for serum total T4 concentrations 
from the seven cats (range, 6.6  - 34.8 %; mean ±sd, 18.4 +9.3 %) was higher than the 
intra-assay c.v.. Two of the cats had mean serum total T4 concentrations (48.91 and 
50.19 nmol/1) within the reference range. Of the 15 daily determinations, three cats had 
six to 11 serum total T4 concentrations within the reference range. In two cats, the 
variations in serum total T4 concentrations were greater during the 15 day period than 
during the 10 hour sampling period. Serum total T3 concentrations were also measured 
and as expected there was a greater frequency of values within the reference range. It 
was concluded that thyroid hormone concentrations are subject to a degree of fluctuation 
in hyperthyroid cats. In cats with mild disease and only marginally elevated serum total 
T4 concentrations, fluctuations can occur to values below those diagnostic for 
hyperthyroidism Multiple blood samples may therefore be required to confirm a 
diagnosis of hyperthyroidism The authors concluded that samples should be collected on 
different days rather than during the same day. An increase in thyroid hormone
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secretion could contribute to increases in circulating thyroid hormone concentrations. 
However, since the biological half life of T4 is measured in hours (Peterson & Becker, 
1983; Broome, Hays & Turrel, 1987; Hays, Broome & Turrel, 1988), it is unlikely that a 
decrease in thyroid gland secretion could account for the acute decreases reported. The 
authors suggested that the short-term changes in circulating total T4 concentrations 
could result from fluctuations in plasma proteins, or from unspecified haemodynamic 
changes. These theories have yet to be investigated further. The degree of fluctuation is 
of little diagnostic significance in cats with markedly elevated serum total T4 
concentrations (Peterson, Graves & Cavanagh, 1987; Broome, Feldman & Turrel, 1988).
The presence of concurrent non-thyroidal illness may also effect serum total T4 
concentrations. In a series of 494 cats with a variety of non-thyroidal illnesses, 63 cats 
had a palpable thyroid nodule (Peterson & Gamble, 1990). In these cases the mean (±sd) 
serum total T4 concentration of 21.70 (+ 10.4) nmol/1 was significantly (P < 0.001) 
higher than in the 431 cats in which a thyroid nodule was not palpated (mean +sd, 12.70 
+8.10 nmol/1). Of the unspecified number of cats with palpable thyroid nodules that 
survived, four developed elevated serum total T4 concentrations consistent with overt 
hyperthyroidism Of the unspecified number that died or were euthanased, two were 
necropsied and both had adenomatous hyperplasia of the thyroid gland on 
histopathological examination. Thus, the authors concluded that at least some cats with 
palpable thyroid nodules had mild hyperthyroidism, but because of their concurrent 
illness, serum total T4 concentrations were depressed into the reference range. In 
addition, these results suggest that following treatment of, or recovery from, the 
concurrent illness, serum total T4 concentrations will increase into the diagnostic 
thyrotoxic range. Given that serum total T4 concentrations are depressed in cats with 
non-thyroidal illness, concurrent hyperthyroidism should be suspected in severely ill cats 
with serum total T4 concentrations within the medium to high end of the reference range. 
When cats are markedly hyperthyroid, the presence of severe concurrent non-thyroidal 
disease appears to have little effect on their serum total T4 concentrations (Thoday & 
Mooney, 1992).
McLoughlin, DiBartola, Birchard & Day (1993) evaluated the effect of concurrent 
non-thyroidal illness in a series of 110 hyperthyroid cats. In all cats, a diagnosis of 
hyperthyroidism was confirmed on the basis of a serum total T4 concentration greater 
than 51.48 nmol/1, or either a positive radionuclide image of the thyroid gland or 
histopathological evidence of adenomatous hyperplasia or carcinoma of thyroid tissue 
obtained by surgical excision or at necropsy. Each cat was also evaluated for systemic 
non-thyroidal illness during the six months prior to, at the time of, and during the six 
months following a diagnosis of hyperthyroidism Diagnosis of non-thyroidal illness was 
established based on results of physical examination, laboratory screening tests (complete 
blood count, serum biochemical profile, urinalysis, FeLV and FIV status), thoracic and 
abdominal radiography, electrocardiography, echocardiography, abdominal 
ultrasonography, and biopsy and cytological examination or bacterial culture of
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appropriate samples where indicated. Non-thyroidal diseases were considered significant 
if the patient required hospitalisation and specific treatment of that disease. Not all 
patients were clinically symptomatic for non-thyroidal disease.
Systemic non-thyroidal illness was diagnosed in 39 (35.5 %) of the cats evaluated. 
The cats were divided into four groups: Group A (n = 6 8 ) included all cats with a serum 
total T4 concentration greater than 51.48 nmol/1 without concurrent disease, Group B (n 
= 28) included all cats with a serum total T4 concentration greater than 51.48 nmol/1 but 
with concurrent disease, Group C (n = 3) included cats with repeated serum total T4 
concentrations lower than 51.48 nmol/1 without concurrent disease and Group D (n = 
11) included all cats with serum total T4 concentrations lower than 51.48 nmol/1 but with 
concurrent disease. Concurrent non-thyroidal illness was diagnosed in 29.1 % ( 28 of 
96 cases) of the hyperthyroid cats with increased serum total T4 concentrations and in
78.5 % (11 of 14 cases) of the cats with reference range serum total T4 concentrations. 
The mean+sd (range) serum total T4 concentration was 142.86 +69.11 (55.34 - 463.32) 
in Group A, 124.32 +66.92 (57.92 - 330.76) in Group B, 45.56 +0.90 (41.06 - 50.58) in 
Group C and 37.32 +9.14 (16.60 - 48.91) nmol/1 in Group D. Serum total T4 
concentrations were significantly decreased in the cats with concurrent illnesses (Groups 
B and D) compared to those in cats with no concurrent diseases (Groups A and C). 
Reference range serum total T4 concentrations were observed in 12.7 % (14 of 110 
cases) of the hyperthyroid cats, representing 28.2 % (11 of 39 cases) of the hyperthyroid 
cats with concurrent diseases and 4.2 % (3 of 71 cases) of the hyperthyroid cats with no 
other diseases. Unfortunately, serum total T4 concentrations after treatment for non- 
thyroidal illnesses were not examined.
There is only one report concerning the possible effect of drug therapy on serum 
total T4 concentrations in hyperthyroid cats (Peterson & Ferguson, 1989b). Eight 
hyperthyroid cats were treated with an immunosuppressive dose of prednisone 
(lOmg/cat) administered intramuscularly. The basal serum total T4 concentrations were 
elevated (mean +sd, 76.8 +44.4 nmol/1), but no significant decrease was detected 24 
hours after the administration of prednisone (mean +sd, 91.9 +53.7 nmol/1). The major 
effect of glucocorticoids in the dog appears to be suppression of pituitary TSH 
(Ferguson & Peterson, 1992). If a similar situation exists in the cat, the results from the 
hyperthyroid cats are not surprising since TSH production and secretion are chronically 
suppressed by the elevated circulating thyroid hormone concentrations.
The TSH and TRH stimulation and T3 suppression tests in hyperthyroid cats
Several additional diagnostic tests have been recommended to confirm a diagnosis of 
hyperthyroidism when serum total T4 concentrations are not diagnostically elevated. 
These include the TSH and TRH stimulation and the T3 suppression tests (Graves & 
Peterson, 1990, 1992; Peterson, Randolph & Mooney, 1994).
Peterson et al. (1983b) reported the results of TSH stimulation in a group of 11 
hyperthyroid cats. The mean serum total T4 concentration of 144.14 nmol/1 after
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administration of TSH was not significantly different from the mean basal concentration 
of 127.41 nmol/1. The authors suggested that either the hyperfunctioning glands were 
secreting thyroid hormones independently of TSH control or that the glands were already 
producing thyroid hormones at a maximal rate. Although all of the cats had 
diagnostically elevated basal serum total T4 concentrations, it was suggested that failure 
to respond to TSH may be a useful confirmatory test in equivocal cases. Feldman & 
Nelson (1987) reported an overlap in TSH stimulation test results between seven 
euthyroid and eight hyperthyroid cats although absolute values were not reported. In the 
largest series of 42 hyperthyroid cats tested (Mooney, 1990; Mooney, Thoday & Doxey, 
1992b), there was a significantly lower serum total T4 response to exogenous TSH 
administration in hyperthyroid cats, confirming the results of Peterson et al. (1983b). 
However, in three cats with equivocal basal serum total T4 concentrations, the response 
to TSH was indistinguishable from healthy, euthyroid cats. Thus, a failure to respond to 
TSH can confirm a diagnosis of hyperthyroidism but a normal response cannot exclude 
it. In addition, it is in equivocal cases, where the test would be of greatest value that a 
normal response is likely to occur. In the two studies where serum total T3 
concentrations were also determined, there was a greater overlap in test results between 
hyperthyroid and euthyroid cats because of the more variable response in this analyte in 
the euthyroid animals (Peterson et al., 1983b; Mooney, Thoday & Doxey, 1992b). 
Additional drawbacks of this test include expense and difficulty in obtaining TSH.
Peterson (1991) reported the results of the TRH stimulation test in a group of 30 
healthy, euthyroid and 21 hyperthyroid cats. Serum total T4 and T3 concentrations were 
determined before and four hours after intravenous administration of TRH (0.1 mg/kg). 
In the healthy cats, TRH caused a significant (P < 0.001) increase in the mean +sd serum 
total T4 concentration from 23 +9.5 nmol/1 to 52 +17 nmol/1, with a percentage T4 
increase over basal values of 131 % (range, 61 - 310 %). In the hyperthyroid cats, TRH 
also caused a significant (P < 0.03) increase in serum total T4 concentrations from a 
mean +sd of 65 +22 to 73 +26 nmol/1, but the mean percentage increase was significantly 
(P < 0.001) less than normal (14.7 %, range, -29 - 81 %). Only one hyperthyroid cat had 
a serum total T4 increase greater than 60 %, which was the lower limit in the healthy 
cats. Serum total T3 determinations were reported to be unhelpfid because of the greater 
variability in the two groups, but absolute values were not recorded. These results and 
others were presented in greater detail by Peterson, Randolph & Mooney (1994) and 
included 31 healthy cats, 35 hyperthyroid cats and 15 cats with nonthyroidal illnesses. A 
consistent increase in serum total T4 concentrations, similar to healthy animals was noted 
in the cats with nonthyroidal illness after administration of TRH. The relative increase 
(percentage) in serum total T4 concentrations after administration of TRH, and the 
discriminative function score for total T4 (using an equation derived from canonical 
discriminant analysis) were the two most sensitive criteria for predicting whether cats 
were hyperthyroid. A rise in serum total T4 concentrations of less than 50 % was 
consistent with mild hyperthyroidism, whereas a value of greater than 60 % was only
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seen in healthy cats or cats with non-thyroidal disease. Values between 50 and 60 % 
were considered borderline or equivocal. For the discriminative function score, 
calculated as 2.2 times the basal total T4 concentration minus the TRH-stimulated total 
T4 concentration, a D value of greater than 30 was consistent with hyperthyroidism, 
whereas a value of less than 20 was considered normal. As with the percentage increase 
in total T4, a value between 20 and 30 was considered ambiguous. The major 
disadvantage reported for the TRH stimulation test was the frequency of adverse 
reactions noted immediately after administration. These included salivation, vomiting, 
tachypnoea and defaecation (Peterson, 1991; Peterson, Randolph & Mooney, 1994).
The T3 suppression test relies on the ability of administered T3 through negative 
feedback, to decrease T4 production by the thyroid gland. In hyperthyroidism, since 
excess circulating thyroid hormone concentrations are already suppressing TSH 
production and secretion, additional T3 has little or no effect on T4 production. Since 
the serum half life of T4 in the cat is only six to eight hours (Broome, Hays & Turrel, 
1987; Hays, Broome & Turrel, 1988), administration of T3 causes a relatively rapid fall 
in circulating total T4 concentrations. Peterson, Graves and Gamble (1990) evaluated 
the response of circulating total T4 concentrations to exogenous T3 (liothyronine) 
administration in 44 clinically healthy cats, 77 cats with hyperthyroidism and 22 cats with 
non-thyroidal disease. Serum total T4 and T3 concentrations were measured before and 
two to four hours after administering liothyronine at an oral dosage of 25 ug three times 
daily for seven doses. A diagnosis of hyperthyroidism was confirmed by the presence of 
clinical signs, the finding of goitre, high-normal or high serum total T4 concentrations 
and an adequate response to appropriate treatment. The mean basal serum total T4 and 
T3 concentrations were significantly higher in the hyperthyroid (53.1 and 1.4 nmol/1) 
than in the healthy (25.3 and 1.3 nmol/1) and the sick (29.5 and 1.4 nmol/1) cats. Of the 
77 cats with hyperthyroidism, 41 (53 %) had basal total T4 concentrations within the 
reference range and 55 (71 %) also had basal total T3 concentrations within the 
reference range. After administration of liothyronine, there was a significant (P < 0.001) 
decrease in mean serum total T4 concentrations and a significant (P < 0.001) increase in 
mean serum total T3 concentrations in all three groups of animals. This suggests that in 
cases of mild hyperthyroidism pituitary TSH secretion has not been completely 
suppressed. However, the mean serum total T4 concentration fell more markedly in the 
healthy and sick cats compared to the hyperthyroid animals. The mean (±sd) post- 
liothyronine serum total T4 concentration in the hyperthyroid cats (48.5 (+20.8) nmol/1) 
was significantly (P < 0.001) greater than that of either the healthy (9.5 (±4.5) nmol/1) or 
sick (9.9 (±4.6) nmol/1) cats. No significant difference was noted between the latter two 
groups. There was no significant difference between mean (±sd) post-liothyronine serum 
total T3 concentrations in the hyperthyroid (2.9 (±0.8) nmol/1), healthy (2.6 (±1.1) 
nmol/1) and sick (2.6 (±1.0) nmol/1) cats. The mean (±sd) percentage decrease in serum 
total T4 concentrations after administration of liothyronine in the hyperthyroid cats (9.1 
(±19) %) was significantly (P < 0 .0 0 1 ) less than the decrease in either the healthy (63
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(±15) %) cats or the cats with non-thyroidal diseases (67 (±16) %). Serum total T4 
concentrations decreased by more than 35 % in all but one healthy cat and one cat with 
non-thyroidal disease. Only six of the 77 hyperthyroid cats (7.8 %) had more than a 35 
% decrease in serum total T4 concentrations. In the remaining hyperthyroid cats, serum 
total T4 concentrations decreased marginally or were unchanged in 51, and were 
increased in 20 cats. All of the cats with hyperthyroidism had post-liothyronine serum 
total T4 concentrations in excess of 20 nmol/1 whereas all of the healthy and sick cats 
had concentrations less than 20 nmol/1. The presence of hyperthyroidism was therefore 
confirmed if the post-liothyronine serum total T4 concentration was greater than 20 
nmol/1 with a percentage decrease of less than 50 %.
Refsal et al. (1991) also evaluated the T3 suppression test in ill cats with serum 
iodothyronine concentrations within the reference range. Serum total and free (by 
analogue assay) T4 and total T3 concentrations were measured before and two to 12 
hours after administering liothyronine at an oral dosage of 15 ug three times daily for six 
or seven doses. All of the 49 cats tested had clinical signs of variable severity that were 
compatible with a diagnosis of hyperthyroidism. Twenty-six animals were subsequently 
confirmed as hyperthyroid either by histopathological confirmation (n = 14) after 
thyroidectomy or necropsy, or by clinical improvement in response to methimazole 
administration (n = 12). Three of these cats were subsequently deleted from further 
evaluation because at the time of the test basal serum total and free T4 concentrations 
had increased into the thyrotoxic range. Twenty-three cats were classified as non­
hyperthyroid on the basis of histopathological confirmation of other diseases by biopsy or 
at necropsy (n = 12), abnormal diagnostic tests supportive of another illness (n = 8) or 
spontaneous recovery from the observed clinical signs without treatment (n = 3). The 
mean ±sd basal serum concentrations of total T4, total T3 and free T4 were 34.3 ±12.7 
nmol/1, 0.85 ±0.33 nmol/1 and 26.6 ±6.4 pmol/1 in the hyperthyroid cats and 27.9 ±10.3 
nmol/1, 0.69 ±0.24 nmol/1 and 21.7 ±5.4 pmol/1 in the non-hyperthyroid cats. The basal 
serum total T4 concentrations were significantly (P < 0.05) higher in the hyperthyroid 
cats, but there were were no significant differences in the other two variables between 
the two groups. The mean ±sd post-liothyronine serum concentrations of total T4, total 
T3 and free T4 were 31.3 ±11.5 nmol/1, 1.60 ±1.19 nmol/1 and 25.6 ±6.9 pmol/1 in the 
hyperthyroid cats and 11.7 ±6.4 nmol/1, 0.97 ±0.51 nmol/1 and 10.4 ±4.4 pmol/1 in the 
non-hyperthyroid cats. The mean serum total and free T4 concentrations were 
unchanged in hyperthyroid cats but decreased significantly (P < 0.001) in the non­
hyperthyroid cats. The mean ±sd percentage decrease in total and free T4 values were 4 
±30 and 2 ±30 % in the hyperthyroid cats and were significantly (P < 0.001) lower than 
the values of 57 ±21 and 50 ±21 % in the non-hyperthyroid cats. However, there was 
considerable variation within each group. In the hyperthyroid cats, 33 % of post- 
liothyronine serum total or free T4 concentrations were within the reference range. An 
additional 50 % of these cats had a 0 to 25 % decrease in these analytes. In 91 % of the
Chapter 7 101
non-hyperthyroid cats, serum total or free T4 concentrations decreased by at least 35 %, 
with a decrease of over 50 % in half of the cats.
For the stepwise discriminant analysis, the estimation of post-liothyronine serum 
free T4 concentrations was the single best diagnostic factor, accounting for 64 % of the 
variation (P < 0.001). A two factor model was also identified which included the post- 
liothyronine serum free T4 concentration (P < 0.001) and the percentage decrease in 
serum total T4 concentrations (P < 0.05). This predictive value was calculated as 1.95 
plus (0.00378 times % decrease in total T4) minus (0.031 times post-liothyronine serum 
free T4 concentration). This two factor model accounted for 67.4 % of the experimental 
variation. The range of values was 0.443 to 1.582 in hyperthyroid cats and 1.417 to 
2.220 in cats with other diseases. In the absence of free T4 data, the single variable that 
best differentiated the two groups was the post-liothyronine serum total T4 
concentration, accounting for 53.6 % of the experimental variation (P < 0.001). 
Addition of the percentage decrease in serum total T4 concentrations was of added 
benefit, accounting for 65.2 % of the experimental variation. Using these two variables, 
a predictive value was calculated as 1.693 plus (0.0056 times % decrease in total T4) 
minus (0.017 times post-liothyronine serum total T4 concentration). These values 
ranged from 0.665 to 1.796 in hyperthyroid cats and 1.382 to 2.185 in cats with other 
diseases. Three hyperthyroid cats were identified as having false-negative results in all 
four models. Two non-hyperthyroid cats were classified as having false positive results 
in all four models. The respective test sensitivity for all four models were comparable at 
0.739, 0.826. 0.783 and 0.783. Test specificity was 0.826, 0.913, 0.652 and 0.565. 
Thus, models incorporating serum free T4 concentrations were better at ruling out 
hyperthyroidism. The authors pointed out that each laboratory would have to establish 
its own predictive values (Refsal et al., 1991).
In response to the findings of Refsal et al. (1991), Peterson, Randolph & Mooney 
(1994) evaluated the use of discriminant analysis in the mildly hyperthyroid cats studied 
by Peterson, Graves and Gamble (1990). This produced a two factor model that 
included the basal and post-liothyronine serum total T4 concentrations. The equation 
was calculated as the post-liothyronine serum total T4 concentration minus 0.5 times 
serum basal total T4 concentration. All cats having a score greater than 8 were 
hyperthyroid, whereas all cats with a score less than 2 were euthyroid. However, eight 
hyperthyroid and five non-hyperthyroid cats had scores between 2 and 8 . Thus, the post- 
liothyronine serum total T4 concentration remained the most sensitive means of 
differentiating the two groups.
Although the T3 suppression test appears to be of more value than either the TSH 
or TRH stimulation tests, it is expensive to perform. It is a relatively prolonged test 
(three days), owners are required to give multiple doses of liothyronine and the cats must 
swallow the tablets. To confirm both owner and cat compliance in administering and 
taking the drug, serum total T3 concentrations must be measured before and after the 
test (Peterson, Graves & Gamble, 1990; Peterson, Randolph & Mooney, 1994). In
Chapter 7 102
addition, absorption of liothyronine may be inadequate in cats with gastrointestinal 
disease (Refsal et al., 1991).
Circulating free thyroid hormone concentrations in hyperthyroid cats 
There are relatively few reports on circulating serum free thyroxine concentrations in 
hyperthyroid cats. Hays, Turrel & Broome (1988) used the equilibrium dialysis 
technique of Sterling & Brenner (1966) to measure serum free T4 concentrations in six 
hyperthyroid cats. Absolute serum free T4 values were not reported. However, the 
mean +sd free T4 fraction was 0.056 +0.006 % in the hyperthyroid compared to 0.057 
+0.009 % in five healthy cats. The corresponding values for T3 were 0.46 +0.09 % and 
0.47 +0.08 %. The authors concluded that in contrast to the situation in humans, the 
unbound percentage of total T4 and T3 is unchanged in hyperthyroidism. Thus, the 
degree of hyperthyroidism could be inferred from measurement of circulating total 
thyroid hormone concentrations alone.
Ferguson, Peterson & Nachreiner (1989) measured serum total and free 
iodothyronine concentrations in a series of 25 hyperthyroid cats. Serum free thyroxine 
concentrations were measured by an unspecified equilibrium dialysis technique and a 
direct RIA. This RIA was identified as an analogue kit method (Magic free T4, Ciba 
Coming Diagnostics) by Refsal et a l  (1991). Serum free T3 concentrations were 
measured by an unspecified direct RIA kit method. Compared to healthy cats (n = 28), 
cats with hyperthyroidism had significantly higher (P < 0.001) mean +sd serum free T4 
concentrations by RIA (80.6 +40.0 versus 23.9 +5.8 pmol/1), serum free T4 
concentrations by equilibrium dialysis (105.8 +58.4 versus 20.4 +11.1 pmol/1) and serum 
free T3 concentrations by RIA (8.8 +3.8 versus 1.6 +7.7 pmol/1). The mean +sd serum 
total T4 and T3 concentrations in the hyperthyroid cats were 100.3 +49.3 and 3.1 +2.3 
nmol/1, respectively. All of the hyperthyroid cats had serum concentrations of total T4 
and T3 and free T4 and T3 concentrations by RIA above their respective reference 
ranges. One cat (4 %) had a semm free T4 concentration by equilibrium dialysis within 
the reference range. In six hyperthyroid cats undergoing treatment with methimazole, 
mean +sd serum concentrations of total T4 (27.5 ±17.4) and free T4 by RIA (29.8 +11.4 
pmol/1) were within their respective reference ranges. In these cats, serum free T4 
concentrations by equilibrium dialysis were significantly higher (mean +sd, 43.7 +17.1 
pmol/1) than in healthy controls. An explanation for this was not offered. In all cats there 
was a significant correlation between total T4 and free T4 concentrations determined 
using either RIA (r = 0.99) or equilibrium dialysis (r = 0.93), as well as between free T4 
concentrations determined using the two techniques (r = 0.97). Compared to equilibrium 
dialysis, the RIA technique tended to overestimate free T4 concentrations in the low- 
normal range and underestimate values in the higher range. The authors concluded that 
serum free T4 concentrations are elevated in hyperthyroidism However, since the 
elevations in free T4 concentrations were directly proportional to those in total T4,
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measurement of free T4 concentrations provided no additional diagnostic information 
over measurement of total T4 concentrations alone.
Refsal et a l,  (1991) also measured serum free T4 concentrations in hyperthyroid 
cats using an analogue kit method (Magic free T4, Ciba Coming Diagnostics). 
However, these cats were specifically chosen because both total and free T4 
concentrations were within the reference range. Serum free T4 concentrations in 
hyperthyroid cats as measured by a direct equilibrium dialysis kit method (Nichols 
Institute Diagnostics) were mentioned but individual values were not reported (Chapters 
4 and 6 ).
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In the small number of hyperthyroid cats studied to date, serum free T4 concentrations 
were elevated (Ferguson, Peterson & Nachreiner, 1989). However, to date there are no 
reports on the comparison of free T4 concentrations in hyperthyroid cats and cats with 
non-thyroidal illnesses. Since serum free T4 concentrations as measured by equilibrium 
dialysis, were found to be occasionally elevated in sick cats (Chapter 6 ), its sole use as a 
diagnostic test may lead to an overdiagnosis of hyperthyroidism. In addition, Hays, 
Turrel & Broome (1988) suggested that the degree of hyperthyroidism could be inferred 
directly from serum total T4 measurements since, in comparison to the situation in 
humans, the free T4 fraction is unaltered in hyperthyroidism. However, only six 
hyperthyroid cats were studied by these authors and no data were supplied on the 
validation of the equilibrium dialysis technique used.
The present study was designed to more clearly evaluate serum free T4 
concentrations in hyperthyroid cats and to assess its specificity and sensitivity as a 
diagnostic test. It was also important to frilly assess whether serum free and total T4 
concentrations reflected the degree of hyperthyroidism, since this was an important 
factor used in determining the dose of radioactive iodine subsequently given for 
treatment (Chapter 8).
7.3 MATERIALS AND METHODS
Clinical material
The case material comprised a series of 95 hyperthyroid cats referred to Glasgow 
University Small Animal Hospital. Two of the cats had had a bilateral thyroidectomy 
eight and 36 months previously, respectively. Three cats had had a unilateral 
thyroidectomy 12, 13 and 18 months previously, respectively. One cat had had two 
surgical thyroidectomies, the last eight months previously. All of the cats exhibited 
historical and clinical features consistent with a diagnosis of thyrotoxicosis.
Of these cats, 57 were female (55 ovariohysterectomised and two entire) and 38 
were male (all castrated). One cat was of unknown age, but had been in the owner's 
possession for 10 years. The remaining cats ranged in age from 9.0 to 19.0 years with a 
mean +sd of 13.2 +2.2 years. Ninety-three of the cats were either domestic short (n = 
84) or long (n = 9) haired. The remaining two cats were Persians.
Most of these cats form part of the survey detailed in Chapter 3. Fifty cats were 
subsequently treated with radioactive iodine as described in Chapter 8 .
The reference ranges for serum total and free T4 concentrations are detailed in 
Chapter 4.
The cats suffering non-thyroidal illnesses described in Chapters 5 and 6 were used 
for comparison purposes.
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Estimation of serum total and free thyroxine concentrations
At the time of initial presentation, providing treatment had not commenced, a serum 
sample was obtained from each cat. Serum total, and if the sample volume allowed, free 
T4 concentrations were measured and the free T4 fraction calculated as described in 
Chapter 4.
Statistical analyses
The Mann Whitney U test was used for statistical analyses. Pearson's correlation was 
used for comparing serum total and corresponding free T4 concentrations. The 
sensitivity, specificity and efficiency of the serum total and free T4 estimations were 
calculated as described by Fraser (1986). Sensitivity was calculated as the percentage of 
true positive results in the hyperthyroid and sick cats. Specificity was calculated as the 
percentage of true negative results in the hyperthyroid and sick cats. Efficiency was 
subsequently calculated as the percentage of all results that were true results.
7.4 RESULTS
Serum free thyroxine concentrations in hyperthyroid cats.
Serum total and free T4 concentrations were both measured in 26 of the cats. The data 
are detailed in Appendix 12 and summarised in Table 10.
Total T4 (nmol/1) Free T4 (pmol/1) % free T4
n 26 26 26
Mean 204.15 233.32 0.11
sd 134.83 177.08 0.04
Minimum 43.83 46.88 0.07
1st quartile 97.64 113.07 0.09
Median 170.06 191.30 0.11
3rd quartile 285.64 259.71 0.12
Maximum 575.57 687.61 0.25
Table 10. Summary statistics of serum total and free thyroxine (T4) concentrations and 
calculated free T4 fractions in hyperthyroid cats.
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None of the cats were suffering any other illness apart from hyperthyroidism The 
lowest serum total T4 concentration of 43.83 nmol/1 corresponded to the lowest free T4 
concentration of 46.88 pmol/1 (case number 117880). Both values were above their 
respective reference ranges (10.75 - 41.25 nmol/1; 8.14 - 41.45 pmol/1) but less than 
three sds from the reference mean (48.87 nmol/1 and 49.78 pmol/1). All of the remaining 
concentrations were above these two values. The highest serum total T4 concentration 
of 575.57 nmol/1 corresponded to a free T4 concentration of 635.01 pmol/1 (case number 
119160). The highest serum free T4 concentration of 687.61 pmol/1 corresponded to a 
total T4 concentration of 272.50 nmol/1 (case number 117850). This cat consequently 
had the highest free T4 fraction of 0.25 %. The next highest value was 0.14 %.
The serum free T4 concentrations were significantly (P < 0.001) higher in the 
hyperthyroid compared to the healthy cats. There was no significant (P > 0.05) 
difference in the calculated free T4 fraction between these two groups. There was a 
highly significant correlation (r = 0.92, P < 0.001) between the serum total and free T4 
concentrations in healthy and hyperthyroid cats taken as one group (Figure 10).
Comparison of total and free thyroxine values for the diagnosis of hyperthyroidism 
The serum total T4 concentrations of the 95 hyperthyroid cats ranged from 39.69 to 
575.57 nmol/1 with a mean +sd of 164.02 +102.10 nmol/1. These values were 
significantly (P < 0 .0 0 1 ) higher than in the 50 healthy cats. Two cats (case numbers 
113704 and 117880) had serum total T4 concentrations above the reference range but 
less than three sds from the reference mean (48.87 nmol/1). Both cats were considered to 
be mildly hyperthyroid. One cat (case number 121116) had a serum total T4 
concentration of 39.69 nmol/1, within the reference range. This cat was severely ill, 
suffering from histiocytic lymphoma with associated necrosis and abscessation of the 
retropharyngeal lymph nodes. The cat was euthanased on humane grounds before 
treatment of the hyperthyroidism commenced.
In the sick cats with non-thyroidal illnesses (Chapter 5), serum total T4 
concentrations were below 48.87 nmol/1 in all cases. From Table 11 the sensitivity of 
serum total T4 estimations for diagnosing hyperthyroidism was 96.9 %. The specificity 
of this test was 100 % and the efficiency 98.5 %.
In the sick cats (Chapter 6 ), serum free T4 concentrations were greater than 3 sds 
above the reference mean in six cases. From Table 12 the sensitivity of serum free T4 
estimations for diagnosing hyperthyroidism was 96.2 %. The specificity of this test was 
93.9 % and the efficiency 94.4 %.
Se
ru
m
 
fr
ee
 
T4
 
c
o
n
c
e
n
tr
a
ti
o
n
 
(p
m
o
l/
1
)
Chapter 7 107
800
600
400
2 0 0 -
0 200 400 600
Serum total T4 concentration (nmol/1)
Figure 10. Serum total and free thyroxine (T4) concentrations in 38 healthy euthyroid 
and 26 hyperthyroid cats.
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Disease Test results
Positive Negative Totals
Hyperthyroid 92 3 95
Not hyperthyroid 0 107 107
Totals 92 110 202
Table 11. The number of true and false positive and negative results for a diagnosis of 
hyperthyroidism as assessed by a serum total thyroxine concentration greater than three 
standard deviations above the reference mean.
Disease Test results
Positive Negative Totals
Hyperthyroid 25 1 26
Not hyperthyroid 6 92 98
Totals 31 93 124
Table 12. The number of true and false positive and negative results for a diagnosis of 
hyperthyroidism as assessed by a serum free thyroxine concentration greater than three 
standard deviations above the reference mean.
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This study confirms previous reports that serum total T4 concentrations are usually 
elevated in hyperthyroidism (Peterson et a l  1983b; Thoday & Mooney, 1992). The mean 
serum total T4 concentration averaged six times the reference mean comparable to the 
factor of seven reported by Peterson et al. (1983b). This is higher than the factor of 2.5 
reported in humans (Larsen, 1972), and presumably reflects the differences in thyroid 
production rates, serum half lives and protein binding between the two species. These 
differences require further investigation.
Many of the cats with non-thyroidal illnesses exhibited clinical signs which have 
been reported in hyperthyroid cats (Peterson et a l , 1983b; Thoday & Mooney, 1992). 
Thus, measurement of serum total T4 concentrations was important in order to eliminate 
a diagnosis of hyperthyroidism. Using the thyrotoxic limit of a serum total T4 
concentration exceeding three sds from the reference mean suggested by Turrel et al 
(1984), all of these cats were correctly classified as non-hyperthyroid. A small number 
(3 %) of hyperthyroid cats had serum total T4 concentrations below the thyrotoxic 
range. As in previous reports, these cats were either suffering mild or early 
hyperthyroidism or in addition to the hyperthyroidism had severe concurrent non­
thyroidal diseases (Peterson et a l , 1983b; Peterson, Graves & Cavanagh, 1987; Peterson 
& Gamble, 1990; Thoday & Mooney, 1992; Broussard & Peterson, 1993; McLoughlin 
et a l , 1993). Thus measurement of serum total T4 concentrations is an extremely 
specific test with good sensitivity.
In this study, measurement of serum free T4 concentrations did not provide any 
additional diagnostic information. There was an excellent correlation between serum 
total and corresponding free T4 concentrations as previously reported (Ferguson, 
Peterson & Nachreiner, 1989). Thus in one cat with mild hyperthyroidism, both serum 
total and free T4 concentrations were below the thyrotoxic limit. In only one case was 
the serum free T4 concentration more elevated than the total T4, but the latter was well 
within the thyrotoxic range. There was no apparent explanation for this aberrant result.
There was no significant difference between the calculated free T4 fraction in the 
hyperthyroid and healthy cats. This confirms the preliminary report of Hays, Turrel & 
Broome (1988). Thus, in hyperthyroid cats it is justifiable to infer the degree of 
hyperthyroidism from measurement of serum total T4 concentrations alone. 
Measurement of circulating total T4 is therefore adequate for use in the assessment of a 
therapeutic dose of radioactive iodine. This contrasts to the situation in humans, where 
serum free T4 concentrations are more consistently elevated in hyperthyroidism 
(Woeber, 1986) and again presumably relates to the differences in binding proteins 
between the two species.
Although measurement of circulating free T4 concentrations proved to be as 
sensitive a test for the diagnosis of hyperthyroidism in cats, it was less specific. This was 
related to the finding of elevated serum free T4 concentrations in cats with non-thyroidal
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illnesses. Thus as a sole diagnostic test its measurement by equilibrium dialysis would 
lead to an over diagnosis of hyperthyroidism It has been suggested that the 
measurement of serum free T4 concentrations would be of benefit in hyperthyroid cats 
with concurrent illnesses and serum total T4 concentrations within the reference range 
(Peterson, Randolph & Mooney, 1994). Only one cat presented here had a serum total 
T4 concentration within the reference range as a result of a concurrent disease. A serum 
free T4 concentration was not measured. However, in cats with non-thyroidal illnesses 
when serum free T4 concentrations were elevated, serum total T4 concentrations tended 
to be within the reference range. Therefore it is unlikely that estimation of free T4 
concentrations in sick hyperthyroid cats would be of benefit.
Estimations of serum total T4 concentrations are less expensive and easier to 
perform, and more frequently available in veterinary laboratories than free T4 estimations 
by equilibrium dialysis. This study established that measurement of serum total T4 
concentrations is as sensitive a test but more specific than measurement of free T4 
concentrations. If serum total T4 concentrations are not diagnostically elevated, but 
hyperthyroidism is suspected additional diagnostic tests should be considered. To date, 
the T3 suppression test appears to be of most use ( Peterson, Graves and Gamble, 1990; 
Refsal et al., 1991). Alternatively, in mild cases of hyperthyroidism, serum total T4 
concentrations could be measured after a period of several weeks when they should have 
increased into the thyrotoxic range. Cats with concurrent non-thyroidal illness could be 
retested on recovery from that illness.
I l l
CHAPTER 8
RADIOACTIVE IODINE THERAPY OF FELINE HYPERTHYROIDISM:
A SIMPLE METHOD OF DOSE ESTIMATION AND COMPARISON OF 
INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATION
8.1 LITERATURE REVIEW 
Treatment options for hyperthyroidism
The introduction of radioactive iodine, (^^Iodine (130j) in 1941 and l^Iodine (^^1) 
in 1946) for the treatment of hyperthyroidism in man proved an historic landmark in 
medical therapeutics and ushered in the field of nuclear medicine (Hamilton & Lawrence, 
1942; Hertz & Roberts, 1942; Hertz & Roberts, 1946). The eight day half fife of ^ 4 ,  
compared to 12 hours for 130^ pr0Ved superior, as treatment became more predictable. 
13 l i  remains the most commonly used isotope in therapeutics today (Solomon, 1986). 
Since the first confirmed description of feline hyperthyroidism (Cotter, 1979; Peterson, 
Johnson & Andrews, 1979) and given its similarity to human toxic nodular goitre 
(Peterson, Becker, Hurley & Ferguson, 1981), administration of radioactive iodine (as 
13 ll) has been recommended as a safe and effective treatment for affected cats 
(Peterson, Becker, Cahill & Ferguson, 1983a).
Unlike Graves' disease in man, spontaneous remission of feline hyperthyroidism 
does not occur and the aim of therapy is to control the excessive secretion of the thyroid 
hormones from affected thyroid tissue by radioablation, surgical thyroidectomy or 
chronic antithyroid drug administration. The disadvantages of surgical thyroidectomy 
have been reviewed previously (Mooney, 1990) and include, the risk of anaesthesia, and 
potential complications such as haemorrhage, laryngeal oedema, laryngeal paralysis, 
hypoparathyroidism, Homer's syndrome, voice change, persistent hyperthyroidism and 
recurrence due to regrowth of tissue left in situ at the time of surgery. Chronic 
antithyroid drug therapy (using propylthiouracil, methimazole or carbimazole) requires 
daily pill administration. In addition, propylthiouracil has been associated with serious 
haematological abnormalities and is now considered too toxic for use in cats (Peterson, 
Hurvitz, Leib, Cavanagh & Dutton, 1984b). Methimazole appears to be safer than 
propylthiouracil with fewer and less serious adverse effects (Peterson, Kintzer & 
Hurvitz, 1988). It is not available in this country. The only alternative is carbimazole and 
although serious adverse reactions have not been associated with its use, mild side effects 
of vomiting and depression can persist requiring withdrawal of the drug (Mooney, 
Thoday & Doxey, 1992a).
Mode of action of radioactive iodine
Radioactive iodine, like stable iodine, is actively concentrated by the thyroid gland. It 
emits both beta particles and gamma radiation. The beta particles, which cause over 80
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% of the tissue damage, travel a maximum of 2 mm in tissue and have an average 
pathlength of 400 urn It is therefore locally destructive and spares adjacent atrophic 
thyroid tissue, parathyroid glands and other cervical structures. Radioiodine produces 
damage by two mechanism, acute radiation thyroiditis and chronic gradual thyroid 
atrophy (Solomon, 1986). Thyroid follicles vary in their uptake of radioactive iodine. 
Thus, some cells will be subjected to high doses and intense radiation and die 
immediately. This acute radiation response generally occurs from three to 10 days 
following administration of radioactive iodine. Later, a progressive atrophy is noted with 
an obliterative endarteritis and interstitial fibrosis. The progressive decline in function of 
surviving cells may be a result of the development of genetic abnormalities that lead to a 
shorter survival time and impaired replication.
Estimation of a therapeutic dose and efficacy of radioactive iodine administration
The aim of radioactive iodine therapy is to restore euthyroidism with the smallest 
possible single dose of radiation, whilst avoiding the development of hypothyroidism or 
the persistence of hyperthyroidism. Considerable controversy surrounds the optimal 
method of dose selection in man. Each method, with or without some modification, has 
been attempted in the cat and this review will concentrate primarily on this species.
Tracer kinetic studies
Theoretically the most valid method of estimation of the optimum dose of ^ 4 ,  and the 
most complicated, is to calculate a therapeutic dose aiming to deliver approximately 
15,000 to 20,000 rad (as with external radiation) per g of thyroid tissue. This method 
involves the administration of a small tracer dose of 13 lj  (3.7 to 11.1 Mega Becquerel 
(MBq)) to determine various parameters of thyroid kinetics including the effective half 
life (which accounts for both the physical half life and duration of radioiodine retention 
by the thyroid gland) and the peak thyroidal uptake. These parameters, together with an 
estimated weight of thyroid tissue determine the required therapeutic dose. This method 
obviously requires two separate isotope injections (the tracer and therapeutic doses) and 
although manual techniques of data retrieval and calculation are applicable (Broome, 
Turrel & Hays, 1988) they are time consuming, so that sophisticated computerised 
nuclear medicine equipment is preferred.
Peterson et a l  (1983a) were the first workers to evaluate this method in a series of 
11 hyperthyroid cats. They attempted to deliver 15,000 rad to thyroid tissue using the 
above method of dose formulation. The administered therapeutic dose ranged from 37 to 
185 MBq with a mean ±sem of 99.9 ±11.1 MBq. The serum total T4 concentration 
decreased to within the reference range in one to nine days with a mean ±sem of 4.1 
±0.7 days. Signs consistent with hypothyroidism developed in one cat together with a 
subreference range serum total T4 concentration, necessitating T4 supplementation. 
Relapse of hyperthyroidism occurred in one cat 18 months after therapy, but was 
successfully retreated with a second injection. Nine cats remained euthyroid for one to
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26 months. The mean ±sem survival time in the 11 cats was 13.5 +2.9 months, and of 
these five were still alive five to 25 months after treatment.
Turrel et al. (1984) attempted to assess the efficacy of treatment using the above 
method of dose estimation compared to cats given a dose based on an "educated guess" 
and to identify some of the factors that affected eventual outcome. Eleven cats were 
treated with 1311 Previous unsuccessful treatments included unilateral thyroidectomy 
(two cats) and medical management with propylthiouracil (seven cats) for one to 14 
months, while two cats had had no prior treatment. Tracer studies were performed in 
seven cats. Thyroid weight was estimated by digital palpation and the appearance of a 
sodium pertechnetate ( ^ mTc0 4 ) scan. The calculated therapeutic dose of 13 l l  aimed 
to deliver 20,000 rad to the thyroid gland and ranged from 37 to 218.3 MBq. Seven cats 
became clinically and serologically euthyroid after therapy, although one of these 
required a second injection at 6 months. Clinical improvement was noted within 1 month 
of therapy and clinical signs were absent within 3 months, while serum total T4 
concentrations were usually within the reference range within 1 month of therapy. 
99mXc0 4 scans performed within 2 to 10 months of therapy depicted decreased activity 
and size of the thyroid gland. Two cats had a partial response to therapy with serum 
total T4 concentrations decreasing to less than half of their pretreatment concentrations. 
These cats were not retreated with 13 I f  Hypothyroidism developed in the remaining 
two cases within one and 11 months of therapy, respectively. One of these cats died 
without being treated while in the other, the lethargy, obesity and subreference range 
serum total T4 concentration were reversed with thyroid hormone supplementation. 
Treatment with a single dose of 13 lj  was successful in those cats that had had no prior 
antithyroid medication, had undergone unilateral thyroidectomy or where 
propylthiouracil treatment had been withdrawn at least one month prior to radiation 
therapy. Of four cats that had received propylthiouracil within one month of 13 fy 
therapy, two remained hyperthyroid despite multiple treatments, the third required a 
second injection and the fourth became acutely hypothyroid. It was suggested that, as in 
humans, antithyroid drug therapy may increase the radioresistance of the thyroid tissue. 
Retrospective calculations based on the therapeutic dose showed that the radiation dose 
delivered to the thyroid gland actually ranged from 7,100 to 64,900 rad. The variation 
between the prescribed and actual therapeutic doses resulted in part because of the four 
cats which did not have tracer scans. This resulted in marked underdosing of two and 
overdosing of two animals. Of those having tracer scans, peak thyroidal uptake and/or 
the biological half life of the therapeutic dose differed significantly from the tracer kinetic 
studies. In addition, the thyroid gland weight was difficult to estimate and thus 
introduced a source of error in the calculation. Markedly elevated pretreatment serum 
total T4 concentrations also adversely affected ultimate outcome, particularly if 
associated with large thyroid lobes. Thyroid tissue was subsequently available for 
histopathological examination in two treated cats at necropsy and areas of necrosis were 
observed. The authors concluded that quantitation of thyroid activity to determine
Chapter 8 114
radiation dose, using sophisticated computerised nuclear medicine equipment, may not 
improve the proportion of cats that respond to treatment, when compared with dosages 
empirically selected on the basis of pretreatment factors.
Despite these reservations, calculation of the therapeutic dose of 13 4  using the 
tracer kinetic formula have been used in the two largest studies on the efficacy of 
radioactive iodine therapy in hyperthyroid cats. Peterson & Turrel (1986) aiming to 
deliver 15,000 to 20,000 rad/g of thyroid tissue, treated more than 300 cats using a dose 
ranging from 37 to 370 MBq 13 I f  Over 90 % of the cats became euthyroid within 3 
months after a single dose, while the remaining cats were successfully cured with a 
second injection, and very few cats developed hypothyroidism. Feldman & Nelson 
(1987) aimed to deliver 20,000 rad to the thyroid gland and this resulted in a success rate 
of over 90 % of 350 cats with 10 % remaining hyperthyroid.
The time to return of euthyroidism in 31 of the cats described by Feldman & 
Nelson (1987) was reported in detail by Meric, Hawkins, Washabau, Turrel & Feldman 
(1986). The therapeutic dose, based on 13 l l  tracer kinetic studies, ranged from 55.5 to 
226.81 MBq. Serum total T4 concentrations decreased rapidly in all cats during the first 
two weeks of therapy, with the most rapid decrease being during the first three to six 
days. Of the 31 cats, 16 (55 %) had serum total T4 concentrations within the reference 
range by day four, while 23 (74 %) had reference range values by day eight. Two weeks 
after treatment, one cat died from undetermined causes, while one was not available for 
reevaluation. One month after treatment, 24 (83 %) of the remaining 29 cats had serum 
total T4 concentrations within the reference range. The serum total T4 concentrations of 
three cats remained elevated, albeit decreased from pretreatment values, and they had 
gained weight, had normal appetites and had resumed normal activity. Further 
evaluation of these cats was not reported. Two cats had subreference range serum total 
T4 concentrations but did not have clinical signs of hypothyroidism.
Broome, Turrel & Hays (1988) subsequently evaluated the predictive value of 
tracer studies for 13 lj in hyperthyroid cats. Peak thyroidal 13 l l  uptakes and effective 
half lives were determined after administration of tracer and therapeutic doses of 13 lj  in 
76 cats. In six additional animals, only peak thyroidal uptakes after administration of 
tracer and therapeutic doses were determined. A good correlation was found between 
peak thyroidal uptakes of tracer and therapeutic doses, but only a fair correlation 
between effective half lives. In 79 % of the cats, the effective half life for the therapeutic 
dose was longer than that for the tracer dose. These data suggested that the effective 
half life determined from a tracer dose was of limited value in calculating a therapeutic 
dose of 13 I f  However, the estimation of thyroid gland weight proved to be the largest 
potential source of error in the calculation since it was recognised that there is no 
reproducible method for accurately determining thyroid gland weight in cats. Despite 
this, the estimation of a tracer compensated therapeutic dose came significantly closer to 
the therapeutic goal than the hypothetical administration of a uniform dose of 111 MBq 
although this latter was a relatively low dose.
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Fixed low dose
A second method of dose determination is to select a relatively low dose of 13 lj  
without determining thyroid gland kinetics. Peterson & Turrel (1986) reported that 
administration of 74 to 148 MBq of 13 4  would produce euthyroidism in the majority of 
cats but would also result in the under or overtreatment of a significant number of cases. 
The obvious advantages of this method are that the need for sophisticated nuclear 
medicine equipment is obviated, two isotope injections are not required and the time 
required to assess thyroid kinetics using a tracer dose is avoided. Several workers have 
reported on the success or otherwise of this method of therapy.
Meric, Rubin & Shaw (1987) treated 25 hyperthyroid cats with a fixed dose of 148 
MBq 13 I f  Further details were not reported. Subsequently, Meric & Rubin (1990) 
reviewed the medical records of 62 hyperthyroid cats treated with a fixed dose of 148 
MBq 13 ll. Fifty cats (81 %) had not been treated for hyperthyroidism prior to 
presentation. One cat had undergone a unilateral thyroidectomy, and another cat had 
undergone a bilateral thyroidectomy at least 2 years previously. Nine cats had been 
treated orally with either propylthiouracil or methimazole. In these cats, treatment was 
discontinued at least 3 weeks before therapy. The history of the remaining cat was not 
reported.
Two cats died within 3 weeks of therapy (one from a cerebral cortical 
haemorrhage and ischaemia and the other of unidentified causes). The remaining 60 cats 
were reevaluated within a mean of 204 days (range; 30 - 850 days) Fifty cats (81 %) 
were biochemically euthyroid at this stage. Five cats (8  %) remained persistently 
hyperthyroid, although the serum total T4 concentrations had decreased from 
pretreatment values. Two of these animals had been given antithyroid drugs. Three of 
the cats had pretreatment serum total T4 concentrations > 263.84 nmol/1. However, six 
other cats with comparable values were successfully treated with a single dose of  ^31j 
Three of the five persistently hyperthyroid cats were subsequently retreated with 148 
MBq 13 lj  xwo responded completely, while the remaining animal died from 
undetermined causes after a third dose of 370 MBq. The owners of the remaining two 
cats declined further treatment.
Serum total T4 concentrations in five cats (8  %) were below the reference range 
when evaluated within 60 days of treatment, although none had clinical signs of 
hypothyroidism Three of these cats were reevaluated six months after therapy, when the 
serum total T4 concentrations had increased into the reference range. The remaining 
two cats were not reevaluated.
Zuber & Allan (1990) also used a fixed dose of 148 MBq 13 lj ^  a series of 21 
hyperthyroid cats. At the time of publication, 18 cats were alive and 16 of these were 
euthyroid while two had not yet been evaluated. Three cats were euthanased for reasons 
unrelated to hyperthyroidism or its treatment. Further details were not reported.
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Fixed high dose
A third method of dose determination is to select a fixed high dose of 13 ^ 1, ranging from 
370 to 1110 MBq (Peterson & Turrel, 1986). However, such doses will destroy both 
hyperplastic and atrophic thyroid tissue and although effective in treating 
hyperthyroidism would undoubtedly induce hypothyroidism in most cases. Such large 
doses are therefore only recommended for treatment of cats with hyperfunctioning 
thyroid carcinomas (Peterson & Turrel, 1986). Turrel, Feldman, Nelson & Cain (1988) 
treated 12 hyperthyroid cats with thyroid carcinoma. Four cats were known to have 
thyroid carcinoma at the time of treatment, and were given doses of between 740 and 
1110 MBq, resulting in thyroid ablation in three of the cats. Eight cats were treated with 
relatively low doses of 13 lj  (37 to 259 MBq), determined on the basis of tracer kinetic 
studies. Three of these cats required further treatment with 13 4  or surgical treatment 
before euthyroidism was achieved. The treatment was unsuccessful in the remaining five 
cats which eventually died from complications of the disease process itself.
Miscellaneous methods of dose estimation
Several miscellaneous methods of dose determination have been recommended, some of 
which would be difficult to reproduce. Chambers, Hightower & Tveter (1987) treated 
43 cats with a dose of 13 l l  ranging from 103.6 to 329.3 MBq. Each individual dose 
was estimated on the basis of "previous experience and the appearance of the ^ mTcO/\ 
thyroid scan". All of the cats showed clinical improvement after treatment as 
demonstrated by improvement in weight gain and behaviour. When measured, most cats 
had serum total T4 concentrations below the reference range but in only "a few" of the 
cases were signs consistent with hypothyroidism observed, necessitating thyroid 
hormone supplementation. However, serum total T4 or T3 concentrations after therapy 
were not available from 33 cats and a definitive success rate is difficult to interpret.
Zuber, Allan & Church (1990) treated 15 hyperthyroid cats with 13 l l  using an 
empirical dose in 12, and based on ^ mTcO^ uptake by the thyroid gland in three cats. 
Ten cats received 148 MBq, three cats 111 MBq and two cats 74 MBq. Two of the cats 
remained hyperthyroid after treatment and required a second dose of 131l within 3 
months of therapy.
From all of these studies it was recognised that markedly elevated serum total T4 
concentrations prior to therapy, large goitre and previous antithyroid drug therapy 
potentially adversely affected the response to 13 l l  therapy. Jones et al  (1991) therefore 
suggested using a dose of 13 lj  individually based on the severity of the clinical signs, 
the size of the thyroid gland, and the circulating free or total T4 concentration. The 
clinical signs were graded as mild, moderate or severe (score 1, 2, 3, respectively), the 
serum free T4 concentration as 30 to 60 pmol/1, 60 to 100 pmol/1 and >100 pmol/1 
(score 1, 2, 3, respectively) and thyroid lobe size as not palpable, < 1.5 x 0.5 cm and >
1.5 x 0.5 cm or bilateral enlargement (score 1, 2, 3, respectively). Total scores of 3 to 5 
received 39 to 60 MBq 13 I f  5 to 7, 60 to 75 MBq and 7 to 9, 75 to 100 MBq. Thirty-
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two cats were treated in this manner. However, in three cases serum free T4 
concentrations were not available. The serum total T4 concentration ranged from 84 to 
260 nmol/1 in these cats, but a scoring system for this parameter was not provided. 
Three cats (9 %) remained hyperthyroid after treatment with no reduction in their serum 
free T4 concentrations. One of these cats had received antithyroid drug therapy, 
although this had been discontinued at least 21 days prior to treatment. In all three 
cases, the pretreatment serum T4 concentration was very high, the clinical signs severe 
and the thyroid gland large and easily palpable, but there were other cats with equivalent 
parameters which apparently responded completely to a single dose of ^  4 . Retreatment 
was successful in two of these cats, but was not yet evaluated in the remaining animal. 
One cat had a serum free T4 concentration below the reference range three months after 
therapy, but this had increased into the reference range by six months. One cat which 
had previously undergone a bilateral thyroidectomy required thyroid hormone 
supplementation after 134 therapy.
Route of administration of radioactive iodine
In all of the previous reports, 134 was administered as a single intravenous bolus. Two 
separate groups of workers recognised the potential dangers to the handler of injecting a 
radioisotope intravenously to a hyperthyroid cat, together with the problem of removing 
a contaminated catheter and the difficulties of obtaining 134 for intravenous use in 
certain countries, and therefore studied the efficacy of treatment using the oral route. 
Klausner, Johnston, Feeney & Walter (1987) treated 23 hyperthyroid cats using a fixed 
dose of 185 MBq 134 administered orally in a gelatin capsule. One cat died within 3 
days of therapy exhibiting grand mal seizures, but the exact cause of death was not 
identified. In the remaining 22 cats, serum total T4 concentrations were within the 
reference range in 19 (86 %) at the time of evaluation 12 to 40 days later. Two cats (9 
%) remained hyperthyroid after therapy one of which had previously received 
methimazole therapy. Three other cats which were successfully treated had also received 
antithyroid drug therapy. Serum total T4 concentrations were below the reference range 
in two cats (9%) 11 and 8 months after therapy, respectively. One of these cats was 
severely uraemic while in the other, the clinical features of lethargy and obesity were 
reversed with thyroid hormone supplementation. Side effects of, or potential dangers 
associated with, oral administration were not mentioned.
Malik, Lamb & Church (1993) also administered 134 orally in a gelatin capsule to 
a series of 40 hyperthyroid cats. The cats received capsules containing between 200 and 
300 MBq 1^4, and each cat typically received 250 MBq. This intermediate dose was 
obtained by administering the capsule earlier or later than the date of calibration. Cats 
with marked thyroid enlargement received the highest doses. Disposable latex gloves 
were worn while the cats were being dosed. Vomiting within a few hours of dosing was 
noted in some cats during the early part of the study but was subsequently avoided by 
introducing a 12 hour fast. Thirty-six (90 %) cats were successfully treated on the basis
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of a resolution of clinical signs and a serum total T4 concentration either within or below 
the reference range. One cat subsequently required thyroid hormone supplementation. 
Four cats remained hyperthyroid after treatment. One cat was given only 200 MBq 
131l? another had an extremely large thyroid gland, while a third had received 
carbimazole before treatment. The drawbacks of oral administration of 13 lj  were 
reported and included the need for a higher dose which may reflect incomplete 
absorption of iodine from the gastrointestinal tract in hyperthyroid cats, greater risk of 
radioisotope spillage during dosing and vomiting after dosing. Despite this, potential 
advantages were considered to be the less stressful administration procedure and minimal 
delay in initiating treatment. The discrepancy between the relatively low dose used by 
Klausner et al. (1987) and the higher dose used by Malik, Lamb & Church (1993) was 
not addressed.
Care of cats treated with radioactive iodine
Regardless of the amount or route of 13 l l  administered, all treated cats should be 
confined to restricted areas that have minimal traffic and should be housed in cages 
where urine and faeces can be collected easily and safely. Personnel handling the cats 
should wear laboratory coats, disposable plastic gloves and appropriate dosimeter 
badges. All material removed from the cages should be classified as radioactive waste 
and disposed of accordingly. Cats can be discharged when the radiation dose level has 
decreased to a predetermined level defined by local radiation regulations. Definite levels 
have been reported by several workers; cats were not discharged to their owners until the 
thyroid surface-dose rate was less than 4.5 milliRoentgens/hour (mR/hr) (Turrel et a l , 
1984; Meric et al., 1986), 2.5 mR/hr (Chambers, Hightower & Tveter, 1987; Klausner et 
al,  1987) or 1.5 mR/hr (Meric & Rubin, 1990). This required hospitalisation from five 
up to 40 days in rare cases and also required frequent monitoring of the thyroid area of 
treated cats. In other studies, where mentioned, hospitalisation periods varied between 
one to three weeks (Peterson & Turrel, 1986; Feldman & Nelson, 1987; Jones et al, 
1991; Malik, Lamb & Church, 1993). When reported, all cats appeared to tolerate the 
hospitalisation period well.
Adverse reactions to radioactive iodine therapy
In humans, potential immediate complications of 13 therapy include an inflammatory 
response in the thyroid tissue resulting in swelling and tenderness around the thyroid 
gland or exacerbation of the thyrotoxicosis, owing to the release of large amounts of 
colloid from damaged follicles. The latter can be prevented by prior antithyroid drug 
therapy (Solomon, 1986). Other complications are extremely rare but include laryngeal 
nerve paralysis and overt hypoparathyroidism (Bauer & Blahd, 1957; Orme & Conolly, 
1971). Adverse reactions appear to be extremely uncommon in cats. In one study, a 
transient change of voice was noted in one cat (Turrel et al., 1984). The development of 
hypothyroidism months to years after radioactive iodine therapy is the most significant
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complication in humans (Solomon, 1986). Although overt hypothyroidism has been 
reported, this complication does not appear to be prominent in cats. The difference may 
be related to the large number of human patients with Graves' disease, rather than toxic 
nodular goitre, who present for radioactive iodine therapy.
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8.2 INTRODUCTION
Since the first description of feline hyperthyroidism in 1979, radioactive iodine (usually 
as 13 li)  has consistently been recommended as a simple, effective and safe treatment for 
affected cats. Methods of estimating a dose of 13 l l  for each individual cat have 
previously involved administration of a small tracer dose of 13 l l  to determine iodine 
kinetics and subsequent calculation of a therapeutic dose using computerized nuclear 
medicine equipment (Peterson et al., 1983a; Turrel et al., 1984; Meric et a l,  1986; 
Peterson & Turrel, 1986; Feldman & Nelson, 1987). Alternatively a fixed dose of 13 l l  
can be administered to each cat (Klausner et al., 1987; Meric & Rubin, 1990; Zuber & 
Allan, 1990) but this may involve overtreatment of a number of animals. Other workers 
have recommended a dose based on previous experience and the appearance of a 
technetium scan, although such recommendations are difficult to reproduce (Chambers, 
Hightower & Tveter, 1987; Zuber, Allan & Church, 1990). The severity of the clinical 
thyrotoxicosis, high circulating thyroid hormone concentrations and large goitres have all 
been implicated as possible reasons for the failure of 13l l  therapy (Jones et a l,  1991). 
In the study described here, a simple method of dose estimation was devised based on 
these three factors but using the more frequently measured serum total rather than free 
T4 concentrations as suggested by Jones et al  (1991). In addition, although 13 l l  has 
usually been administered intravenously, a comparison of efficacy using the simpler 
subcutaneous route was made. This is the first large study on the efficacy of radioactive 
iodine therapy in hyperthyroid cats in the United Kingdom and suggests a protocol that 
can easily be adopted at other referral institutions.
8.3 MATERIALS AND METHODS 
Clinical material
The case material comprised a series of 50 hyperthyroid cats. Two of these cats had 
each had a bilateral thyroidectomy eight and 36 months previously. One further cat had 
had two surgical thyroidectomies, the last eight months previously. Thirty four of the 
cats were female (all ovariohysterectomised) and 16 were male (all castrated). They 
ranged in age from 9.0 to 19.0 years. There was only one pedigree cat (a Persian), the 
remainder being either domestic short (n = 46) or long haired (n = 3). In each case, a 
tentative diagnosis of hyperthyroidism was made on the basis of historical and clinical 
features and the diagnosis was confirmed by demonstrating an elevated serum 
concentration of total T4 as described in Chapter 4. In 26 of the cases, corresponding 
serum free T4 concentrations were measured as described in Chapter 4 and these results 
are discussed in Chapter 7. Due to the constraints of handling radioactive material, any 
animals with evidence of severe concurrent non-thyroidal illness (as assessed by clinical 
examination, full biochemical and haematological profiles and radiography if necessary) 
were refused this mode of treatment.
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Estimation of dose
The dose selected for each individual cat was based on the severity of the clinical signs, 
the circulating total T4 concentration and the size (length and width) of goitre estimated 
by palpation, each being graded out of a possible score of 5, respectively (Table 13). 
Low scores (3 to 9) obtained a dose of less than or equal to 120 MBq, medium scores 
(9 to 12) 120 to 150 MBq and high scores (> 12), 160 MBq or more with greater 
weighting being given in each group to the size of the goitre.
Score Severity of clinical signs Serum total T4 concentration Size of goitre
1 Mild <80 Palpable with difficulty
2 Mild - moderate < 100 1.0 x 0.5 cm
3 Moderate 100- 150 1.5 x 0.5 cm
4 Moderate - severe 150 - 400 > 1.5 x 0.5 cm
5 Severe >400 Visible to naked eye
Table 13. The scoring system for estimation of a dose of radioactive iodine ( ^ 1 )  for 
treatment of hyperthyroid cats. The serum total thyroxine (T4) concentrations are 
expressed in nmol/1.
Treatment protocol
Each animal was sedated with a ketamine (Vetalar, Parke-Davis) and midazolam 
(Hypnovel, Roche) mixture (10 mg/kg and 0.2 mg/kg, respectively) administered 
intramuscularly. A 22 gauge catheter was placed in a cephalic vein if the isotope was to 
be injected intravenously. The 13 lj  was injected intravenously as sodium iodide in an 
approximate 2 ml volume. The catheter was subsequently flushed with sterile saline and 
removed. The solution was diluted with an equal volume of sterile water if injected 
subcutaneously. After injection of isotope, the animals were housed in an isolation unit 
for 30 days and all excreta were disposed of as radioactive waste. At 30 days the thyroid 
gland and injection site were monitored for detectable radiation. A full clinical 
examination was carried out and a blood sample obtained for a total T4 determination 
prior to being discharged to the owners. Each animal was rechecked, as far as was 
possible, three months following therapy and every six months thereafter.
If applicable, at the time of euthanasia or immediately following death, the thyroid 
lobes were removed and fixed in 10 % formol saline. After fixation, the thyroid tissue 
was processed to paraffin and 4 to 5 um sections were stained with haematoxylin and 
eosin and sirius red.
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Statistical analyses
Student's paired t test was used to analyse the serum total and free T4 concentrations 
before and after treatment. All other data were analysed using Fisher's exact probability 
test or where appropriate, Chi-square analysis.
8.4 RESULTS
The pretreatment serum total, and where applicable, free T4 concentrations, dose of 
13 4  administered, route of administration and immediate post treatment free and/or total 
T4 concentrations for each individual cat are detailed in Appendix 13.
Efficacy of l^ l l  treatment
The mean dose of 13 4  administered was 143 +24 MBq. All of the cats improved over 
the course of the isolation period as noted by a decrease in the severity of observable 
clinical signs and an obvious gain in weight. When initially palpable, there was a notable 
decrease in the size of the goitre. There was a significant (P < 0.001) decrease in the 
serum total T4 concentration from a mean +sd of 181.29 +111.40 nmol/1 (range; 43.83 -
575.57 nmol/1) to a mean +sd of 19.03 +29.57 nmol/1 (range; 2.00 - 175.73 nmol/1) 30 
days following the injection of radioisotope (Figure 11).
Five cats remained hyperthyroid at the 30 day check, although the serum total T4 
concentration had decreased from a mean +sd of 273.01 +210.53 nmol/1 (range; 86.67 -
575.57 nmol/1) to a mean +sd of 93.32 +46.83 nmol/1 (range; 61.46 - 175.73 nmol/1). 
Two of these cats became euthyroid within three and five months of therapy, 
respectively. Two cats were not re-examined, (one dying from an acute neurological 
illness four months after treatment, whilst the other was reportedly well but thin 12 
months later). The remaining cat was successfully retreated four months later using a 
low dose (80 MBq) of 13 lj
The serum total T4 concentration was below the reference range in 29 (58 %) cats 
30 days following treatment. In 19 of these cases, the serum total T4 concentration 
increased into the reference range 1.5 to 20 months later. In seven cases, the serum total 
T4 concentration has remained low in follow up periods of one to 15 months. Two cats 
died apparently from unrelated causes 12 and 13 months following treatment, 
respectively and repeat samples were not available. Repeat samples were not available 
from the remaining cat. Clinical signs suggestive of hypothyroidism were not apparent in 
any of the cats examined.
The treatment was deemed effective in controlling the hyperthyroidism in 47 (94.0 
%) cats. Recurrent hyperthyroidism did not develop in any cat in follow-up periods of 
one to 32 months (mean +sd; 10.9 +9.0 months).
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PRE POST
Treatment group
Figure 11. Box and whisker plot of serum total thyroxine (T4) concentrations in 50 cats 
before and 30 days after treatment with 13 I f  The box encloses the middle half of the 
data and is bisected by a line representing the median. The whiskers represent the range 
of typical values. Possible outliers are represented by * and probable outliers by 0. The 
probable outliers post treatment correspond to the five cats that remained persistently 
hyperthyroid.
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Efficacy of dose
The results of the three dose categories are presented in Table 14. All 12 cats treated 
with the low dose were effectively cured. One cat treated with the medium dose 
remained hyperthyroid at 30 days, but subsequently became euthyroid four months later. 
Goitre was not palpable in this cat when originally computing the dose. Four cats 
treated with the high dose remained hyperthyroid at thirty days, although one 
subsequently became euthyroid within three months. There was a significant difference 
(P < 0.05) in the number of cats that remained hyperthyroid after treatment with the high 
dose than those that remained hyperthyroid after treatment with low and medium doses 
taken together. There was no significant difference (P > 0.05) in the number of cats with 
serum total T4 concentrations below the reference range after treatment with the three 
different doses.
Pretreatment total T4 Post treatment total T4
n with n with
Dose n mean ±sd range mean ±sd range subnormal
T4
elevated
T4
80-120 12 145.8 ±93.5 43.8-382.1 12.9 ±9.3 3.2-35.5 8 0
130-150 21 162.9 ±89.6 70.6-400.8 14.1 ±14.0 2.0-61.5 12 1
160-200 17 227.3 ±130.1 86.7-575.6 29.4 ±46.9 2.0-84.44 9 4
n = number of cats
Table 14. The effect of the three different dose categories of 13 lj (MBq) on serum 
total thyroxine (T4) (nmol/1) concentrations in hyperthyroid cats. Thirty days elapsed 
between the pre- and post treatment results. The number of cats with subreference range 
and elevated serum total T4 concentrations after therapy are included.
Efficacy of injection route
The radioactive iodine was injected intravenously in the first 27 cats presented, and 
subcutaneously in the remaining 23 animals. There was no significant difference (P >
0.05) in the number of cats treated with the low, medium and high dose between these 
two groups. There was no significant difference (P > 0.05) in the outcome between the 
group injected intravenously and the group injected subcutaneously. None of the cats 
exhibited any obvious side effects when injected using either route.
Effect of therapy on serum free thyroxine concentrations
Serum free T4 concentrations were measured before and 30 days after therapy in 26 cats. 
There was a significant (P < 0.001) decrease in the serum free T4 concentrations from a
Chapter 8 125
mean +sd of 233.32 +177.08 pmol/1 (range; 46.88 - 687.61 pmol/1) to a mean +sd of 
24.89 +40.49 pmol/1 (range; 1.00 - 186.13 pmol/1). In four cats, the serum free T4 
concentration was above the reference range after therapy, as were the corresponding 
serum total T4 concentrations. In 10 cases, both the corresponding serum free and total 
T4 concentrations were below the reference range. In three cases, the total T4 
concentration was below the reference range after therapy while the corresponding free 
T4 concentrations were just within the reference range at 12.66, 12.73 and 9.94 pmol/1, 
respectively. In one case, the serum free T4 concentration was below the reference 
range, while the corresponding serum total T4 concentration was just within the 
reference range at 11.00 nmol/1. In all the remaining cats both corresponding serum free 
and total T4 concentrations were within the reference range.
Histopathological appearance of radioablated thyroid tissue
Thyroid tissue was available from two cases following 13 lj therapy. Case number 
117880 was euthanased 18 months after therapy because of persistent vomiting resulting 
from an alimentary lymphosarcoma. Case number 119218 died suddenly 11 months after 
therapy from hypertrophic cardiac disease resulting in acute congestive cardiac failure. In 
both cases, the thyroid lobes were grossly small with no visible nodules. The 
histopathological appearance of the thyroid tissue from case number 117880 is presented 
in Figure 12. There was marked fibrosis of the tissue with the acini containing poorly 
stained colloid and lined by cuboidal epithelium Normal thyroid tissue and a few areas 
of hyperplasia were interspersed throughout.
8.5 DISCUSSION
This study emphasises the advantages of radioactive iodine therapy in hyperthyroid cats 
and exemplifies the locally destructive action of 13 lj  As exhibited by these cats, 
adjacent parathyroid tissue and other important cervical structures were spared and there 
were no untoward systemic effects. 13 lj therapy also appeared to spare atrophic thyroid 
tissue since a return to euthyroidism was presumably a result of reactivation of this 
tissue. Serum total T4 concentrations below the reference range developed in over 50 % 
of the cats immediately after treatment and there was often a lag period before 
biochemical euthyroidism was restored. During this period clinical signs suggestive of 
hypothyroidism (Thoday, 1990b; Rand, Levine, Best & Parker, 1993) were not apparent. 
When measured, corresponding serum free T4 concentrations also tended to be low, and 
thus an increased free T4 fraction could not account for the maintenance of clinical 
euthyroidism In the face of a low circulating T4 concentration there may be increased 
peripheral conversion of T4 to the more metabolically active T3 thereby maintaining 
euthyroidism (Mooney, Thoday & Doxey, 1992a). Serum total T3 concentrations were 
not measured in this study.
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(b)
Figure 12 (a) and (b). The histopathological appearance of radioablated thyroid tissue 
(case number 117880) stained with sirius red. The thyroid tissue is largely replaced by 
fibrous tissue (a). More normal thyroid tissue is apparent in (b).
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In both humans and cats controversy has surrounded the most accurate method of 
estimating the lowest possible dose that will restore euthyroidism without producing 
hypothyroidism Using the most sophisticated method, various parameters of thyroid 
kinetics are determined using a small tracer dose of 13 lj and a therapeutic dose is 
calculated aiming to deliver between 15,000 to 20,000 rad/g of thyroid tissue. Doses of 
between 37 and 370 MBq have been used (Peterson et a l,  1983a; Turrel et al., 1984; 
Meric et al., 1986; Peterson & Turrel, 1986; Feldman & Nelson, 1987) resulting in a 
success rate of from 64 % (Turrel et al., 1984) to 90 % in the largest study of over 350 
cats (Feldman & Nelson, 1987). Subsequently, the use of higher fixed doses of 185 MBq 
(Klausner et a l,  1987) and 148 MBq (Meric & Rubin, 1990) were recommended and 
these effectively controlled hyperthyroidism in 91 % of 22 and 60 cats, respectively. 
Zuber & Allan (1990) also used a fixed dose of 148 MBq with a known success in 16 
(88.9 %) of 18 cats. Such a method may however under or overdose cats unnecessarily.
The method of dose estimation used in the present study was easy to compute and 
effectively controlled the thyrotoxicosis in 94 % of the cats, a success rate comparable to 
or higher than either the tracer-compensated dose or fixed dose regimen. Computerised 
facilities were not required, and by comparison with the fixed dose regimen, over 60 % 
of the cats were effectively treated with a dose of less than or equal to 150 MBq. Few 
required a dose approaching or in excess of 185 MBq. Using a low dose was desirable 
both with a view to radiation safety and the constraints imposed on the premises of a 
maximum allowable dose of 250 MBq and may explain why clinical hypothyroidism has 
not been seen to date in any of the cats. The method of dose estimation described is 
similar to that recommended by Jones et al. (1991). However, in their study a scoring 
system was only reported for serum free T4 concentrations which ranged from 42 to 238 
pmol/1 in 29 cats, by comparison to a range of 46.88 to 687.61 pmol/1 as reported in 26 
cats in this study. The lower serum free T4 concentrations may explain why a similar 
success rate was achieved in their study when using lower doses of 39 to 100 MBq.
Five of the cats in this study remained biochemically hyperthyroid 30 days after 
13 Iq therapy. Two cats subsequently became euthyroid without further treatment. The 
effects of 1311 are variable in any one gland since there is a difference in the uptake of 
iodine between individual follicles (Solomon, 1986). Some cells are subjected to intense 
radiation and die immediately. Others undergo various degrees of damage resulting in 
progressive atrophy and fibrosis and possible genetic damage in surviving cells ultimately 
impairing survival, explaining the lag period seen in some cases before euthyroidism is 
achieved. In humans, persistent hyperthyroidism is rarely retreated until four months 
have elapsed from the original treatment (Toft, Campbell & Seth, 1981; Solomon, 1986). 
Based on the results of this study, a similar time period is recommended but with 
monthly checks to monitor serum total T4 concentrations as an indicator of a possible 
late return to euthyroidism. If rapid control of hyperthyroidism is required, another form 
of therapy should be sought because of this possible lag period before euthyroidism is 
achieved.
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The reasons for an incomplete response to 13 lj  are unclear but suggestions have 
included errors in dose estimation, previous antithyroid drug therapy, size of the goitre, 
high circulating thyroid hormone concentration, severity of the thyrotoxicosis and the 
presence of a thyroid carcinoma (Turrel et al., 1984; Meric et al., 1986; Turrel et a l , 
1988; Meric & Rubin, 1990; Jones et a l , 1991). In the present study, none of the cats 
had recently been treated with antithyroid drugs and there was no clinical evidence 
(large, immobile locally invasive mass, distant metastases) to suggest the presence of a 
carcinoma. In one of the five persistently hyperthyroid cats, goitre was not palpable at 
the time of initial presentation and a medium dose was administered which may have 
been lower than that required. In the remaining four cats a high dose was required, 
based on the severity of the clinical signs, serum total T4 concentration and size of the 
goitre. If cats requiring such a high dose were not treated, a success rate approaching 
100% would have been achieved. It is possible that a combination of surgical excision 
followed by low dose therapy would be more successful in such cases particularly if the 
premises are constrained with regard to the maximum dose allowed. In such cases, a 
potential benefit of radioactive iodine therapy is that unlike surgery (Welches, Scavelli, 
Matthiesen & Peterson, 1989; Swalec & Birchard, 1990), recurrence of hyperthyroidism 
appears to be extremely rare, was not seen in any of the treated cats in follow-up periods 
of up to 32 months and has been previously described in only one cat (Peterson et a l,  
1983a). Recurrence of hyperthyroidism, once euthyroidism has been achieved, is also 
extremely rare in humans (Solomon, 1986).
13l i  is usually administered to cats by intravenous injection (Peterson et al,  
1983a; Turrel et a l ,  1984; Meric et al, 1986; Peterson & Turrel, 1986; Chambers, 
Hightower & Tveter, 1987; Feldman & Nelson, 1987; Meric & Rubin, 1990; Zuber, 
Allan & Church, 1990; Jones et a l,  1991) although oral administration is equally as 
effective (Klausner et a l,  1987) but may be complicated by vomiting, an increased risk 
of spillage and a higher dose requirement of 200 to 300 MBq (Malik, Lamb & Church,
1993). In the present study, there were no complications associated with either the 
intravenous or subcutaneous routes of administration and neither affected the ultimate 
outcome. The use of the subcutaneous route was simpler and safer to personnel since 
prior insertion of a catheter was not necessary and potential complications such as 
removal of the contaminated catheter or the need for haemostasis at a contaminated site 
were avoided. The subcutaneous route is therefore recommended for routine 
administration of 13 lj
For radiation safety, cats are not usually discharged to their owners until the 
thyroid surface-dose rate is less than 4.5 mR/hr (Turrel et a l,  1984; Meric et a l,  1986),
2.5 mR/hr (Chambers, Hightower & Tveter, 1987; Klausner et a l,  1987) or 1.5 mR/hr 
(Meric & Rubin, 1990) and this requires hospitalisation from five up to 40 days in rare 
cases. In this study, cats were routinely hospitalised for 30 days by which time there was 
no detectable radiation from the neck region or injection site. All of the cats tolerated 
this period of isolation and no untoward effects were noted. The fixed hospitalisation
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period avoided unnecessary handling of the cat to measure thyroid radioactivity and was 
well accepted by all the clients.
The histopathological appearance of the thyroid lobes after radioablation was as 
expected and similar to that described in humans, the major changes being atrophy and 
fibrosis (Solomon, 1986). Although some areas of hyperplasia were apparent, these 
were not considered to indicate a recurrence of the problem. Non-functional or "cold" 
nodules of hyperplasia are known to exist in affected thyroid tissue, normal thyroid tissue 
and even atrophic thyroid tissue (Carpenter et a l , 1987).
Administration of 13 4  is an effective method of controlling hyperthyroidism in 
cats. By comparison to humans, where multiple doses are often required to control 
hyperthyroidism (Solomon, 1986), a single injection, as administered in this study 
appears to be effective in most cats. The dose for each individual cat can be calculated 
simply on the basis of the severity of the clinical signs, a serum total T4 concentration 
and the size of goitre estimated by palpation. In addition, the development of overt 
hypothyroidism or recurrence of hyperthyroidism appears to be extremely rare. 13 4  can 
be injected subcutaneously rather than intravenously. Modification of the technique in 
this way reduces the health risk to personnel by reducing their handling of, and exposure 
to 13 I f
130
CHAPTER 9
GENERAL CONCLUSIONS AND FUTURE RESEARCH AREAS
9.1 INTRODUCTION
The objectives of this study were outlined in Chapter 1. The completion of the work has 
increased our knowledge of the older cat in general and thyroid dysfunction in particular. 
However, as with most studies of this kind more questions were posed than answered 
and even greater deficiencies in our knowledge uncovered. In this chapter, the findings 
are briefly summarised and possible areas of future research highlighted.
9.2 THE GERIATRIC CAT
The medical diseases affecting geriatric cats seen between 1990 and 1992 were 
compared to those seen between 1970 and 1972. Neoplastic and renal disorders have 
remained of significance in the older cat population. However, viral infections and 
hyperthyroidism were common in the latter time period, but were not diagnosed in any 
cats in the former. For viral infections, this presumably was related to a lack of 
awareness of their presence rather than a true increase in incidence. For hyperthyroidism, 
there was no conclusive evidence of its presence between 1970 and 1972. This supports 
the post-mortem study of Peterson & Ferguson (1989a) who reported that thyroid 
abnormalities were rare prior to 1977. Thus, it would appear that feline hyperthyroidism 
has shown a true increase in incidence.
There was a disproportionate increase in the number of aged cats (greater than five 
years old) seen between the two time periods, and between 1990 and 1992 the cats were 
significantly older. This supports the premise that the emergence of hyperthyroidism may 
be partly related to an increased longevity of cats (Peterson, Randolph & Mooney,
1994). This study did not address the possibility that extra- or intra-thyroidal stimuli 
enhance or sustain the progression of the disease. This therefore, remains an important 
area for future research.
This study was undertaken in a referred population of cats and provides a starting 
point for future research. It is clear however, that a more detailed demographic study of 
the current proportion of aged cats in the population, disease categories and their 
prevalence should be undertaken.
9.3 THYROID HORMONE CONCENTRATIONS IN HEALTH AND DISEASE
The equilibrium dialysis kit method designed for use with human serum was capable of 
measuring serum free T4 concentrations in cats and avoided the problems associated 
with other, in particular analogue, kit methods (Ekins, 1985) Although a relatively 
expensive test, it was readily adaptable for routine application in a clinical laboratory.
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Apart from the necessary validation steps, the assay required no modification and would 
appear to be applicable to a wider range of species. Through the use of this assay and a 
total T4 RIA, absolute serum free T4 concentrations and the free T4 fraction were 
reported for healthy, euthyroid cats. Given that the measurement of free T4 parameters 
for cats have been rarely reported, this study provided the necessary database for a 
comparison of possible abnormalities in disease states. The effects of age, sex, breed, 
heredity and environment on circulating total T4 concentrations have been reported. Due 
to the experimental limitations of this study the effects of these factors on serum free T4 
concentrations were not addressed and require further study.
As expected, and as previously reported by Peterson & Gamble (1990) serum total 
T4 concentrations were profoundly depressed in cats with non-thyroidal diseases. This 
was a consistent response to illness similar to the situation in the dog, but occurred more 
frequently than in humans (Ferguson, 1988; Nicoloff & LoPresti, 1991). As in humans, 
there was an excellent inverse correlation between mortality and serum total T4 
concentrations (Slag et al., 1981a; Kaptein et al., 1982b). Thus, apart from its use as a 
diagnostic test for hyperthyroidism, measurement of serum total T4 concentrations can 
now be considered as a useftd prognostic indicator.
The measurement of serum free T4 concentrations and calculation of the free T4 
fractions in sick cats, previously unreported, provided an important insight into thyroid 
abnormalities and the possible mechanisms involved in disease states. Despite depression 
of serum total T4 concentrations in sick cats, euthyroidism was maintained because 
serum free T4 concentrations tended to remain within the reference range and the free 
T4 fraction increased. Serum free T4 concentrations were occasionally elevated but 
tended to occur in association with reference range serum total T4 concentrations. 
Serum free T4 concentrations were rarely subnormal. The abnormalities found closely 
resembled the situation in humans when serum free T4 concentrations are measured 
using similar techniques (Faber et al., 1987; Nelson & Tomei, 1988; Surks et al., 1988). 
Thus , in the cat as in man, suppression of serum TSH is not an important mechanism in 
depression of serum total T4 concentrations. Since controversy surrounds the possible 
mechanisms involved in humans, the cat could now be regarded as an appropriate model 
for future research. Most importantly, the existence of thyroid hormone binding 
inhibitors, believed to be involved in humans (Chopra et al., 1979b; Woeber & Maddux, 
1981; Oppenheimer etal., 1982; Chopra et al., 1982, 1984, 1986) requires investigation 
in the cat.
Hypothyroidism is a common disease in the dog, but is difficult to diagnose 
because serum total T4 concentrations are depressed in a variety of non-thyroidal 
illnesses. If serum free T4 concentrations are largely unaffected by non-thyroidal disease 
as they are in cats, its measurement could be useful for the diagnosis of hypothyroidism. 
Attempts have been made to address this issue, but the controversial analogue kit 
methods, which are unlikely to reflect the true circulating free T4 concentration, have
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been used (Montgomery et a l,  1991; Nelson et a l,  1991). This issue requires future 
study using the more appropriate technique of equilibrium dialysis.
As expected and as previously reported, serum free T4 concentrations are elevated 
in hyperthyroidism (Ferguson, Peterson & Nachreiner, 1989). However, its 
measurement provided no additional diagnostic information over measurement of 
circulating total T4 concentrations alone. Importantly, because of the correlation 
between these two parameters, the degree of hyperthyroidism could be inferred by 
measurement of serum total T4 concentrations alone. However, from this study 
measurement of serum free T4 concentrations at least by equilibrium dialysis, is not 
recommended as a sole diagnostic test for hyperthyroidism since concentrations may be 
elevated in euthyroid cats with non-thyroidal diseases.
9.4 RADIOACTIVE IODINE THERAPY FOR FELINE HYPERTHYROIDISM
The dose of radioactive iodine was simply chosen on the basis of serum total T4 
concentrations, clinical severity of the thyrotoxicosis and size of goitre estimated by 
palpation. Hyperthyroidism was effectively cured without side effects in over 90 % of 
cases. This technique obviated the need for sophisticated computerised nuclear medicine 
equipment and avoided fixed dosing of cats with its attendant problems. In addition, 
injection of the isotope was equally effective when administered intravenously or 
subcutaneously but the latter was considered simpler and safer. This method of dose 
estimation and administration is now recommended for routine use and can easily be 
adopted at other referral institutions.
Serum total T4 concentrations were frequently below the reference range after 
radioactive iodine therapy, but clinical signs of hypothyroidism were not noted. 
Corresponding serum free T4 concentrations were also below the reference range. Thus 
the maintenance of euthyroidism is presumably related to circulating T3 concentrations, 
as it is during carbimazole therapy (Mooney, Thoday & Doxey, 1992a).
In a small number of cases there was a lag period after treatment before 
euthyroidism was achieved. Thus retreatment with ^ l j  js not recommended until four 
months have elapsed after administration of the first dose.
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APPENDIX 1
SUPPLIERS OF REAGENTS AND EQUIPMENT
Analytical Software,
1958 Eldridge Avenue, PO box 130204, St. Paul, MN 55113, USA 
Boehringer Mannheim GmbH,
Boehringer Mannheim UK (Diagnostics and Biochemicals) Limited, Bell Lane, 
Lewes, East Sussex, England.
Coming Limited,
Halstead, Essex, England.
P.R. Edwards,
Department of Molecular Endocrinology, University College & Middlesex School 
of Medicine, Mortimer Street, London, England.
IDEXX Laboratories,
Milton Court, Churchfield Road, Chalfont St. Peter, Nr Gerrards Cross, Bucks., 
England.
Immunodiagnostic Systems Limited,
Boldon Business Park, Boldon, Tyne & Wear, England.
Instrumentation Laboratories,
Kelvin Close, Warrington, Cheshire, England.
Nichols Institute Diagnostics,
White House, High Street, Newport, Saflron Walden, Essex, England.
Packard Instrument Company,
Canberra Packard, Brook House, 14 Station Road, Pangboume, Berks., England 
Parke-Davis,
Parke-Davis Research Laboratories, Lambert Court, Chestnut Avenue, Eastleigh, 
Hants., England 
Roche,
Roche Products Limited, PO Box 8, Welwyn Garden City, Herts., England. 
Sarstedt,
68 Boston Road, Leicester, England 
Scottish Quality Assessment Scheme,
Biochemistry Department, Victoria Infirmary, Glasgow, Scotland.
Sigma Chemical Company Limited,
Fancy Road, Poole, Dorset, England.
Technicon Instruments Corporation,
Hamilton Close, Houndsmills, Basingstoke, England.
UKEQAS,
United Kingdom External Quality Assurance Scheme, Department of Clinical 
Chemistry, Queen Elizabeth Medical Centre, Edgbaston, Birmingham, England.
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Case numbers for the geriatric cats seen at the Small Animal Clinic, University of Glasgow 
Veterinary School between January 1990 and June 1992
84488 114484 116203 117456 119150
94222 114510 116205 117472 119160
98872 114764 116320 117486 119218
105374 114810 116434 117664 119239
109077 114861 116438 117670 119242
109384 115020 116439 117673 119282
109692 115155 116492 117703 119330
110531 115162 116588 117727 119364
112094 115182 116596 117732 119408
113117 115304 116607 117735 119415
113174 115449 116681 117756 119451
113235 115452 116742 117790 119457
113275 115459 116746 117793 119480
113280 115570 116817 117850 119489
113345 115628 116862 117880 119521
113414 115649 116890 117934 119624
113480 115699 116982 117935 119662
113578 115713 116986 117958 119691
113607 115769 117020 117989 119885
113632 115813 117085 118355 119898
113635 115931 117093 118383 119919
113669 115935 117094 118405 119940
113703 115938 117116 118406 120189
113704 115953 117245 118430 120191
113822 116040 117246 118483 120207
113866 116042 117249 118629 120210
113929 116055 117254 118645
113961 116057 117263 118681
113995 116059 117265 118694
114007 116117 117266 118746
114166 116128 117396 119072
114198 116132 117403 119077
114332 116168 117449 119140
114450 116201 117454 119145
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Case numbers for the geriatric cats seen at the Small Animal Clinic, University of Glasgow 
Veterinary School between January 1970 and June 1972
42530 44355 45918 47813 48979
42723 44686 46106 47868 49025
42935 44710 46417 47992 49034
43059 44835 46553 48067 49620
43188 44850 46812 48101 49694
43436 45018 47018 48106 49901
43823 45103 47058 48498 49957
44038 45225 47384 48550 50121
44039 45567 47399 48576 50157
44093 45574 47438 48711
44291 45676 47697 48790
44320 45834 47795 48936
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Total thyroxine (T4) concentrations of the medium pool serum assayed repeatedly for
calculation of intra-assay precsion.
Number Concentration (nmol/1)
1 31.33
2 30.09
3 30.07
4 28.99
5 27.97
6 30.59
7 24.75
8 32.52
9 31.39
10 33.55
11 30.29
12 30.47
13 27.45
14 32.16
15 30.10
16 32.15
17 29.86
18 31.77
19 30.39
20 30.56
Mean +sd 30.33 +1.96
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Free thyroxine (T4) concentrations of the medium pool serum assayed repeatedly for
calculation of intra-assay precision.
Number Concentration (pmol/1)
1 25.73
2 20.68
3 27.04
4 21.65
5 26.65
6 23.48
7 23.89
8 24.00
9 22.90
10 24.18
Mean +sd 24.02 +2.04
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Total thyroxine (T4) concentrations of the low, medium and high pool sera assayed for 
calculation of interassay precision. For the calculation of possible drift the low, medium and 
high pools were placed at the beginning and the end of the first four assays, respectively. 
All concentrations are expressed in nmol/1.
Beginning of assay End of assay
Assay Low Medium High Low Medium High
1 16.07 32.68 139.57 13.38 25.23 128.81
2 14.64 33.64 155.75 12.34 29.25 134.23
3 16.90 31.98 150.89 16.29 34.96 155.23
4 14.07 33.68 146.38 14.48 29.74 149.26
5 18.13 33.90 160.62
6 17.29 31.66 163.92
7 17.27 33.20 155.20
8 16.59 30.98 149.81
9 18.33 29.89 166.68
10 15.56 33.04 137.91
11 16.39 41.49 162.74
12 16.54 34.07 157.09
13 13.49 33.54 154.12
14 13.99 28.38 148.51
Mean +sd 16.09+1.54 33.01 +2.95 153.51 +8.65
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Free thyroxine (T4) concentrations of the medium and high pool sera assayed for
calculation of interassay precision. All concentrations are expressed in pmol/1.
Assay Medium High
1 25.52 115.74
2 33.49 129.97
3 27.55 143.73
4 22.04 154.51
5 22.31 115.62
6 26.32
Mean +sd 26.20 +4.19 131.91 +17.18
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The recovery of thyroxine (T4) added to serum samples for assessment of accuracy for the 
total T4 assay. Each sample was spiked with 24.70 nmol/1 T4. All concentrations are 
expressed in nmol/1.
Sample Basal concentration Spiked concentration Amount recovered % recovered
Low
Medium
High
6.52 30.66 24.14 97.7
4.49 28.22 23.73 96.1
4.76 31.14 26.38 106.8
1.24 27.81 26.57 107.6
4.30 25.80 21.50 87.0
31.72 57.49 25.77 104.3
30.33 55.35 25.02 101.3
30.89 52.56 21.37 86.5
26.23 56.19 29.96 121.3
29.68 53.66 23.98 97.1
155.58 182.16 26.58 107.6
165.78 186.10 20.32 82.3
150.97 177.61 26.64 107.9
149.98 173.21 23.23 94.0
Mean +sd 99.8+10.5
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Free thyroxine (T4) concentrations found in the quality control samples supplied by the 
manufacturer. Sample J had a predicted concentration of between 8.62 - 23.17 pmol/1 and 
Sample K, 25.74 - 50.19 pmol/1. All concentrations are expressed in pmol/1.
Assay Sample J Sample K
1 13.23 37.25
2 16.30 43.55
3 9.76 37.19
4 13.19 33.11
5 13.54 36.70
6 13.69 37.39
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Serum total and free thyroxine (T4) concentrations and the calculated free T4 fraction (%)
in 50 healthy, euthyroid cats.
Animal Breed Sex Age Total T4 (nmol/1) Free T4 (pmol/1) % free T4
1 Burmese Mn 8.0 31.33 25.36 0.08
2 SHD Fn 2.0 11.67 20.61 0.18
3 SHD Mn 2.0 12.50 30.51 0.24
4 SHD Fn 11.0 21.68 20.44 0.09
5 SHD Mn 8.0 12.94 47.72 0.37
6 SHD FN 8.0 21.01 26.61 0.13
7 SHD Mn 5.5 22.04 19.53 0.09
8 SHD M 1.1 17.07 6.63 0.04
9 SHD Fn 5.0 30.78 34.00 0.11
10 SHD Mn 11.0 20.81
11 Siamese F 4.0 16.79 15.62 0.09
12 SHD Mn 4.0 17.66 26.25 0.15
13 SHD Mn 3.0 31.37 24.02 0.08
14 SHD Fn 7.0 33.63
15 SHD Mn 5.0 18.01 13.58 0.08
16 SHD Fn 6.0 42.28 22.98 0.05
17 Chinchilla M 0.1 33.26 21.78 0.07
18 Persian F 1.0 25.49 19.49 0.08
19 SHD Fn 13.0 18.20
20 SHD F 0.5 29.00 41.38 0.14
21 SHD M 0.5 35.21 35.48 0.10
22 BSH Mn 0.6 26.56 14.89 0.06
23 Birman M 2.0 34.85 29.51 0.08
24 SHD M 6.0 30.01
25 Birman F 4.0 33.39 18.25 0.05
26 Birman F 1.0 44.33 20.21 0.05
27 BSH Mn 9.0 34.47 18.97 0.06
28 BSH Fn 5.0 34.55 29.18 0.08
29 SHD Mn 0.8 17.55
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Animal Breed Sex Age Total T4 (nmol/1) Free T4 (pmol/1) % free T4
30 Siamese M 2.5 27.53 21.44 0.08
31 SHD M 7.0 21.70 24.68 0.11
32 SHD F 14.0 36.53 18.05 0.05
33 SHD F 2.0 28.69
34 SHD F 1.0 19.79
35 SHD F 0.6 21.29
36 Persian F 4.0 14.73
37 Persian F 4.0 20.45 25.03 0.12
38 SHD Mn 12.0 28.63
39 SHD Fn 5.0 36.68 32.13 0.09
40 Siamese Mn 1.1 26.86 11.38 0.04
41 SHD Fn 8.0 31.37 28.64 0.09
42 SHD Fn 7.0 30.38
43 SHD F 1.6 26.88 35.81 0.13
44 SHD Mn 2.6 21.65 20.58 0.10
45 Burmese Fn 2.0 29.30 35.26 0.12
46 SHD M 1.0 23.76
47 SHD Mn 3.0 23.55 21.64 0.09
48 SHD Mn 3.0 23.19 27.40 0.12
49 SHD Mn 3.9 21.96 23.74 0.11
50 SHD Fn 3.2 26.64 33.41 0.13
SHD, Short haired domestic 
BSH, British Short Hair 
M, Male
Mn, Castrated male 
F, Female
Fn, Ovariohysterectomised female
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Serum total and free thyroxine (T4) concentrations, and the calculated free T4 fraction in
107 sick cats.
Case number Breed Sex Age Total T4 (nmol/1) Free T4 (pmol/1) % free T4
84488 SHD Mn 14.0 2.16
94222 LHD Mn 6.0 8.28
105374 SHD Fn 15.0 17.48 31.11 0.18
109212 SHD Fn 7.1 4.37 21.70 0.50
109384 SHD Mn 6.3 22.37 22.07 0.10
110531 SHD Fn 14.5 16.16 70.84 0.45
112094 SHD Mn 5.2 19.87 27.84 0.14
112570 SHD Fn 13.7 25.16 43.39 0.17
113048 Persian Mn 2.5 24.19 30.72 0.13
113117 Siamese Fn 10.0 20.36 35.20 0.17
113129 SHD Fn 4.0 23.63 32.72 0.14
113235 SHD Fn 9.0 15.62 75.31 0.48
113275 SHD Mn 6.0 14.01 22.80 0.16
113351 SHD Mn 2.0 20.06 27.31 0.14
113414 SHD Fn 10.0 14.63 21.44 0.15
113669 SHD Mn 6.0 10.06 8.89 0.09
113701 SHD Mn 4.0 2.00 42.06 2.10
113703 SHD Mn 16.0 26.63 16.95 0.06
113929 SHD F 7.0 22.12 75.54 0.34
114049 SHD Mn 1.0 17.82 62.31 0.35
114450 SHD Fn 5.0 23.52 48.12 0.20
114484 SHD Mn 18.0 13.33 40.33 0.30
114510 Siamese Fn 8.0 9.88 26.48 0.27
114579 SHD Mn 3.0 31.39 29.51 0.09
114584 SHD Mn 3.0 2.00 1.52 0.08
114640 Persian Fn 2.0 25.68 24.59 0.10
114764 Siamese Fn 11.0 17.68 15.57 0.09
114769 SHD Mn 1.5 2.00 35.47 1.80
114854 SHD Mn 1.0 6.43 33.57 0.52
114861 SHD Fn 7.0 45.33
114894 SHD Fn 3.0 16.97 23.21 0.14
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Case number Breed Sex Age Total T4 (nmol/1) Free T4 (pmol/1) % free T4
115128 Burmese Mn 2.6 16.22 38.33 0.24
115155 SHD Fn 13.0 14.55 25.78 0.18
115182 SHD Mn 5.0 17.52 31.10 0.18
115304 SHD Mn 13.0 12.53 8.45 0.07
115332 Burmese F 0.5 12.41 48.10 0.39
115378 SHD Mn 3.4 30.58 23.93 0.08
115449 Siamese Fn 7.0 5.21 30.94 0.59
115452 Siamese Fn 7.0 19.48
115459 SHD Mn 12.0 11.05 24.27 0.22
115485 SHD Fn 1.5 10.03 51.34 0.51
115570 SHD Mn 11.0 25.02 26.59 0.11
115769 SHD Fn 13.0 11.87 36.30 0.31
115938 Siamese Fn 13.5 16.41 20.23 0.12
115950 SHD M 4.5 2.41 23.06 1.00
115953 SHD Mn 7.1 4.64 38.26 0.82
116040 SHD Mn 12.0 27.97 25.86 0.09
116117 SHD Fn 7.0 22.95 37.30 0.16
116128 SHD Mn 11.0 15.02 55.08 0.37
116132 SHD Mn 12.0 11.42 14.37 0.13
116168 Persian F 6.0 20.60 14.62 0.07
116201 SHD Fn 15.0 15.46 23.11 0.15
116205 SHD Fn 20.0 10.22 25.41 0.25
116320 SHD F 12.0 26.87 42.79 0.16
116330 SHD F 3.5 2.00 6.85 0.34
116392 SHD M 1.5 19.21 24.44 0.13
116439 SHD Fn 6.0 17.85 24.81 0.14
116492 SHD Fn 13.0 20.38 19.08 0.09
116596 SHD Fn 11.0 10.28 20.48 0.20
116967 SHD Fn 4.0 13.03 22.05 0.17
117020 Persian Mn 14.0 11.68 16.58 0.14
117116 SHD Mn 11.0 4.75 17.92 0.38
117245 BB M 8.0 10.62 35.64 0.34
117246 BB M 8.0 19.57 27.78 0.14
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Case number Breed Sex Age Total T4 (nmol/1) Free T4 (pmol/1) % free'
117249 SHD Mn 5.0 19.54 31.83 0.16
117254 Siamese Mn 13.5 17.81 15.37 0.09
117268 Persian Mn 4.0 2.89 4.06 0.14
117396 SHD Fn 5.0 12.43
117416 SHD Mn 4.0 26.53 42.20 0.16
117524 Persian M 3.0 9.65 27.37 0.28
117934 Siamese Fn 8.0 17.95 23.57 0.13
117935 SHD Fn 8.0 15.26 19.88 0.13
117989 Siamese Mn 6.0 43.77 38.29 0.09
118355 Persian Mn 5.5 20.87 19.04 0.09
118383 SHD Mn 7.0 15.58 33.29 0.21
118430 SHD Mn 10.0 29.29 40.82 0.14
118645 LHD Mn 8.0 13.39 10.33 0.08
118676 LHD Mn 0.5 28.23 23.51 0.08
118677 LHD Mn 0.5 24.40 14.87 0.06
119077 SHD Mn 8.1 21.03
119145 SHD Mn 15.0 23.18 30.73 0.13
119163 SHD Mn 1.8 30.55 24.13 0.08
119165 SHD Mn 4.0 15.39 21.42 0.14
119282 Siamese Mn 13.0 2.00 14.86 0.74
119364 Siamese F 9.6 23.88 32.68 0.14
119415 SHD Fn 9.0 23.58
119451 SHD Mn 8.5 9.99 19.66 0.20
119556 DR M 0.5 17.96 25.65 0.14
119624 SHD Mn 14.0 33.51 25.08 0.13
119856 SHD Mn 2.0 18.52 20.97 0.11
119898 Birman Fn 12.0 28.73 25.08 0.09
120191 SHD Mn 13.0 18.19
120466 SHD Fn 13.0 23.47 15.40 0.07
120532 SHD Fn 15.0 20.96 19.24 0.09
121224 SHD Fn 12.0 23.13 26.25 0.11
121273 Siamese Mn 0.6 21.78 20.78 0.10
121501 LHD Mn 5.0 14.80 15.05 0.10
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Case number Breed Sex Age Total T4 (nmol/1) Free T4 (pmol/1) % free T4
121548 SHD Mn 7.0 14.59 29.89 0.20
121563 SHD Fn 5.6 16.11 16.80 0.10
122198 SHD Mn 14.0 22.95
122298 Siamese Mn 1.9 20.30 22.19 0.11
122354 Siamese Mn 9.0 12.77 23.35 0.18
122377 LHD Mn 10.0 20.82 19.51 0.09
122548 LHD Mn 2.0 20.94 29.38 0.14
122578 SHD Fn 15.6 7.01 16.92 0.24
122648 SHD Fn 13.0 11.36 12.69 0.11
122677 SHD Mn 5.0 30.76 34.89 0.11
SHD, Short haired domestic 
LHD, Long haired domestic 
BB, British Blue 
DR, Devon Rex 
M, Male
Mn, Castrated male 
F, Female
Fn, Ovariohysterectomised female
The case number refers to the hospital number at the Small Animal Clinic, University of 
Glasgow Veterinary School.
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Serum total and free thyroxine (T4) concentrations and the calculated free T4 fraction in 95
hyperthyroid cats.
Case number Breed Sex Age Total T4 (nmol/1) Free T4 (pmol/1) % free T4
98872 SHD Mn 15.0 51.60
109077 SHD Fn 15.2 74.77
109692 SHD Mn 9.4 65.02
113280 SHD Mn 11.0 161.78
113578 LHD Mn 15.0 60.27
113607 SHD Fn 12.6 79.76
113632 Persian Mn 10.0 46.57
113635 SHD Fn 13.0 382.05
113704 LHD Mn 16.0 54.84
114166 SHD Mn 13.0 97.51
114332 SHD Fn 10.0 546.20
115020 SHD Fn 11.6 193.30 218.63 0.11
115628 SHD Fn 15.0 400.77 281.63 0.07
115649 SHD Mn 12.0 67.74
115713 SHD Mn 14.0 82.14
115931 SHD Mn 11.5 151.71
115935 SHD Fn 14.5 98.73
116055 SHD Mn 15.5 79.21
116057 SHD Fn 14.0 147.60
116059 SHD Mn 14.5 111.11
116203 SHD Fn 13.0 117.70
116438 SHD Mn 14.0 200.81
116588 SHD Mn 11.0 210.60
116681 SHD Mn 14.0 76.40
116742 SHD Fn 12.0 282.70 347.06 0.12
116746 SHD Fn 15.7 270.96
116862 SHD Mn 13.0 58.65
116890 LHD Fn 13.0 220.70
116982 SHD Fn 11.6 187.73 242.47 0.13
116986 SHD Mn 16.1 505.80 649.84 0.13
117085 SHD Mn 16.0 167.61
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Case number Breed Sex Age Total T4 (nmol/1) Free T4 (pmol/1) % free T4
117093 LHD Fn 15.0 214.49
117099 SHD Mn 16.0 181.72
117265 LHD Fn 11.1 93.03 105.91 0.11
117449 SHD Mn 15.0 294.48 208.09 0.07
117454 SHD Fn 14.0 146.72 174.90 0.12
117456 SHD Mn 12.0 165.57
117670 SHD Fn 14.1 271.37 252.41 0.09
117703 SHD F 18.0 144.52
117727 SHD Mn 12.0 152.98 183.21 0.12
117732 SHD Fn 17.0 168.43
117790 SHD F 10.0 167.69
117793 SHD Fn 13.0 165.87
117850 SHD Fn UK 272.50 687.61 0.25
117880 SHD Fn 10.0 43.83 46.88 0.11
117958 LHD Mn 14.5 191.56
118405 SHD Fn 15.0 167.32 199.39 0.12
118406 SHD Fn 14.6 287.80
118483 SHD Fn 11.0 98.21 101.89 0.10
118629 SHD Mn 13.0 110.94 121.70 0.11
118681 SHD Fn 11.0 296.30
118694 SHD Fn 14.0 172.80 232.47 0.13
118746 SHD Fn 14.0 62.88
119072 SHD Mn 10.5 62.34 91.83 0.15
119140 LHD Fn 9.0 95.31
119150 SHD Fn 15.0 117.31 115.46 0.10
119160 SHD Fn 10.0 575.57 635.01 0.11
119218 SHD Mn 13.0 296.19 240.26 0.08
119239 SHD Fn 15.0 214.64
119330 SHD Mn 12.0 143.69
119408 SHD Fn 12.6 167.81
119480 SHD Mn 10.0 78.29
119489 SHD Fn 9.0 70.60
119521 LHD Fn 14.0 309.15 381.14 0.12
119919 SHD Mn 10.0 78.29
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Case number Breed Sex Age Total T4 (nmol/1) Free T4 (pmol/1) % free T4
119940 SHD Mn 14.6 93.57
120189 SHD Mn 12.2 90.73 74.57 0.08
120207 SHD Fn 14.0 178.43 160.41 0.09
120395 SHD Mn 16.0 95.92 65.30 0.07
120467 SHD Fn 19.0 101.26 122.78 0.12
120473 SHD Fn 12.0 138.56
120712 SHD Mn 9.0 232.18
120713 SHD Fn 14.0 114.17
120819 Persian Fn 14.0 194.56
121015 SHD Mn 14.0 105.19
121027 SHD Fn 15.6 150.84
121116 SHD Mn 10.0 39.69
121427 SHD Fn 11.5 156.64
121534 SHD Fn 13.3 130.18
121561 SHD Fn 13.0 112.74
121646 SHD Fn 10.0 128.12
121778 LHD Fn 14.0 78.41
121785 SHD Mn 16.0 129.28
121801 SHD Mn 15.5 176.11
121853 SHD Fn 16.0 98.00
122097 SHD Fn 14.0 245.17
122102 SHD Fn 12.0 264.44
122175 SHD Fn 14.0 124.27
122205 SHD Fn 11.0 137.10
122254 SHD Fn 18.0 97.15
122256 SHD Mn 10.5 179.31
122278 SHD Fn 14.0 91.98
122346 SHD Fn 11.0 122.55
122381 SHD Fn 12.0 158.24
122528 SHD Mn 12.0 196.43
SHD, Short haired domestic 
LHD, Long haired domestic 
Mn, Castrated male
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F, Female
Fn, Ovariohysterectomised female 
UK, unknown
The case number refers to the hospital number at the Small Animal Clinic, University of 
Glasgow Veterinary School.
APPENDIX 13
153
Serum total and free thyroxine (T4) concentrations in 50 cats prior to and 30 days after 
administration of radioactive iodine ( ^  4 )  for the treatment of hyperthyroidism The ^  4  
was administered intravenously in the first 27 cases, and subcutaneously in the remainder.
Case number Dose of 13 lj 
(MBq)
Pre total T4 
(nmol/1)
Pre free T4 
(pmol/1)
Post total T4 
(nmol/1)
Post free T4 
(pmol/1)
115020 100 193.30 218.63 6.94 5.76
115628 150 400.77 281.63 61.46 54.28
116057 120 147.60 3.24
116438 160 200.81 84.44
116588 150 210.60 8.12
116681 120 76.4 10.32
116742 160 282.70 347.06 11.00 7.18
116982 160 187.73 242.47 2.00 1.00
116986 160 505.80 649.84 2.71 1.00
117265 150 93.03 105.91 14.04 13.77
117449 150 294.48 208.09 30.49 37.11
117403 180 86.67 125.50 69.34 52.55
117454 170 146.72 174.90 3.60 1.48
117670 160 271.37 252.41 12.13 12.33
117727 180 152.98 183.21 4.03 5.18
117850 160 272.50 687.61 27.36 40.96
117880 100 43.83 46.88 9.31 12.66
118405 140 167.32 199.39 3.36 1.00
118483 110 98.21 101.89 10.63 12.73
118629 150 110.94 121.70 12.99 17.76
118694 160 172.80 232.47 3.47 4.70
119072 110 62.34 91.83 7.64 9.94
119160 160 575.57 635.01 175.73 186.13
119150 150 117.31 115.46 2.00 1.00
119218 130 296.19 240.26 6.40 2.41
119489 140 70.60 8.58
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Case number Dose o fl3 1 l 
(MBq)
Pre total T4 
(nmol/1)
Pre free T4 
(pmol/1)
Post total T4 
(nmol/1)
Post free T4 
(pmol/1)
119521 200 309.15 381.14 16.39 34.35
119940 130 93.57 9.09
120189 120 90.73 74.57 22.98 17.24
120207 160 178.43 160.41 6.09 1.00
120395 150 95.92 65.30 12.41 9.32
120467 170 101.26 122.78 75.61 104.36
120712 140 232.18 9.68
120713 150 114.17 2.00
120819 170 194.56 2.00
121027 120 150.84 5.14
113607 130 79.76 6.90
121015 140 105.19 14.67
121427 160 156.64 2.39
121561 130 112.74 24.04
121646 140 128.12 6.73
121778 130 78.41 13.25
121801 150 176.11 5.12
121853 167 98.00 2.00
122102 150 264.44 9.12
113635 110 382.05 35.46
122097 120 245.17 13.29
122205 100 137.10 8.16
122256 130 179.31 36.44
122346 80 122.55 21.10
The case number refers to the hospital number at the Small Animal Clinic, University of 
Glasgow Veterinary School.
GLOSSARY
ACTH adrenocorticotropin hormone
AP alkaline phosphatase
ALT alanine aminotransferase
AST aspartate aminotransferase
BEI butanolol-extractable iodine
CBPA competitive protein-binding displacement assay
c.v. coefficient of variation
EDTA ethylenediamine tetraacetic acid
ELISA enzyme-linked immunosorbent assay
FCoV feline coronovirus
FeLV feline leukaemia virus
FIV feline immunodeficiency virus
FIP feline infectious peritonitis
FTI free thyroxine index
HDL high density lipoprotein
IgM immunoglobulin M
130j l^Ojodj^e
13 lj l^llodine
kBq kilo Becquerel
LDH lactate dehydrogenase
MBq Mega Becquerel
mR/hour milliRoentgens/hour
n number of observations
NSB non-specific binding
PBI protein-bound iodine
RIA radioimmunoassay
rT3 3,3',5'-L-triiodothyronine (reverse T3)
sd standard deviation
sem standard error of the mean
T3 3,5,3'-triiodothyronine
T4 3,5,3',5'-L-tetraiodothyronine (thyroxine)
TBG thyroxine-binding globulin
TBPA thyroxine-bindingprealbumin
TC total count
99nrrc 0 4  pertechnetate
THUT thyroid hormone uptake test
TRH thyrotropin releasing hormone
TSH thyroid stimulating hormone (thyrotropin)
VLDL very low density lipoprotein
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